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ABSTRACT 
In response to DNA damage, two general but fundamental processes occur in the 
cell: (1) a DNA lesion is recognized and repaired, and (2) concomitantly, the cell halts 
the cell cycle to provide a window of opportunity for repair to occur. A key factor 
involved in the DNA damage response is the heterotrimeric protein complex Replication 
Protein A (RPA), which is not only essential for the repair of damaged DNA, but also is 
post-translationally modified on at least two of the three subunits in response to DNA 
damage by checkpoint kinases. Of particular interest is the 32-kDa subunit, called Rpa2, 
which is hyper-phosphorylated on its serine/threonine-rich N-terminus following DNA 
damage in human cells. This unstructured N-terminus is often referred to as the 
phosphorylation domain (PD) and is conserved amongst eukaryotic Rpa2 subunits, 
including Rfa2 in Saccharomyces cerevisiae. In this work we aim to characterize the 
function of Rfa2 N-terminus (Rfa2 NT) in DNA damage response and develop yeast as a 
tool to study human RPA. 
With the help of mutagenesis we developed Rfa2 NT extreme mutants, which 
showed that the phosphorylation of Rfa2 NT is dispensable in DNA damage response. 
However, the presence of Rfa2 NT is essential for cells to survive in stressed condition 
indicating an uncharacterized function. We further discovered seven S/T sites are 
responsible for the damage sensitive phenotype of Rfa2 NT extreme mutants. And the 
phosphorylation affects protein interaction of RFA complex.  
Although, the phosphorylation event of Rfa2 NT is dispensable in S. cerevisiae 
the cells have conserved the ability to phosphorylate Rfa2 N terminus. With the help 
Rfa2 NT fusion mutants we showed that S. cerevisiae could phosphorylate N terminus 
 	   iv
from seven different eukaryotic species. Hence, we successfully developed yeast as a tool 
to study Rpa2 phosphorylation amongst various eukaryotic species.   
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CHAPTER 1. REPLICATION PROTEIN A (RPA): A KEY PLAYER IN DNA 
METABOLISM 
Introduction 
Replication Protein A (RPA) is a single-stranded DNA (ssDNA) binding protein 
conserved in all eukaryotes. It is a heterotrimeric complex composed of Rpa1 (70 kDa), 
Rpa2 (32 kDa) and Rpa3 (14 kDa). All the three subunits are essential, as deletion of any 
one subunit renders cells nonviable in Saccharomyces cerevisiae (BRILL and STILLMAN 
1991). This indicates the importance of this complex and the necessity for maintaining 
the integrity of the complex for cell survival. Replication Protein A was first discovered 
as a factor essential for Simian Virus 40 (SV40) replication in vitro (WOLD and KELLY 
1988). It is noteworthy that all three subunits were required for the SV40 DNA replication 
(KENNY et al. 1990; UMBRICHT et al. 1993). Since its discovery, RPA is known to have 
role in numerous cellular processes. These processes include DNA replication, repair, 
recombination, cell cycle regulation and telomere maintenance (OAKLEY and PATRICK 
2010a). These various roles indicate that RPA is central to all DNA metabolic processes 
and is touted as the regulator of “DNA metabolic traffic”.  
By virtue of its indispensable role in DNA metabolism, RPA is linked to have a 
role in cellular diseases arising from genetic mutations (e.g. cancer). Elevated RPA 
expression has been linked to many cancers; like cervical, esophageal, and colon cancer 
(PETERS et al. 2001; TOMKIEL et al. 2002; GIVALOS et al. 2007; KANG et al. 2009). When 
RPA expression was knocked down in esophageal cancer cells, the previously 
radioresistant cells showed enhanced radiosensitivity (DI et al. 2014). In esophageal 
cancer, an elevated RPA expression was observed in tumor cells compared to the 
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adjacent non-tumor tissues (DAHAI et al. 2013). The RPA overexpression is reported as a 
prognostic indicator in many cancers (LEVIDOU et al. 2011).  
Although no naturally occurring RPA mutations have been linked to human 
cellular diseases, the RPA complex has been directly implicated in maintaining genomic 
integrity to prevent cancer formation in mammals. In mice, a missense mutation in Rpa1 
(L221P) leads to lymphoid tumors (WANG et al. 2005). In humans, when rpa1-L221P 
mutation was tested it caused defects in replication and repair and does not allow the cell 
to progress through the cell cycle (HASS et al. 2010). Since the RPA complex is central to 
all DNA processes known to be important in maintaining the genomic integrity, further 
understanding of its cellular roles furthers understanding of its cellular roles and may 
provide information as to how RPA might serve as a therapeutic target for cancer. 
RPA structure and conservation amongst species 
RPA structure 
The RPA complex binds single-stranded DNA (ssDNA) via six oligonucleotide 
/oligosaccharide binding fold (OB fold) domains to protect it from nucleases and 
secondary structure formation (Figure 1.1). The 70 kDa (largest) Rpa1 consists of four 
DNA-binding domains (DBDs), while the 32 kDa Rpa2 subunit and the 14 kDa Rpa3 
subunit each contain one DBD (FANNING et al. 2006a). Rpa2 also has a winged-helix 
domain at its carboxyl-terminus (C-terminus) and is shown to be important for protein-
protein interactions (NAGELHUS et al. 1997a; PARK et al. 2005; ARUNKUMAR et al. 2005). 
Structural analysis has revealed that Rpa1 DBD-C, Rpa2 DBD-B and Rpa3 (DBD-E) are 
important for heterotrimerization of RPA complex (BOCHKAREVA et al. 2000). The Rpa2 
N terminus is unstructured and appears to have co-evolved with Rpa1 N terminus, as both  
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Figure 1.1: A block diagram showing structural features of the RPA complex. The 
RPA complex has six OB-folds represented here as the DBD A-F. The trimerization 
core represents the region important fo heterotrimeric complex formation. The most 
important regions in ssDNA-binding are DBD-A and DBD-B. The DBD-F, DBD-A and 
is involved in protein-protein interactions; similarly the C-terminus of Rpa2 is also 
thought to participate in interactions with other proteins. The N- terminus of Rpa2 
(represented by P) is S/T rich domain and undergoes hyper-phosphorylation in response 
to DNA damage in human.  
 
domains are missing in archaeal (CHÉDIN et al. 1998).The DBD-E participates in the 
trimerization of the complex and not yet known to be involved in any other function of 
RPA (WOLD 1997; FANNING et al. 2006b).    
RPA forms a highly stable complex. Human RPA is stable in up to 6M Urea and 
2M HCl (WOLD 1997). Soluble RPA has only been obtained as the complete trimeric 
complex or as a sub-complex of Rpa2 and Rpa3. Rpa1 does not form a soluble complex 
when expressed with either Rpa2 or Rpa3 alone (WOLD 1997). Similar results were 
observed when the Schizosaccharomyces pombe subunits were co-expressed in 
Escherichia coli (ISHIAI et al. 1996).   
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RPA across species 
The non-eukaryotic ssDNA-binding proteins (SSBs) are generally monomers or 
homo-oligomers (LOHMAN and FERRARI 1994). The eukaryotic SSB (i.e. RPA) differs in 
that it is a heterotrimer, yet SSB functions are conserved. Dr. Marc Wold reviews the 
sequence comparisons of RPA subunits in detail (WOLD 1997). This review states that, 
Rpa1 is better conserved across species as it shows more sequence similarity as compared 
to the other two subunits.  
RPA exists as two different complexes in human cells. These have been termed as 
the canonical and alternative RPA complexes. In the alternative RPA complex, Rpa2 
subunit is substituted by its homologue Rpa4 (KESHAV et al. 1995; KEMP et al. 2010). 
The canonical RPA supports both in vitro and cellular (in vivo) DNA replication whereas 
alternative RPA does not (HARING et al. 2010). This indicates that RPA subunit 
homologs in the same species can drive the RPA complex to have differential functions.  
Plants are somewhat unique in that they often have multiple RPA subunit 
homologs. In Arabidopsis thaliana, there are five homologs of Rpa1 and two each for 
Rpa2 and Rpa3 and sub-compartmentalization of various homologs is observed (CHANG 
et al. 2009; ESCHBACH and KOBBE 2014). These homologs form different RPA 
complexes and each displays differential function. In Oryza Sativa there are three 
homologs of Rpa1 and Rpa2 each, while only one Rpa3 exists. These form various 
complexes and have different subcellular distribution in plant tissues (ISHIBASHI et al. 
2001, 2006). Thus far, plants and mammals are the only eukaryotic species where 
multiple RPA homologs have been identified to function in distinct RPA complexes that 
may be necessary for different cellular functions in cells. 
 	   5 
DNA-binding properties of RPA 
RPA binds ssDNA as a heterotrimeric complex with an affinity of 109-1011 M-1 
(KIM et al. 1994). RPA complex has the ability to bind double stranded DNA (dsDNA) 
and RNA but with three folds lower affinity as compared to ssDNA binding affinity (KIM 
et al. 1992). Both human and yeast RPA binds poly-pyrimidine rich sequences and binds 
with a defined 5’-3’ polarity (KIM et al. 1992; IFTODE and BOROWIEC 2000). However, 
the sequence specificity is dispensable for RPA function.   
The dsDNA-binding property of RPA is important for interaction with 
transcription regulation elements like 5’UTR sequences, the importance of which is 
unknown. The dsDNA-binding activity is important for helix destabilization by RPA 
(LAO et al. 1999). Also the RPA complex binds damaged ds DNA, which may have a 
role in repair (BURNS et al. 1996; PATRICK and TURCHI 1998). Both these activites 
suggest that the RPA binds damaged DNA and destabilizes the helix, so the ssDNA is 
available for processing. Interestingly, dsDNA-binding activity is reduced in presence of 
hyper-phosphorylated Rpa2 NT (OAKLEY et al. 2003).  RPA binds the ssDNA utilizing 
domains A-D, with the DBD-A and DBD-B being the most important (BOCHKAREVA et 
al. 2001a).The four aromatic amino acids important for Rpa1 binding to ssDNA are 
located in these domains, two of which are conserved in eukaryotes and E. coli 
(PHILIPOVA et al. 1996; WALTHER et al. 1999) .  
The binding of RPA is dependent on the length of ssDNA. In fact there are four 
ssDNA-binding modes of RPA proposed (Figure 1.2): (a) binding of RPA to ssDNA is 
initiated by DBD-A; and binds around five nucleotides. (b) As the binding progresses 
DBD-A and B bind around 8-10 nucleotides. (c) DBD-C is thought to bind next, but if it 
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binds with DBD-D simultaneously is unclear. It was shown that the DBD-C and DBD-D 
contribute in ssDNA-binding synergistically (BOCHKAREVA et al. 2000). (d) RPA 
complex can bind around 27-30 nucleotide sequences and requires all four DNA-binding 
domains A to D. (BOCHKAREVA et al. 2001b, 2002; BASTIN-SHANOWER and BRILL 2001; 
FANNING et al. 2006a). The N-terminus of both Rpa1 and Rpa2 do not appear to 
participate in ssDNA-binding activity, but are important in protein binding and 
interaction with DNA substrates (e.g., 5’ssDNA/dsDNA junctions). The N terminus of 
Rpa2 is modified by phosphorylation (FANG and NEWPORT 1993; LIU et al. 2006). 
 
 
 
Figure 1.2: Different modes of ssDNA-RPA interaction. The ssDNA-binding of RPA 
is initiated through DBD-A of Rpa1. DBD-A and DBD-B bind 8-10 nucleotide sequence. 
DBD-C of Rpa1 and DBD-D of Rpa2 contribute to 28-30 nucleotide sequence binding. 
The N-terminal regions of both Rpa1 and 2 do not contribute detectably to ssDNA-
binding by RPA. 
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RPA-protein interactions and cellular function 
Single-stranded DNA is an intermediate product of all the DNA processes 
involving duplication and repair of DNA. RPA binds ssDNA with high affinity, so in 
order to access the ssDNA and complete a particular DNA process, one of the two things 
must happen: (1) the RPA complex must be displaced from the ssDNA in order to 
facilitate interaction of ssDNA with another protein(s) and /or (2) RPA must interact with 
the incoming protein to recruit it to ssDNA site. In both cases, the interaction of RPA 
with other protein partners is essential to complete the ongoing DNA metabolic process. 
In this section, known RPA-protein interactors are discussed. 
Protein interactions in replication 
RPA was discovered as a factor essential for SV40 DNA replication. The human 
RPA interacts with SV40 large T antigen and DNA polymerase alpha (pol α) 
(DORNREITER et al. 1992).  Thus RPA assists in DNA unwinding initiating pol α activity. 
In mouse, RPA interacts with MCM complex components (Mcm2, Mcm4 and Mcm6) as 
well as Orc2, all proteins important in replication initiation (KNEISSL et al. 2003). RPA 
also plays a role in other stages of DNA replication. Dna2 is an ATP dependent 
helicase/nuclease important in Okazaki fragment processing. RPA interaction with Dna2 
occurs via Rpa1 NT and is required for maximum activity of Dna2 (BAE et al. 2003).        
Protein interactions in repair 
RPA interacts with xeroderma pigmentosum damage-recognition protein (XPA), 
but only Rpa1 is necessary for the interaction. The RPA interaction enhances the ability 
of XPA to bind damaged DNA (LI et al. 1995). RPA also binds the endonuclease XPG 
involved in damage recognition and repair and XPF-ERCC1 (HE et al. 1995; FISHER et 
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al. 2011). Loss of RPA interaction with XPF-ERCC1 leads to mislocalization of XPF and 
loss of nucleotide excision repair (NER) activity. RPA plays an important role in 
nucleotide excision repair presumably through the coordination of a number of proteins 
involved in NER via.  
Base excision repair (BER) is a pathway whereby specific chemical changes in 
the DNA structure are recognized. These include the 8-OxoG, a product of oxidative 
stress (G pairs with A instead of C). Or when cytosine is converted to uracil by 
hydrolysis it can pair with Adenine causing mutation. As compared to the NER pathway 
BER acts on smaller adducts and repairs short patches. Base excision repair requires 
DNA glycosylase activity. Incidentally RPA interactions with DNA glycosylases UNG2 
and hMYH have been reported, indicating a role of RPA in BER (NAGELHUS et al. 
1997b; MER et al. 2000; PARKER et al. 2001). The importance of these interactions is 
unclear in cells.  
After recognition of a mismatched basepair(s), the base is removed and the DNA 
from one strand is removed by exonucleases. This sequence is then filled in to repair the 
DNA lesion. The resection of DNA is carried out by EXOI exonuclease. RPA functions 
in inhibiting the exonuclease activity thus regulating MMR. This activity of RPA was 
thought to be dependent on MutLα but later was dismissed due to lack of evidence 
(GENSCHEL and MODRICH 2003, 2009).     
RPA interacts with a variety of DNA repair proteins especially helicases. RPA is 
reported to interact with BLM, WRN and RecQ helicases to enhance their helicase 
activity (BROSH et al. 1999, 2000; SOMMERS et al. 2005). These interactions are 
important to unwind the DNA duplex and have a role in replication and repair. The 
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SMARCAL1 is an ‘annealing helicase’, meaning it stabilizes the replication fork through 
the reformation of dsDNA. SMARCAL1 interacts with RPA1; this interaction is thought 
to be important in removal of RPA from ssDNA and activation fork stabilization (BHAT 
et al. 2015).   
Protein interactions in recombination 
One of the ways to fix double stranded break is through homologous 
recombination (HR). Once the DNA break is recognized, the DNA strands are resected in 
a 5’→3’ direction generating 3’ ssDNA overhangs that are bound by RPA. To facilitate 
HR, RPA is displaced by Rad52, which assists in the loading of Rad51 onto (and 
displacement of Rad52 from) the ssDNA. This Rad51-ssDNA filament then invades 
homologous DNA resulting in the formation of a Holliday junction (HJ). Once the 
homology is established the damaged strand is fixed by DNA synthesis and resolution of 
HJs.  
RPA interacts with proteins involved in homologous recombination. This includes 
proteins of the MRN (Mre11-Rad50-Nbs1) complex which is required for 5’→3’ 
resection of broken DNA (SHIBATA et al. 2014). Specifically, RPA interacts with Mre11 
and Nbs1 through Rpa1 NT. These interactions were characterized in vitro, and the 
molecular mechanism for how MRN-RPA interaction facilitates homologous 
recombination is unclear. A potential explanation is discussed in following sections. The 
interaction of RPA with Rad52 has been demonstrated to require both the Rad52 C-
terminus and both the Rpa2 NT and Rpa1 DBD-A and DBD-B (JACKSON et al. 2002). 
Rad51 interacts with Rpa1 DBD-A, an interaction important in exchanging ssDNA 
between RPA and Rad51 (STAUFFER and CHAZIN 2004).  In addition to DBD-A and 
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DBD-B, the Rpa1 NT has also been demonstrated to be involved in HR through studies 
of the rfa1-t11 mutation located in DBD-F. This mutant is recombination deficient and 
this deficiency is proposed to be due to the slow displacement of RPA from ssDNA by 
Rad51 observed in rfa1-11 (KANTAKE et al. 2003).  
Other protein interactions 
The p53 protein is a tumor suppressor protein. In response to DNA damage, p53 
is activated and it triggers a cell cycle checkpoint, replication arrest, and sometimes even 
induces apoptosis. p53 (aa 38-58) interacts with RPA (Rpa1 aa 1-120) and inhibits RPA 
activity in SV40 replication (DUTTA et al. 1993). The sequestration of p53 by RPA results 
in down-regulation of p53 mediated transcription resulting in down-regulation of 
apoptosis (KAUSTOV et al. 2006; RAJAGOPALAN et al. 2010).The hyper-phosphorylated 
RPA does not interact with p53, releasing it to activate damage response (ABRAMOVA et 
al. 1997). Another tumor suppressor protein; BRCA2 also interacts with RPA only in 
humans. This interaction is of interest, because the cancer-predisposing mutation Y42C 
in Brca2 disrupts interaction with RPA (WONG et al. 2003). This indicates that RPA 
interaction with Brca2 has important role in prevention of cancer formation, presumably 
through regulation of regulation of DNA replication and repair. 
RPA is phosphorylated by phosphatidylinositol-3 kinase-related kinase (PIKK) 
family of kinases (e.g.,ATM, ATR, and DNA-PK) in response to DNA damage (LIU et 
al. 2012). The ATM and ATR are well known checkpoint kinases involved in the DDR to 
cause cell cycle arrest (i.e.,checkpoint activation). RPA physically interacts with these 
kinases. Since RPA is the first responder to bind ssDNA generated in response to DNA 
damage, RPA activation is one of the early steps in checkpoint activation. The ATR 
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interacting protein (ATRIP) is important in recognition of ssDNA coated with RPA and 
mediates the ATR-ATRIP interaction with RPA. This is true in both yeast and human 
cells. Another set of proteins necessary for normal cellular checkpoint response is Rad17-
Rfc2-5 complex and Rad9-Rad1-Hus1 (9-1-1) complex (MAJKA et al. 2006).The RPA 
recruits the 9-1-1 damage clamp to DNA through interaction with Rad17-RFC. RPA 
further interacts with Rad9 and Hus1to establish proper checkpoint activation (WU et al. 
2005; JANKE et al. 2010). 
Post-translational modification of RPA 
RPA phosphorylation 
RPA phosphorylation is extensively studied; especially in human cells.  However, 
the role of this post-translational modification still remains obscure. The human Rpa2 N-
terminus (Rpa2 NT) consists of nine serine/ threonine (S/T) residues within first 35 
amino acids (>25%). The Rpa2 NT is phosphorylated in cell cycle-dependent manner in 
humans, S. cerevisiae, Schizosaccharomyces pombe and Xenopus laevis. This 
phenomenon appears to be conserved in all eukaryotes, although the importance of this is 
unclear, phosphorylated human Rpa2 had no effect on in vitro SV40 DNA replication 
(PAN et al. 1995).  
The damage response of cells can be broadly divided into four steps (1) DNA 
recognition and initial processing of DNA lesion, (2) Checkpoint activation to halt the 
cell cycle and DNA replication until the damage is repaired, which includes replication, 
(3) recruitment of factors necessary to further process and repair the damage, and (4) the 
resumption of cell cycle following repair. As mentioned previously, RPA participates in 
and/or recruits factors for all of the steps following lesion recognition. In response to 
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DNA damage Rpa2 NT becomes hyper-phosphorylated in human cells. The kinases 
ATM, ATR and DNA-PK have been identified to phosphorylate Rpa2 NT in response to 
DNA damage, and these reactions require priming (LIU et al. 2012). The Rpa2 NT 
phosphorylation sites, the kinases involved and priming patterns summarized by Liu et al 
are shown in Figure 1.3. Hyper-phosphorylation of Rpa2 NT regulates cellular RPA 
function, potentially through regulation of RPA interactions with many factors necessary 
to carry out DNA replication, repair and cell cycle regulation.  
	  	  
Figure 1.3: A figure from Liu et al 2012 showing the Rpa2 NT phosphorylation 
pattern. Reprinted (Figure-9) from Nucleic Acid Research 40 (11) Liu et al. 2012, 
10780- 10793, with permission from Oxford journals (License number 3603810892063) 
A) The PIKKs/ CDK phosphorylate subset of sites on Rpa2 NT B) The priming pattern 
of Rpa2 NT phosphorylation lead by specific sites.    
 
With respect to checkpoint activation, it has been demonstrated that RPA hyper-
phosphorylated on Rpa2 NT does not interact with p53, presumably releasing p53 to 
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activate the DNA damage response (ABRAMOVA et al. 1997). Also, both ATR-ATRIP 
and 9-1-1 (Rad9- Rad1-Hus1) complex are important for the ATR mediated checkpoint 
response. Although Rpa1 NT is important for interaction with both ATRIP and Rad9 
(WU et al. 2005; BALL et al. 2007). The Rad9 interaction is also dependent on Rpa2 and 
is modulated by Rpa2 NT hyper-phosphorylation. In fact, Rad9 precipitation was only 
observed in presence of hyper phosphorylated Rpa2 (WU et al. 2005). This indicates a 
role of Rpa2 NT hyper-phosphorylation in establishing checkpoint arrest.  
Once the cells are arrested from progressing through the cell cycle, the DNA 
damage intermediate must be further processed and repaired. RPA has been shown in 
yeast to not only control initial processing of a DNA lesion (e.g., regulates resection 
length after DSB), but also to control how an ssDNA intermediate is processed. 
Homologous recombination is one to repair DNA damage that arises from DSB. As 
mentioned previously, Rad51 and Rad52 are important for displacing RPA from ssDNA 
and performing strand invasion to repair the DNA. Rpa2 NT hyper-phosphorylation is 
reported to enhance the interaction of RPA with these proteins in humans (DENG et al. 
2009).  
Once the damage is repaired the cell cycle is resumed. Recent studies indicate a 
probable role of Rpa2 NT in recovery after DNA damage. In humans, the hyper-
phosphorylated Rpa2 recruits partner and localizer of BRCA2 (PALB2) to the replication 
fork to stabilize them after replication stress (MURPHY et al. 2014). In Candida albicans 
it was demonstrated that the de-phosphorylation of Rfa2 in by PPH3 is important in 
normal G1 cycle, as well as in response to replication stress (WANG et al. 2013). It has 
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also been shown that RPA, and specifically Rpa2 N-terminus may be important for 
release from a checkpoint. 
Rpa2 hyper-phosphorylation has been associated with decreased replication, in 
UV irradiated cells (OLSON et al. 2006). A hyper-phosphorylation mimetic mutant of 
Rpa2 NT recruits RPA away from the replication centers (VASSIN et al. 2004).  
A phospho-mimetic Rpa2 NT peptide was shown to interact with the Rpa1 N-
terminus peptide, in solution via NMR data (BINZ et al. 2003). Given that many proteins 
for which the location of the interaction has actually been mapped to interact with Rpa1 
N-terminus, this provides a convenient model for how Rpa2 hyper-phosphorylation 
regulates protein interactions. Mre11 interacts with Rpa1 through its N-terminus, and this 
interaction is decreased in presence of phosphorylated Rpa2 (OAKLEY et al. 2009). 
Similarly, Rpa1 N-terminus is required for Dna2 interaction and this interaction is 
thought to get affected by phosphorylation of Rpa2 NT leading to inhibition of Okazaki 
fragment processing (OAKLEY and PATRICK 2010b). The NBS1 mutant deficient in RPA 
interaction fails to support proper recovery of replication fork (SHIOTANI et al. 2013). 
These data suggest that hyper-phosphorylated Rpa2 NT aids in replication arrest. 
Other post-translational modifications of RPA 
Rpa1 is sumoylated in vivo at lysine 449 and 577 (DOU et al. 2011). The Rpa1 
subunit is sumoylated by small ubiquitin-like modifier 2/3 (SUMO-2/3) in response to 
replication stress. The Rpa1 sumoylation facilitates the Rad51 recruitment, initiating 
homologous recombination repair (DOU et al. 2010). Both Rpa1 and Rpa2 are ADP-
ribosylated however whether this modification affects the function of RPA is unknown 
(EKI and HURWITZ 1991).        
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Specific aims of this study 
A common intermediate (ssDNA) is formed during most DNA metabolic 
processes (i.e. replication, repair and recombination). This makes the ssDNA-binding 
protein RPA central to each of these processes, and the importance of this complex is 
reflected to the fact that it is essential for cell survival. The field has progressed towards 
understanding the regulatory role of RPA, and many studies have focused on the hyper-
phosphorylation of Rpa2 as a means to enact the regulatory mechanism. However, RPA 
is involved in numerous cellular processes, and it is still relatively unclear how a single 
protein complex regulates coordinates these processes simultaneously is still relatively 
unclear. In the studies described in this dissertation we have attempted to decipher how 
RPA function in regulated through the use of genetics, molecular and cellular biology, 
and biochemistry studies in the model organism S. cerevisiae. The specific aims 
/hypotheses of each study in this thesis is as follows: 
1. Modifying yeast as a tool to study human RPA: Human RPA is of utmost 
interest, since further understanding its role may open new avenues for drug 
development against diseases like cancer. Currently, the best models available are 
the human cell lines derived mostly from cancerous cells are the best models 
available. These are expensive and hard to maintain. Furthermore human genome 
manipulation is difficult and tedious. Budding yeast on the other hand, are easy to 
maintain, non-pathogenic, and their genome is easily manipulated. We aimed to 
develop yeast cells as a tool to study human RPA in a simpler system (Chapter 2). 
2. Understanding the antagonistic function of Rpa2 and Rpa4: Rpa4 is a 
homolog of Rpa2 in human cells. These two genes form two separate complexes, 
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which have antagonistic functions at least with respect to DNA replication. We 
aimed to study the contradictory function of these two genes utilizing siRNA and 
yeast two-hybrid assays. We hypothesized that the ‘Rpa2/Rpa4 ratio decides the 
fate of cell cycle progression or arrest’. 
3. Yeast Rfa2 N-terminus phosphorylation: The Rpa2 NT is hyper-
phosphorylated in response to DNA damage. This post-translational modification 
of Rpa2 is extensively studied, but its function is not well understood in humans. 
Rfa2 in S. cerevisiae  (yeast Rpa2) is not well studied, although it has many 
putative phosphorylation sites on its N-terminus. In this study we hypothesized 
that Rfa2 NT is also phosphorylated and is important in inducing the DDR in S. 
cerevisiae. Mutation analyses were used to characterize the role of Rfa2 NT in 
yeast cells.      
4. Protein interactions of RPA complex: It is evident from literature that RPA 
coordinates cellular processes through various protein interactions. In order to 
understand the role of RPA complex in cells we need to gain insight into RPA-
protein interactions. We employed a yeast two-hybrid assay to uncover potential 
protein interactions of RPA. We aimed to determine if: (1) Rpa2 and Rpa4 utilize 
different protein network to establish opposing cellular functions, and (2) the 
protein-protein interactions of RPA complex are affected by phosphorylation state 
of yeast Rpa2 NT.      
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CHAPTER 2. STUDYING EUKARYOTIC RPA FUNCTION IN HUMAN TISSUE 
CULTURE AND IN BUDDING YEAST1 
Introduction  
Single-stranded DNA is a common intermediate generated in all DNA metabolic 
processes such as replication, repair, and recombination. The stabilization and protection 
of this intermediate is the basic biochemical function of RPA (FANNING et al. 2006). Any 
error in these processes can lead to DNA lesions which if untreated can lead to cellular 
diseases like cancer. To treat such diseases it is important to understand how these 
processes are regulated. In order to understand the molecular mechanisms of these 
processes, it is important to understand the function of each of the proteins involved in 
them. Our lab focuses on understanding the function of the RPA complex.  
Multiple forms of the RPA complex have different cellular functions 
As mentioned in chapter 1, RPA is a heterotrimeric complex consisting of Rpa1, 
Rpa2, and Rpa3. The complex is conserved in all eukaryotes. This complex although 
conserved in terms of function, does not show a lot of sequence similarity amongst wide 
variety of species (WOLD 1997). The major conserved protein is Rpa1 which was shown 
to be conserved in 36 different eukaryotic species (AVES et al. 2012). The most 
conserved regions are the DBDs, which are essential for ssDNA interaction. However, 
regions that appear to be important in RPA ‘regulatory functions’ (e.g., the Rpa1 N-
terminus; DBD-F), are not identifiable in lower eukaryotes (e.g., Crithidia fasciculata; 
BROWN et al. 1994). 
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The RPA complex can exist in a variety of forms that are proposed to perform a 
variety of functions. For example, in the plant species Arabidopsis thaliana, there exist 
five different homologs of Rpa1, two homologs of Rpa2, and two homologs of Rpa3 
(ESCHBACH and KOBBE 2014). In humans, Rpa4; a homolog of Rpa2 forms an alternative 
RPA complex (KESHAV et al. 1995a). The canonical form supports DNA replication 
while the alternative form does not (MASON et al. 2009; HARING et al. 2010a). But the 
alternative RPA complex is functional in repair and recombination (KEMP et al. 2010a). 
The antagonistic functions of these two complexes are not well understood. In this 
chapter I describe my attempts to develop tools to study the antagonizing function of 
canonical and alternative RPA complexes and the species-specific function of the Rpa2 
N-terminus.  
Yeast – an ideal model to study RPA 
Due to the complex nature of human cells and intrinsic difficulties in studying 
mutant forms of a protein and its long-term effects (beyond 1-2 generations), it is 
somewhat difficult to study RPA in human cells. Budding yeast on the other hand is easy 
to maintain and has a number of advantages as a model system, including: 
• Rapid growth rate, non-pathogenic nature, and comparatively smaller genome 
size. 
• Growth as dispersed cells facilitating replica plating and mutant isolation.  
• Highly efficient recombination machinery that makes yeast cells a great vehicle 
for gene cloning and manipulation of the genome. 
• Cells that exist as haploids or diploids, making them a good tool for genetic 
studies and recombination analysis. 
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• A large-range of genetic techniques developed in yeast, such as yeast two-hybrid 
analysis, that can help to understand protein function better.  
History and Hypothesis  
We wanted to develop a model yeast system in which the human RPA functions 
in yeast cells as a sole source of the ssDNA-binding complex. This system would be ideal 
to study human RPA, as it would provide a molecular toolbox not available for tissue 
culture, and many of the results could be extrapolated to human cells. It is evident from 
literature that such model system has been very useful to study certain proteins; an 
example would be studies with mitochondrial DNA polymerase (QIAN et al. 2014).  
However this was not the first attempt to clone, express, and examine function of 
a human RPA subunit in yeast. Human Rpa2 has been expressed in yeast cells where the 
endogenous RFA2 gene had been deleted (rfa2Δ::TRP1); however, the human protein did 
not allow for cell viability (i.e., human Rpa2 did not complement the rfa2 defect) (BRILL 
and STILLMAN 1991). A similar attempt has been made by replacing yeast RFA1 with 
human Rpa1; this was not successful (PHILIPOVA et al. 1996). Although these attempts 
indicate that individual human RPA subunits may not be able to support yeast cellular 
processes, we hypothesize that this is due to lack of formation of full RPA complex 
containing both yeast and human RPA proteins.  
The canonical and alternative forms have antagonistic functions to one another. 
Furthermore, given that Rpa4 is intronless and lies on the X chromosome, it has been 
proposed that Rpa4 and Rpa2 may have important functions in different stages of 
development. Expression of canonical RPA is important in cell proliferation. In fact 
increased expression of Rpa1 and Rpa2 is correlated to various cancers (KANAKIS et al. 
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2011) (LEVIDOU et al. 2011). On contrary, Rpa4 is expressed at different levels in 
different tissues examined and its expression is reduced in cancerous tissues (KESHAV et 
al. 1995b; KEMP et al. 2010b).Hence we hypothesize that the cellular ratio of Rpa2/Rpa4 
is a deciding factor towards cell proliferation or quiescence (Figure 2.1). 
  	  
Figure 2.1: Model of ratio Rpa2/Rpa4 determination cellular fate. The canonical 
RPA complex consists of Rpa2 (represented by blue) while the alternative RPA complex 
(aRPA) consists of Rpa4 (orange). The canonical RPA supports cell proliferation while 
aRPA supports quiescence.   
 
An effective technique to examine the importance of expression levels of a gene 
is through manipulation of its expression. In one such study, depletion of RPA in HeLA 
cells has been shown to slow S phase progression, G2/M cell cycle arrest through ATM 
activation, and apoptosis (DODSON et al. 2004). Rpa2 was found to be up-regulated in 
response to DNA damage by MMS in yeast (KIM et al. 2011). Elevated Rpa2 expression 
were correlated with survival of BRCA1 tumors (BOULEY et al. 2010). These data 
indicate that the manipulation of RPA expression is useful in depicting its function. In 
order to study our central hypothesis (Figure 2.1) we decided to manipulate RPA 
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expression by developing siRNA to target RPA subunits. We also worked on a TET-ON 
system to target overexpression of RPA subunits.  
This chapter discusses development of tools to study effect of the RPA subunit 
expression on cancerous human cell lines and yeast. We also studied the compatibility of 
the human RPA complex in budding yeast cells.  
Materials and Methods 
Strains, cell lines, and media 
The yeast strains used in these experiments are RMY122-A and EGY48. The 
RMY122-A (Appendix A) is a haploid strain with a chromosomal deletion of RFA1 and 
RFA2. These deletions are supported by supplementary plasmids expressing wild-type 
copies of RFA1 and RFA2 driven from their native promoters. This strain was utilized in 
plasmid shuffle assays. The EGY48 (Appendix A) strain is utilized in yeast two-hybrid 
assay and was also used for in vivo cloning by homologous recombination. YPD media is 
rich non-selective growth media that contains 2% dextrose, 1% yeast extract, and 2% 
peptone. Synthetic complete media contained 2% sugar (dextrose or galactose; SD or 
SG), 0.5% ammonium sulfate, and 0.17% yeast nitrogen base without amino acids. This 
media was then supplemented with the appropriate dropout amino acid supplement. YPG 
media was similar to YPD except it contained 3% glycerol instead of 2% dextrose.  
The different types of human cell lines utilized in the development and study of 
human RPA subunit expression were HEK293T, HT29, and DLD1. The HEK293T cell 
line was maintained in DMEM medium (10% FBS) in 5% CO2 at 37°C. The HT29 cell 
line was maintained in McCoy’s 5A medium (10% FBS) in 5% CO2 at 37°C. The DLD-1 
cell line was maintained in RPMI medium (10% FBS) in 5% CO2 at 37°C.  
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Polymerase chain reaction and cloning  
The primers designed for amplifying different RPA genes from the template 
pEGFP-RPA plasmid series were unique to incorporate ends homologous to pJM132 to 
develop a vector expressing all RPA genes (primers O-1 to O-10 Appendix B). Two 
micrograms (2 µg) of pJM132 plasmid DNA was digested with an appropriate restriction 
enzyme in a total of 20µl reaction. About 1/3 of the confirmed PCR product and 10 µL of 
digested DNA were co-transformed into EGY48 cells. The cells were then plated onto 
SD-Ura (lacking uracil) media and allowed to grow at 30°C for 3 days. A scrape of 
multiple colonies from these plates was used to start a culture in SD-Ura liquid media. 
The liquid culture was grown at 30° C overnight and was utilized to make genomic prep 
by glass bead disruption method. 
The pEGFP-RPA plasmid series was also used as a template to amplify RPA 
genes with or without GFP tag to clone into pLVX-Tight-Puro1 using traditional cloning. 
The shRNA oligos (primers O-101 to O-114 Appendix B) were ordered from Integrated 
DNA Technologies (IDT; Coralville, IA) and were allowed to anneal to form a double-
stranded insert by mixing the two strands at equimolar concentrations and in STE buffer 
(100 mM Tris•Cl pH 7.5, 500 mM NaCl, 10 mM EDTA pH 8.0). The shRNA for Rpa1 
and Rpa2, and Rpa3 were the same as used in previous studies (HARING et al. 2010b). 
Four different shRNA sequences were designed for Rpa4 knockdown using the online 
tool available through Dharmacon. These were then cloned in pLVX-shRNA1 or pLVX-
shRNA2 from Clontech Laboratories (containing a ZsGreen gene to allow for detection 
in cells) by traditional ligation cloning. 
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Construction and isolation of RPA containing plasmid 
pJM132, a plasmid containing the yeast RFA1, RFA2, and RFA3 genes was 
stepwise digested and used to clone in each of the corresponding human RPA subunit 
genes. The first step was to replace RFA2 with either Rpa2 or Rpa4. To do this, pJM132 
was linearized with HpaI and co-transformed with Rpa2 PCR fragment consisting of ends 
homologous to pJM132. The successful recombination events were selected on SD-Ura 
media and genomic/plasmid DNA was isolated from multiple yeast colonies. The DNA 
was then transformed into DH10B cells. Using colony cracking followed by restriction 
digestion with BglII, we screened bacterial colonies and selected appropriate positive 
constructs. The constructs were further confirmed by DNA sequencing (Eton 
Biosciences).  
Table2.1: A list of restriction enzymes used to linearize and confirm constructs in 
the construction of pJM132 with the RPA subunit genes. 
 
Gene Plasmid RE to 
Linearize 
Gene 
Replaced 
Diagnostic 
RE 
Rfa1 pJM132 AatII Rpa1 XhoI 
Rfa2 pJM132 HpaI Rpa2 BglII 
Rfa3 pJM132 MscI Rpa3 MscI 
Rfa2 pJM132 HpaI Rpa4 EcoRI 
Ura3 pJM132 SbfI and NsiI G418r BstZ17I 
 
This plasmid was used as vector backbone to replace yeast RFA3 with human 
Rpa3, followed by replacement of yeast RFA1 with human Rpa1. An example of colony 
cracking followed by XhoI digest to confirm Rpa1 insertion in pJM132-Rpa2+3 is shown 
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in Figure 2.2. All of the enzymes used for linearizing and diagnosis of correct insertions 
are listed in Table 2.1. Finally, once all three yeast genes had been swapped with their 
corresponding human genes, the G418 selectable marker was inserted to replace the 
URA3 marker originally on the plasmid. This helped us switch from screening for the loss 
of pJM132 to being able to select for it. This stepwise replacement method helped us 
build a plasmid expressing either the canonical or alternative RPA complex with G418 as 
a selectable marker.  
	  
	  
Figure 2.2: Agarose gel XhoI digest confirmation of Rpa1 insert in pJM132-Rpa2+3 
vector. The Rpa2+3 is the control lane whereby the linearized plasmid is ≈ 11Kbp. The 
expected pattern after Rpa1 insertion is a ≈ 3.5Kbp and 8.5Kbp fragment. Hence 
candidates in lane 3 and 5 are successfully cloned. 
 
Construction of human-yeast rfa2 N-terminal mutants 
Human-yeast rfa2 N-terminal mutants were constructed by in vivo homologous 
recombination of synthesized gene fragments into the plasmid vector pRS315-rfa2-ΔNx. 
This plasmid expresses an rfa2 gene that is missing the N-terminal coding sequence. This 
vector was linearized using restriction enzyme HpaI. The Rfa2 N-terminal (2NT) coding 
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sequences from various organisms were commercially ordered as gBlocks (IDT). These 
gBlocks not only had the required 2NT sequences from various organisms, but also 
flanking regions homologous to the vector to facilitate homologous recombination 
cloning. About 250 ng of vector and 50 ng of gBlock were co-transformed into EGY48 
cells. Cells where the appropriate recombination event had potentially occurred were 
recovered on SD-Leu (lacking leucine) plates.  
A scrape of multiple colonies was used to inoculate overnight yeast culture to 
isolate yeast genomic DNA. One microliter (1µL) of genomic DNA was transformed in 
to DH10B cells using electroporation. Cells were plated on LB+Amp plates.  The 
plasmids were isolated from bacterial cells (colony cracking), and correct clones were 
confirmed using diagnostic restriction digest with restriction enzyme (SspI). The clones 
were further confirmed by sequencing from Eton Biosciences (San Diego, CA). 
Detection of correct clones by colony cracking method 
Individual colonies were used to inoculate overnight bacterial cultures. One 
milliliter (1 mL) of this culture was pelleted, and the pellet was dissolved in 50 µL of 1x 
lysis buffer (2 mg/mL lysozyme, 15% sucrose, 0.2 mg/mL DNase-free RNase A, 10 mM 
Tris•Cl pH 8.0, 1 mM EDTA pH 8.0, 0.1 mg/mL BSA). This cell/lysis buffer mixture 
was boiled at 100°C for 90 sec, followed by centrifugation at 15,000 RPM for 10 min. 
The clarified supernatant was used to set up a diagnostic restriction digest using 
appropriate restriction enzyme (Table 2.1). The correct inserts were further confirmed by 
sequencing (Eton Bioscience).  
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Plasmid shuffle assay using RPA expression vectors 
A plasmid containing all human RPA subunits and a G418 selectable marker was 
transformed with LiAc/PEG method into RMY122-A cells (GIETZ and WOODS 2002). 
The cells were plated on YPD+G418 media to select for transformants containing this 
plasmid. A YPD+G418 overnight culture was inoculated with scrape of these cells and 
grown at 30°C. The culture was again plated on YPD+G418 plate to isolate single 
colonies. A master plate was picked from these plates onto a YPD+G418 plate, and this 
master plate was used for replica plating onto YPD, YPG, and 0.8 µg/µl of 5-FOA (to 
select for cells that can lose the original pJM132 plasmid). 
DNA damage assays 
The colonies that have lost pJM132 were used to inoculate an overnight YPD 
culture incubated at 30°C. The next day cultures were sonicated five times at 20% power 
(0.5 sec on, 1 sec off) and were counted counted using a cellometer (Nexcelom). The 
concentration was adjusted to 1(10)7 cells/mL followed by 1:10 serial dilutions. Five 
microliters (5 µL) of each of the dilutions were spotted in a row on different DNA 
damaging agent-containing plates to test sensitivity (Refer Table 2.2)  
Table 2.2: DNA damaging agents used in studies 
 
DNA damaging agent Concentrations used Mode of DNA damage 
Methyl methanesulfonate 
(MMS) 
0.015%-0.12% Alkylating agent 
Camptothecin (CPT) 0.2-25 µg/mL Topoisomerase I inhibitor 
Phleomycin (PHL) 0.2-25 µg/mL DNA intercalating agent 
Hydroxyurea (HU) 40-320 mM Depletion of dNTPs causes 
replication fork stalling 
resulting in replication stress 
 
 	   35 
Yeast two-hybrid assay 
Human Rpa1 was cloned into pEG202 (Appendix C) to express lexA N-
terminally tagged Rpa1. This is referred to as the ‘bait’ construct. This cloning was 
performed using homologous recombination where pEG202 was linearized with NcoI and 
Rpa1 was amplified using primers O-260 and O-261 (Appendix B). All three yeast 
subunits and all four human RPA subunits were cloned into pJG4-5 vector to express B42 
N-terminally tagged proteins. These are referred to as “prey” constructs and were 
generated by in vivo homologous recombination by Erica Mueller. About 200 ng of bait, 
prey, and reporter/supplementary plasmid were co-transformed into EGY48 cells and 
isolated on SD-HTU (lacking histidine, tryptophan, and uracil) plates to select for 
transformation of all three plasmids. Individual colonies were picked as patches on SD-
HTU media. These patch plates were then replica plated onto YPD, YPG, SD-HTU, SG-
HTU, SD-HLTU, SG-HLTU and SG-HTU+X-gal plates. Protein interaction was 
determined by growth on SG-HLTU plates after replica plating. The development of blue 
color on media containing X-gal was used as indicator of positive interaction.  
Transfection of cell lines and flow cytometry analysis  
Three micrograms (3 µg) of the shRNA vector was mixed with 15 µL of Lenti-X 
HT Packaging mixand was transfected into HEK293T cells using LentiPhos (Clontech), 
as per manufacturer’s instructions. Lipofectamine 2000  (Invitrogen) was also used for 
transfection of 3 µg of vector into HEK293T cells, as per manufacturers instructions. 
Lentivirus was collected 2 days post-transfection.  
Different volumes of the virus (0 µL, 25 µL, and 500 µL) were used for 
transduction (with 2 µg/µL of polybrene) into HEK293T or HT29 cell lines. The cells 
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were observed for 6 days for increase in the number of green cells and on the 6th day, the 
cells were harvested for flow cytometry. Cells were collected by trypsinization, rinsed 
with 1x PBS, centrifuged, and treated with RNase A for one hour. The cells were divided 
into two aliquots: one was used for propidium-iodide (PI) staining and the other was used 
for detection of ZsGreen protein. The samples were examined through an Accuri flow 
cytometry using the FL1-A channel for green fluorescence and the FL2-A channel for red 
fluorescence (PI staining for DNA content). About 50,000 events were counted, and only 
healthy cells (as determined by forward and side scatter (FSC and SSC, respectively) 
were analyzed for ZsGreen expression or DNA content. 
Protein extraction, gel electrophoresis, and western blotting 
The protein expression of RPA and RFA subunits was measured using western 
blot analysis. The RMY122-A strain (with pJM132) served as control for this experiment. 
The RMY122-A (control) cells were grown for 16 hr in YPD at 30°C, while the 
RMY122-A cells expressing canonical RPA complex (+123) and alternative RPA 
complex (+143) were grown in YPD media containing G418 to retain the 
RPA-expressing plasmids. Cultures were maintained in log (exponential growth) phase 
and protein was isolated using the Kushirnov method (REF). Cell concentrations were 
measured using a cellometer (Nexcelom), and approximately 5(10)7 cells were collected. 
The collected cells were treated with NaOH for 10 min, pelleted, and the supernatant was 
removed. The cell pellet was then dissolved in Kushnirov (modified SDS sample loading) 
buffer, followed by incubation at 100°C for 3 min. Cellular debris was pelleted, and the 
supernatant was collected. Five microliters (5 µL) of each sample was loaded for 
detection of RFA and RPA proteins.  
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For detection of Rpa2 and Rfa2 a 12% SDS PAGE gel was used, while for Rfa1 
and Rpa1 protein a 6% SDS-PAGE gel was used (both percentage gels were run at 
constant current). The proteins were transferred to a 0.4 µm nitrocellulose membrane at 
40 mA for 15 hr. The Rfa1 and Rfa2 protein were detected using rabbit polyclonal 
antibody (1:40,000 and 1:20,000, respectively). These antibodies were kindly provided 
by Dr. Steve Brill (Rutgers University). Rpa2 was detected by rabbit polyclonal antibody 
(N2.2; kindly provided by Dr. Marc Wold) to human Rpa2 using a 1:5,000 dilution. Rpa1 
was detected using 1:1,000 dilution of mouse monoclonal antibody against human Rpa1 
(ab176476; Abcam).  
Detection of RPA and RFA mRNA expression using quantitative PCR  
For the isolation of total cellular mRNA, RMY122-A cells were grown in YPD 
for 16 hrs at 30°C. RMY122-A expressing canonical RPA or alternative RPA were 
grown in YPD+G418 media. The exponentially growing 1.5 mL culture was pelleted, and 
the mRNA is isolated using YeaStar RNA Kit (Zymo Research) followed by genomic 
DNA cleanup using DNA-free RNA kit (Zymo Research). The isolated RNA was then 
quantitated using a Nanodrop (Thermo), and 1 µg of RNA was used to synthesize cDNA 
utilizing the AMV First-Strand cDNA Synthesis Kit (New England BioLabs). The 
primers to detect RFA subunit expression were designed using PrimerQuest (IDT) and 
ordered from IDT, and primers for detection of RPA subunit were designed using Primer 
Express (ABI) and ordered from IDT. The UBC6 gene was used as normalizing control 
for qPCR, and the primer sets are as shown in Table 2.2. The PCR was performed using 
PerfeCTa SYBR Green FastMix Low ROX (Quanta Biosciences), and the reactions were 
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carried out on AB7500 Real-Time PCR (Applied Biosystems) machine. The data were 
analyzed using Sequence Detection System software v1.2 (Applied Biosystems).  
Results 
RPA complex is unable to support normal RFA cellular function 
 
 
Figure 2.3: A replica-plating assay testing survival of candidates expressing 
canonical and alternative RPA complex in yeast. The WT RFA expressing cells are 
shown at the top row, the middle row shows six candidates expressing canonical RPA 
complex and the last row shows six candidates expressing alternative RPA complex.  
 
The aim of this study was to replace the yeast RFA complex with human 
canonical RPA or human alternative RPA, so that the yeast cells might serve as a tool to 
study human RPA function. The RMY122-A cells containing either canonical RPA or 
alternative RPA complex were grown in YPD+G418 media to saturation at 30°C. The 
cells containing RFA1 (HIS3 plasmid) and RFA2 (LEU2 plasmid) served as positive 
control for the ability of cells to lose pJM132 (URA3 plasmid). The cells were patched 
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onto YPD+G418 plates and were replica plated to YPD, YPG, and 5-FOA media. 
Survival on 5-FOA plates was indicator of loss of pJM132, and only cells where the 
substituted form of RPA can take the place of yeast RFA will be able to lose pJM132.  
As shown in Figure 2.3, the cells containing canonical RPA and alternative RPA 
complex were unable to survive on 5-FOA plates. This indicates that the cells were not 
able to lose pJM132 containing the yeast RFA complex. The cells were able to grow on 
both YPD and YPG indicating that the inability to grow on 5-FOA was not due to 
defective cellular function or defective mitochondria, respectively.  
RPA is expressed at slightly-to-moderately lower levels compared to RFA in yeast 
cells 
The success of the shuffle out reactions depends on two things. First, the human 
genes should be expressed at the mRNA level similarly to the yeast RFA genes. In order 
to optimize the likelihood that they are expressed at similar levels, we cloned the human 
RPA genes downstream of the native yeast RFA promoters. Second, the translation of 
this mRNA must occur similarly for both human and yeast RPA genes. It was possible 
that levels of translation could be affected due to codon bias in yeast vs. humans. 
Using qPCR, we quantified the mRNA expression of all RPA subunits present in 
the yeast cells. The RMY122A cells served as the negative control for this experiment, as 
these cells did not express any human RPA genes. The ‘canonical RPA’ expressing cells 
(denoted cRPA) and the ‘alternative RPA’ expressing cells (denoted aRPA) express 
human Rpa1 and Rpa3, with the difference being that cRPA cells express Rpa2 and 
aRPA cells express Rpa4. The RNA isolation and cDNA synthesis was performed as 
described, and the amount of RNA used for the production of cDNA was the same for all 
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samples. As expected, the RMY122-A cells do not show any measurable human RPA 
subunit expression. As seen in Figure 2.4, only cRPA cells express Rpa2 and only aRPA 
cells express Rpa4. In either cRPA- or aRPA-expressing cells, the middle subunit (Rpa2 
or Rpa4) is expressed at high levels as compared to the Rpa1 or Rpa3. Also, the 
expression of all genes was higher in cRPA cells; we suspect this was partially due to 
genomic DNA contamination as indicated in the (-) reverse transcriptase control (not 
shown). 
	  
 
Figure 2.4: A chart showing the quantification of expression of various human RPA 
subunits in various strains using qPCR. The RMY cells serve as a negative control and 
only express yeast RFA subunits. The 123 cells express canonical RPA and hence do not 
show any Rpa4 expressed (purple). The 143 cells should only express ‘alternative RPA 
complex’ and hence do not show expression of Rpa2 (red). 
 
We next tested the expression of yeast RFA genes, and as expected all cell types 
showed expression of RFA1, RFA2, and RFA3 mRNA (Figure 2.5). The RFA3 expression 
observed is probably higher than in other yeast strains due to these cells having two 
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copies of this gene (one on pJM132 plasmid and one chromosomal copy). Also, Rfa2 
expression is higher compared to RFA1, indicating that these cells naturally produce 
more RFA2 mRNA. Therefore, it is not surprising that for our human RPA subunit gene 
expression, we also always observed increased Rpa2 or Rpa4 expression compared to the 
other human RPA genes, as Rpa2 and Rpa4 are driven by the native RFA2 promoter 
(Figure 2.4). 
 
 
Figure 2.5: A chart showing quantification of expression of RFA subunits in various 
cells using qPCR. This chart shows that all the three strain types used in this experiment 
show expression of RFA subunits. The Rfa2 is always expressed more than Rfa1 subunit.  
 
We further calculated whether the human RPA subunit genes are expressed at 
similar to the yeast RFA subunit genes. In Figure 2.6, human RPA subunit mRNA 
expression is compared to its yeast homolog. Rpa1 and Rpa2 are expressed at ~50% of 
the levels measured for RFA1 and RFA2, respectively. The lowest relative level was 
measured for human Rpa3 mRNA, which was expressed at about 10% compared to yeast 
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RFA3. Considering that the cells also have chromosomal copy of RFA3, we can estimate 
that the comparative expression level of human Rpa3 to yeast RFA3 mRNA is about 
20%. Given that human subunit mRNA expression levels are only 20-50% of the yeast 
subunit mRNA expression levels, it still remains possible that lack of complementation 
(function) of human RPA in yeast cells is due to reduced expression. 	  
 
 
Figure 2.6: A chart displaying the percentage of human RPA subunit expression as 
compared to its yeast counterpart. The chart here displays the expression of RPA 
subunits in RPA1+2+3 and RPA1+4+3 cells compared to expression of RFA complex 
subunits in RMY122A cells. The Rpa2/4 is showing expression of Rpa2 in 1+2+3 cells 
compared to Rfa2 expression and the expression of Rpa4 in comparison to Rfa2 
expression.  	  
The human Rpa1 and Rpa2 proteins are translated and stable in yeast 
As described previously, codon bias in yeast vs. human cells might interfere in the 
overall translation and stability of human RPA proteins in yeast. To determine if human 
RPA subunits were translated and stable in yeast cells, western blotting was utilized. 
Yeast Rfa1 and Rfa2 proteins are detected at similar levels in all three strains (without or 
with human cRPA or aRPA) utilized in this assay. This demonstrated that RFA mRNA 
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translation into protein or yeast protein stability is not affected by the presence of human 
proteins. Furthermore, human Rpa1 was detected in both cRPA- and aRPA-expressing 
yeast cells (Figure 2.7), indicating that the protein is translated and that it is stable. 
Although appearing slightly lower in cRPA-expressing cells, human Rpa1 protein is still 
observed. A more quantative assessment of protein expression was not performed. 
 	  
Figure 2.7: A western blot assay showing expression of different RFA and RPA 
subunit proteins in various yeast strains used in this study. The first column 
represents protein from WT cells (RFA only). The second column shows proteins from 
1+2+3 cells (RFA+ cRPA). The third column shows proteins from 1+4+3 cells (RFA+ 
aRPA). The α stands for ‘anti’ and represents anti-protein antibody.  
 
It has been demonstrated in human cells that Rpa1 is not stable without Rpa2 protein 
expression. Therefore, one would predict that Rpa2 (or Rpa4) protein expression would 
also be observed. Rpa2 is expressed only in the cRPA-expressing strain as expected, and 
the protein appears stable. Rpa3 and Rpa4 protein expression could not be confirmed via 
western blotting, as there are currently no reliable antibodies available for either. An 
Rpa3 antibody was purchased from Abcam (ab 37679); however, reliable detection of 
Rpa3 protein was not observed (data not shown). At this point, we cannot state whether 
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the failure of pJM132 to shuffle out is due to lack of proper RPA subunit expression or 
lack of proper protein translation (and folding). 
The Rpa1 protein is unable to interact with yeast RFA subunits in the two-hybrid 
assay 
Replication Protein A is involved in vital processes and it forms a strong complex 
that is stable in 6 M urea (WOLD and KELLY 1988) (FAIRMAN and STILLMAN 1988) 
(BRILL and STILLMAN 1989). This stability indicates that the complex needs all the 
subunits of the complex to carry out its function. This is why simultaneous replacement 
of all three subunits was attempted. Thus far, we have determined that the human RPA is 
unable to replace the yeast RFA complex (Figure 2.3). Another approach mentioned 
previously to study human RPA in yeast was to replace only one subunit and study its 
function, and as mentioned, these attempts have been unsuccessful (PHILIPOVA et al. 
1996). The question of complex formation between yeast and human RPA subunits has 
been examined somewhat examined in vitro by the ability to purify a soluble hybrid RPA 
complex (MSW, unpublished results). We asked whether inter-species interactions could 
occur in yeast cells using the two-hybrid assay. In this assay we used Rpa1 as bait and 
tested its ability to interact with yeast RFA subunits. We also tested Rpa1 interaction with 
other human RPA subunits to understand complex formation and as a positive control for 
two-hybrid assay results. 
Rpa1 is unable to interact with any of the yeast RFA subunits (Figure 2.8). In this 
assay we see normal growth SG-HTU indicating all plasmids are present in the cells and 
expression does not affect the viability of the cells. However, the lack of growth on SG-
HLTU indicates lack of interaction between Rpa1 and yeast RFA subunits. Also, there 
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was no β-galactosidase activity detected on SG-HTU+Xgal plates, further supporting lack 
of interaction. 	  
	  
	  
Figure 2.8: Replica plating assay with BD-Rpa1 to test interaction with the RFA 
complex subunits. Rpa1 does not interact with Rfa1, Rfa2 or Rfa3 in yeast two-hybrid 
assay. The replica plating is performed using dextrose or galactose (SD or SG) containing 
media lacking His (H), Trp (T), Ura (U) and Leu (L). The β-galactosidase activity is 
tested on media containing xgal (SG-HTU+XGAL). 	  
Rpa1 does not interact with Rpa3 in two-hybrid assay 
We also tested the Rpa1 interaction with human RPA subunits. Generally this 
complex is isolated as a soluble heterotrimer; however, it can also be purified as an Rpa2-
Rpa3 heterodimeric subcomplex. Yeast two-hybrid analysis yields similar results. Rpa1 
can interact with Rpa2 and Rpa4 (as indicated by blue color on SG-HTU+X-gal plates) 
and it does not form a dimer with itself (Figure 2.9). The interesting observation was the 
lack of detectable interaction with the Rpa3 subunit. As discussed earlier although Rpa1 
and Rpa3 are part of the same complex, it is possible that this is not a direct interaction 
and requires a mediator (Rpa2 or Rpa4) for complete complex formation. To test this 
idea, we examined the Rpa1 and Rpa3 interaction in presence or absence of Rpa2 or 
Rpa4 (mediator) protein. 
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Figure 2.9: Replica plating assay with BD-Rpa1 to test interaction with the RPA 
complex subunits. Rpa1 bait interacts with Rpa2 and Rpa4 as prey in yeast-two hybrid 
assay. Rpa1 is not able to interact with Rpa3. The replica plating is performed using 
dextrose or galactose (SD or SG) containing media lacking His (H), Trp (T), Ura (U) and 
Leu (L). The β-galactosidase activity is tested on media containing xgal (SG-
HTU+XGAL). 	  
Rpa1 and Rpa3 are do not interact with each other in the absence of Rpa2 (or Rpa4) 
When a supplementary plasmid is introduced to express either Rpa2 or Rpa4, growth on 
SG-HLTU (indicating interaction) was observed (Figure 2.10). This is complicated 
somewhat by the observation of autoactivation when Rpa2 or Rpa4 are expressed (Figure 
2.10; rows 2 and 3). Rpa2 and Rpa4 have both shown autoactivation (data not shown) 
when present in the bait construct, and we propose that activation here might be a 
consequence of Rpa2 or Rpa4 interacting with BD-Rpa1. However, when Rpa2 and Rpa3 
(or Rpa4 and Rpa3) are both expressed from the supplementary plamid, autoactivation is 
reduced (lack of growth on SD-HLTU), yet growth is observed on SG-HLTU. This 
would appear to indicate that Rpa1 and Rpa3 interact, but only when Rpa2 or Rpa4 are 
present. 
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Figure 2.10: Replica plating assay for determination of Rpa1 and Rpa3 interaction 
in absence or presence of supplementary plasmid expressing either Rpa2 or Rpa4. 
The replica plating is performed using dextrose or galactose (SD or SG) containing media 
lacking His (H), Trp (T), Ura (U) and Leu (L). The β-galactosidase activity is tested on 
media containing xgal (SG-HTU+XGAL). 	  
The Rpa2 N-terminus is interchangeable between species 
The yeast two-hybrid data indicated that the reason behind the inability of any 
individual RPA subunits to support cell survival was a lack of inter-species interactions. 
While this study has also indicated that the full RPA complex is not able to support cell 
survival, it was shown in previous studies that individual domains (subregions) of yeast 
RFA (DBD-A and DBD-B, Figure 1.1) were replaceable with the human equivalent 
domains (PHILIPOVA et al. 1996). As discussed earlier, Rfa1 is the largest subunit with 
the ssDNA-binding properties and shows the most sequence similarity amongst species 
(WOLD 1997). Apart from Rfa1, Rfa2 is the next major subunit showing sequence 
similarity amongst species (ISHIAI et al. 1996). 
 A major focus of our lab is on the function of the Rfa2 N-terminus 
phosphorylation in DDR (described more in chapter 3). In chapter 3, I will describe how 
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the Rfa2 N-terminus is not detectably phosphorylated in response to DNA damage, 
unlike the human Rpa2 N-terminus in both human and yeast cells. Since we could 
measure human Rpa2 N-terminal phosphorylation in yeast cells (GHOSPURKAR et al. 
2015b), we asked whether yeast might be a useful tool for measuring phosphorylation of 
other eukaryotic Rpa2 N-termini. To do this, we developed hybrid Rfa2-expressing 
constructs, where the N-terminus of the Rfa2 is replaced with the Rpa2 N-terminal 
sequence from other eukaryotic species. These will be referred to as Rpa2 N-terminus 
(2NT)-Rfa2 hybrids. In this study we have cloned in the Rpa2 N-termini from six 
different eukaryotic species (Table 2.3), including: Mus musculus (Mm), Xenopus laevis 
(Xl), Arabidopsis thaliana (At), Orzya sativa (Os), Candida albicans (Ca), and 
Schizosaccharomyces pombe (Sp). The plants A. thaliana and O. sativa have multiple 
Rpa2 subunits, which are referred to as Rpa32A and Rpa32B or Rpa32-1, Rpa32-2, and 
Rpa32-3 in both organisms, respectively. 
Table 2.3: A list of species whose Rpa2 NT phosphorylation was studied 
 
Fungi Plants Animals 
S. pombe A. thaliana (Rpa2 A) X. laevis 
S. cerevisiae A. thaliana (Rpa2 B) M. musculus 
C. albicans O. sativa (Rpa2 1) H. sapiens 
 O. sativa (Rpa2 2)  
 
First, we tested the ability of these mutants to support cell survival in the 
unstressed condition (on rich media). In Figure 2.11, it is observed that all of the mutants 
can support viability of yeast cells; however, cells expressing the Oryza sativa (Os) 
Rpa2-2 N-terminus showed the lowest shuffle out rate (indicating some lack of function). 
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The overall shuffle out rate (ability to support cell growth) of the different rfa2 hybrid 
2NT mutants in increasing order is as follows:  
Os2-2 < Sp < At2A and Xl < At2B and Os2-1 < Ca and S. cerevisiae (Sc). 
It is notable that the N-terminus of homologs from the same species has a 
different effect on cell survival. For example, Os2-2 shows a defect in the ability for 
yeast cells to grow, while Os2-1 shows growth indistinguishable from WT budding yeast 
Rfa2. As mentioned in the introduction (chapter 1), there is the hypothesis that different 
homologs of RPA may participate in different cellular functions, and it is possible that 
this is a reflection of inhibition of Rfa2 function depending on the N-terminus that is 
present. 
 	  
Figure 2.11: The shuffle out assay of 2NT-Rfa2-Hybrid mutants. The first column is 
to test the viability of cells with all three plasmids an SD-HLU (lacking his, leu and ura). 
The second column is to test ability of cells to lost WT Rfa2. The Os1NT and Os2NT 
represent two homologs from O. sativa. Similarly, the two homologs from A. thaliana are 
represented as AtANT and AtBNT 
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A)	  
	  
B)	  
	  
	  
Figure 2.12: The DNA damage assay of various rfa2 hybrid 2NT mutants. A) The 
DNA damage assay of rfa2 2NT hybrid mutants with increasing HU concentration B) 
The DNA damage assay of rfa2 2NT hybrid mutants with increasing CPT concentration. 
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Figure 2.13: The DNA damage assay of rfa2 hybrid 2NTmutants with increasing 
MMS concentration. The highest MMS concentration was toxic to cells and we did not 
recover any colonies however the difference in sensitivity is seen on the 0.06% MMS 
containing plates. 	  
The rfa2 hybrid 2NT mutants show varying responses to DNA damage 
The Rpa2 N-terminus is phosphorylated in response to DNA damage in human 
cells (DUTTA and STILLMAN 1992) (DIN et al. 1990). This leads to the proposed 
recruitment of RPA complex away from replication sites and to sites of DNA damage 
(VASSIN et al. 2004). Hence, the phosphorylation of Rpa2 N-terminus is an important 
event in DDR. A different study in our lab showed that the Rfa2 N-terminus 
phosphorylation in yeast appears to be at least partially dispensable DDR (chapter 3; 
GHOSPURKAR et al. 2015a). However, the Rfa2 N-terminus is required for the DDR. 
Here we studied the rfa2 hybrid 2NT mutants in presence of DNA damaging 
agents. We tested four different agents as listed in Table 2.2. As shown in Figure 2.12, 
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the Os1NT mutant was the most sensitive, although all of them, except At2B, show some 
degree of sensitivity to higher concentration of damaging agents (0.06% MMS and 25 
µg/mL CPT). The human N-terminal hybrid (Hs2NT) served as a positive control in this 
assay. The order of sensitivity in increasing order is as follows 
At2B< XL < At2A and Mm < Ca< Os2-1, Os2-2 and Sp <Hs2NT 
The above order was based on the results observed in presence of MMS. The 
Os1NT, Os2Nt, SpSSB, Ca2NT, and Mm2NT also show sensitivity on the HU and CPT 
plates. 
The yeast cells are able to phosphorylate the N-terminus region of different species 
Phosphorylation of the yeast Rfa2 N-terminus was undetectable (chapter 3) in 
response to DNA damage. However, we have shown that when the Rfa2 N-terminus was 
swapped for the human Rpa2 N-terminus, this N-terminus was now detectably 
phosphorylated in response to DNA damage (GHOSPURKAR et al. 2015b). The 
significance of this remains undetermined. What this did demonstrate is that although the 
yeast cells do not detectably phosphorylate the Rfa2 N-terminus in response to DNA 
damage, they do possess the capability (i.e., kinases) to phosphorylate an amino acid 
sequence on the N-terminus. Therefore, yeast cells are a potential tool for studying Rpa2 
N-terminal phosphorylation. 
As shown in Figure 2.14, yeast Rfa2 from WT cells does not show any detectable 
phosphorylation in presence of phleomycin. However, the yeast cells are able to 
phosphorylate the human Rpa2 N-terminus (hs2NT). When we examined protein isolated 
from the rfa2 hybrid 2NT mutants in the absence or presence of DNA damaging agents, 
the observation of slower migrating species indicated that except for Os2NT, the 
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remainder of the hybrid proteins are phosphorylated in response to DNA damage. When 
homologs from the same species are not phosphorylated, it is consistent with the idea that 
these homologs may be carrying out different functions in cells. The data presented here 
is from two of three independent experiments with three independent colonies. We found 
similar results in all three sets. Since RPA antibodies detecting RPA subunits from 
different species often do not cross react (WOLD 1997), this system allows for anti-Rfa2 
polyclonal antibody, to recognize the yeast Rfa2 portion of the rfa2 hybrid 2NT proteins.. 
As observed in Figure 2.14, the intensity of phosphorylation and number of 
phosphorylated species produced varies from species to species. Also, in Os1NT and 
AtBNT samples we observe that the undamaged sample displays a detectable amount of 
phosphorylation. This is not unusual as human Rpa2 is phosphorylated during the cell 
cycle, in addition to after DNA damage. The intensity of phosphorylation often increases 
in response to DNA damage in most of these samples. The Hs2NT served as a positive 
control, and the Mm2NT samples were expected to show phosphorylation similar to 
human Rpa2 NT, as mouse and human Rpa2 NT have highest sequence similarity (95%) 
(NAKAGAWA et al. 1991).  
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Figure 2.14:  Western blots to detect the phosphorylation pattern of rfa2 hybrid 
2NT mutants. A) The western blot of 2NT-Rfa2-Hybrid mutants showing the 
phosphorylation of two different homologues in Oryza Sativa and Arabidopsis thaliana. 
B) The western blot of 2NT-Rfa2-Hybrid mutants showing the phosphorylation of 
Arabidopsis thaliana Mus Musculus and Schizosaccharomyces Pombe. C) The western 
blot of 2NT-Rfa2-Hybrid mutants showing the phosphorylation Rpa2 N terminus of 
Candida Albicans and Xenopus Laevis in the yeast cells.  
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Lipofectamine 2000 increases transfection efficiency of Rpa4-shRNA lentivirus 
Attempts were made to study human Rpa2, and particularly Rpa4, in the context 
of human cells. The first step towards testing the effect of Rpa4 knockdown on cells was 
the production of Rpa4 shRNA-expressing lentivirus. We tested two different 
transfection reagents to transfect HEK293T cells: (1) LentiPhos and (2) Lipofectamine 
2000. Generally, we observed that Lipofectamine 2000 was more efficient for 
transfection of cells as compared to LentiPhos (Figure 2.15). Non-transfected cells served 
as a negative control for this experiment. 
 
 
Figure 2.15: Transfection of HEK293T cells with Rpa4 shRNA containing lentivirus 
using different transfection reagents. The transfection efficiency of the Rpa4 shRNA 
containing lentivirus was increased with use of Lipofectamine 2000. 
 
The transduction efficiency of Rpa4-shRNA lentivirus varies with different cell lines 
To test the transduction efficiency of Rpa4 shRNA-expressing lentivirus, we used 
three different cell lines DLD1, HT29 both derived from human colorectal 
adenocarcinoma and HEK293T cell lines derived from human embryonic kidney cells. 
The DLD1 cells did not show much green cells after 6 days via fluorescence microscopy, 
and therefore flow cytometry was not performed on those samples. Three different 
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volumes (0 µL, 25 µL, and 500 µL) were used to examine the transduction efficiency into 
HT29 and HEK293T cells. It was observed that the increasing amount of virus did not 
correlate with the transduction efficiency that is addition of 20 times more volume did not 
increase transduction by 20-fold (Figure 2.16). HEK293T cells were found to be more 
receptive to viral transduction, and the highest transduction efficiency observed was 
36.1% (Figure 2.17). Experiments were not performed further due to an inability to 
achieve the transduction efficiency necessary to elucidate potentially subtle differences in 
cell growth and replication. 
                            
  
Figure 2.16: Transduction efficiency of Rpa4-shRNA containing lentivirus in HT29 
cells. The transdunction was tested with increasing volume of virus. 
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Figure 2.17: Transduction efficiency of Rpa4-shRNA containing lentivirus in 
HEK293T cells. The transduction efficiency was tested with increasing volume of virus. 	  
Discussion 
The inability of the RPA complex to substitute for RFA complex in yeast suggests a 
conservation of species-specific interactions 
RPA complex is a well-conserved complex in all species with respect to cellular 
function and complex formation. In previous attempts to replace RFA by RPA, species-
specific interactions were suggested to be responsible for non-complementation 
(PHILIPOVA et al. 1996). However, in all these experiments only a single subunit was 
replaced and tested for complementation. Lack of interaction between the BD-Rpa1 and 
subunits of RFA complex (Figure 2.8) in our experiments clearly supports these 
observations and extend them to demonstrate how the subunits might interact. When 
specific domains of Rpa1 (DBD-A and DBD-B) were swapped into RFA1 in yeast cells, 
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these domains successfully complemented the yeast RFA. It is noteworthy that when 
swapped individually (i.e., DBD-A or DBD-B), these domains did not complement 
(PHILIPOVA et al. 1996). These two domains were found to be essential for the ssDNA-
binding activity of the RPA complex. To eliminate any species-specific inability to form 
a complete complex, we swapped all the three subunits and tested for survival on 5-FOA 
(Figure 2.3). It is clear from these experiments that the RPA complex cannot support 
yeast cellular functions. The human and yeast proteins are shown to have similar binding 
affinity and activity, but differences in in vitro properties have also been observed. For 
example, human RPA was found to bind deoxycytidine polymers more tightly while 
yeast RFA bound deoxythymidine polymers better (KIM et al. 1992). These minute 
differences can be attributed as the reason why there was a need to swap both the 
domains together. 
As evident from the examples above if we consider that swapping the subunits or 
proteins according to their simple biochemical function of binding ssDNA, one would 
have predicted that human RPA should be able to substitute for yeast RFA in yeast cells. 
The failure of this experiment is more likely explained by considering two factors: (1) 
species-specific regulation of RPA and (2) protein interactions with RPA. There can be 
certain modifications that RPA undergoes in human cells to regulate its function, which 
are potentially missing from yeast cells (i.e., RPA phosphorylation). This might render 
human RPA non-functional in yeast. Also, if we consider just the DNA metabolic 
pathways, in human cells there might exist some additional/different protein components, 
which are missing from the yeast cells. In order to study the full human RPA complex 
one also needs to introduce these necessary components in yeast cells. Alternatively, it 
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could be that the mechanism(s) by which proteins associate are different in human vs. 
yeast cells. Therefore, studying the individual domains and their effect on yeast cells 
might be a better approach to studying human (or other eukaryotic) RPA in yeast.  
Secondly, from our qPCR and western blot data it is observed that human RPA 
genes are not expressed at similar levels as the yeast genes (Figures 2.4-2.7). This could 
be contributing factor to the failure of shuffle out assay. Hence, our next goal would be to 
increase expression (or cause over-expression) of these genes and determine if that 
improves the ability of cells to lose the pJM132 plasmid. However, it must be taken into 
consideration that in our hands, overexpression of RFA1 was found to be toxic to cells 
(unpublished data). 
Yeast cells are able to phosphorylate the Rpa2 N-terminus from various species 
The goal of this study was to develop yeast cells, which can express human RPA 
complex and serve as a tool to study human RPA function. So far, we were not able to 
successfully develop a strain, which can exclusively express the human RPA complex. In 
the past, small parts of the complex have been replaced by the corresponding human 
region successfully. In this study we successfully developed hybrid protein-expressing 
cells where the Rfa2 N-terminus was replaced by its homolog from different species. 
These mutants were able to support cell survival in unstressed conditions, and supported 
cell growth to varying degrees after a DDR was established. Interestingly, the 
phosphorylation of the yeast Rfa2 N-terminus is not observed in response to DNA 
damage in yeast cells. From an evolutionary perspective this could mean that the yeast 
cells lack the ability to phosphorylate the Rfa2 N-terminus. However, since in our assay 
almost all of the hybrid mutants were phosphorylated in response to DNA damage 
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(Figure 2.14), we would suggest that there is purpose to the lack of phosphorylation 
observed for yeast Rfa2 in yeast cells.  
This study indicates that the ability of the Rpa2 N-terminus phosphorylation 
exists from single-celled eukaryotes to multicellular organisms. However, the implication 
of this event in DDR is unclear from species to species. This data suggests that the Rpa2 
NT phosphorylation evolved over time as a mechanism to regulate DNA damage 
response. This model system can potentially serve as a useful tool to study Rpa2 
phosphorylation, especially in response to DNA damage. For example, a homolog from 
rice is not phosphorylated in response to DNA damage (Os2NT) may indicate that it is 
not involved in repair function in rice, compared to another rice homolog (Os1NT). 
Another important study will be to express these hybrid proteins in cells containing 
kinase deletions to determine which kinase(s) is important for phosphorylation of Rpa2 in 
the DDR.  
Rpa3 does not interact with Rpa1 directly, but is essential for stability of Rpa1 and 
Rpa2 interaction 
RPA complex was originally isolated as an essential component in SV40 DNA 
replication (FAIRMAN and STILLMAN 1988; WOLD and KELLY 1988). It was isolated as a 
complex of four different polypeptides of which the 53 kDa peptide was found to be the 
cleavage product of Rpa1 (70 kDa) (WOLD and KELLY 1988). The RPA complex is 
soluble only when all three subunits are expressed (WOLD 1997). The individual subunits 
are difficult to isolate, and the only sub-complex that is able to be purified is the Rpa2 
and Rpa3 heterodimer (HENRICKSEN et al. 1994). 
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Our data clearly supports the observations that Rpa1 bait can interact with Rpa2 
or Rpa4, but does not interact with Rpa3 (Figure 2.9). This suggests that Rpa2 and Rpa3 
or Rpa4 and Rpa3 must form a sub-complex before interacting with Rpa1 either directly 
through Rpa2 or Rpa4. Alternatively, Rpa2 or Rpa4 may be necessary to stabilize Rpa3 
and allow it to interact with Rpa1. 
The Rpa1 and Rpa3 proteins interact only in presence of either Rpa2 or Rpa4 
(Figure 2.10). This clearly indicates that in the complex formation Rpa2 acts as a 
mediator between these two proteins. Since there is no direct interaction between Rpa1 
and Rpa3, the role of Rpa3 is thought to be important in stabilizing the complex. It is 
possible that Rpa2 and Rpa3 sub-complex can perform certain cellular function without 
Rpa1. In fact, only Rpa2 was found to be associated with chromosomes in M phase of 
cell cycle (ADACHI and LAEMMLI 1992).  
It can be hypothesized that the Rpa2+Rpa3 complex can participate in cellular 
functions independent of Rpa1. In our assay when we co-express Rpa2+Rpa3 as a 
supplementary plasmid we detect some auto activation (Figure 2.10). This auto activation 
is observed when the protein in question can act as a transcriptional activation domain. 
Rpa2 and Rpa4 were shown to auto activate in our lab when used as baits. But in this 
experiment Rpa1 is the bait and it can auto activate when the full complex is expressed. 
This phenomenon was never reported before.  
The transduction of Rpa4-shRNA is not as efficient as desired  
The Rpa4 protein, exclusively characterized in humans (and found in primates) is 
a homolog of Rpa2. However, Rpa2 is found to support DNA replication, while Rpa4 
does not. Rpa4 was also reported to be expressed in tissue specific manner (KESHAV et al. 
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1995c) and is thought to be found in differentiated cells, perhaps providing a genome 
maintenance function without providing a cell proliferation function. Rpa2 is also found 
to have increased expression in cancer or proliferative cells (GLANZER et al. 2014) 
(BANERJEE et al. 2013). These observations lead us to hypothesize that the ratio of Rpa2: 
Rpa4 might help determine whether a cell is proliferative or quiescent (Figure 2.1). 
In order to test this hypothesis, an undergraduate student, Kit Wong, carried out 
experiments whereby Rpa2 and Rpa4 mRNA expression were measured by qPCR in 
different tissue types. In his studies he found that Rpa4 was expressed in all tissues 
studied. Rpa4 expression was always lower than Rpa2, but there was no definitive 
correlation with the ratio and whether a cell was proliferative or not (Figure 2.18).  
The reason that our experiments were not very successful was we needed better 
transfection and transduction efficiency. A future option might be to switch to an 
electroporation technique or pursue further optimization. Using different cell line(s) may 
also be helpful since different cell lines may have different effect with respect to viral 
transfection efficiencies.  
Rpa4 is expressed in quiescent cells and often not so much in commonly used 
tissue culture cell lines. If this observation displays generality, then using cancerous cell 
lines may not be very useful in studying Rpa4 knockdown. Instead, these cell lines should 
be used to study the effect of overexpression of Rpa4 to determine if its overexpression 
can slow down/halt cell growth. Another effective method to study Rpa4 would be to use 
primary cell line and determine if its knockdown can make these divide for more 
generations or become immortalized. 
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Figure 2.18: Comparison of Rpa2 and Rpa4 expression in various tissue types. This 
chart shows mRNA expression of Rpa2 and Rpa4 various human tissues.   	  
Future Directions 
1. In order to improve cell survival with a sole copy of RPA, we need to increase the 
expression of these genes in yeast cells. 
2. With the help of rfa2 hybrid 2NT proteins, we can identify which organisms 
potentially display Rpa2 NT phosphorylation and perhaps define the importance 
of this event from an evolutionary perspective. 
3. Also, extension of eukaryotic Rpa2 NT examination might help define the role of 
various homologs in species containing multiple forms of the RPA complex. 
4. With the help of genetic assays where we combine the kinase deletion mutant and 
the rfa2 hybrid 2NT mutants we will be able to identify kinases responsible to 
establish the DDR, or at least phosphorylate Rpa2 NT in response to DNA 
damage. 
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5. If efficiency of DNA delivery can be optimized, studies examining the importance 
of Rpa4 to human cells might elucidate whether it plays a regulatory role in the 
decision for a cell to proliferate or quiesce. 
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CHAPTER 3. THE N-TERMINUS OF RFA2 IS ESSENTIAL BUT ITS 
PHOSPHORYLATION IS DISPENSABLE IN SACCHAROMYCES CEREVISIAE2 
Introduction 
Cells are continuously exposed to environmental stresses that can lead to DNA 
lesions. These DNA lesions or errors in DNA metabolic processes, if not recognized and 
repaired properly by the cell, can lead to mutations. The accumulation of mutations has 
been implicated as a major cause of many cellular diseases, including cancer. These 
lesions can be generalized in two types (1) a nick in DNA strand, whereby one DNA 
strand is affected (e.g., pyrimidine dimers) or (2) double stranded break, when both the 
strands are affected at the same time. Cells have the ability to recognize and repair DNA 
lesions through a number of mechanisms. These include nucleotide excision repair 
(NER), base excision repair (BER), or double-strand break repair (DSBR), which can 
occur via non-homologous end joining (NHEJ) or homologous recombination (HR) 
(SRIVASTAVA and RAGHAVAN 2015). Once the DNA lesion is recognized, a signal(s) is 
transduced to halt the cell cycle and allow for time to repair the lesion. This includes the 
recruitment and activation of cell cycle checkpoint proteins (e.g., ATM and ATR) that 
further transduce the signal through activation of downstream proteins (COOPER et al. 
2014). Generally, the activation of downstream targets is achieved through post-
translational modification(s) that include phosphorylation and sumoylation. 
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RPA is a substrate of kinases responsible for activating the DNA damage response 
(DDR)   
A protein essential in NER, BER and DSBR processes and a target of 
Phosphoinositide 3-kinase (PI3) family of kinases is Replication Protein A (RPA; 
RAMILO et al. 2002; DEMOTT et al. 1998). In humans, the amino (N)-terminus of Rpa2 
(Rpa2 NT) is phosphorylated in a cell cycle-dependent manner (i.e., during DNA 
replication and mitosis) and hyper-phosphorylated in response to DNA damage (WANG et 
al. 2001).  Hyper-phosphorylated RPA changes interactions with both single-stranded 
DNA (ssDNA) and proteins (OAKLEY et al. 2003) and is conjectured to regulate RPA’s 
cellular function in the DNA damage response. Therefore Rpa2 NT hyper-
phosphorylation is touted as an important player in DDR. 
Rpa2 is a direct substrate of ATR kinase, and its phosphorylation results in poor 
localization of RPA at replication sites; halting replication and mediating repair process 
(LIU et al. 2006; OLSON et al. 2006). The S4, S8, T21 and S33 located in N-terminus of 
human Rpa2 (Figure 3.1) are phosphorylated by DNA-PK in response to UV irradiation 
(ZERNIK-KOBAK et al. 1997). Phosphorylation at S4 and S8 of Rpa2 by DNA-PK helps 
suppression of sister chromatid exchange during mitosis to facilitate DNA repair (LIAW 
et al. 2011). ATM also phosphorylates Rpa2 in response to UV irradiation (WANG et al. 
2001) and plays a role in helping cells in mitotic exit (ANANTHA et al. 2008). It is 
proposed that phosphorylation of Rpa2 by ATR is important when lesions occur during 
DNA replication (i.e., replication stress), and phosphorylation by ATM is important when 
lesions occur during G2 and M phase. Distinct from its role in NHEJ, DNA-PK also 
assists in the DDR during both S and G2/M phase.  
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The cell cycle-dependent phosphorylation of RPA occurs by the action of cyclin-
dependent kinases. Rpa2 is phosphorylated during S-phase by cyclin A-Cdk2 and during 
mitosis by cyclin B-Cdk1 (OAKLEY and PATRICK 2010).S23, S29 and S33 are 
constitutively phosphorylated during S phase . These phosphorylation events in the 
unstressed cells are thought to be priming for phosphorylation that occurs during the 
DDR. 
 
Figure 3.1: Sequence comparison between amino acid 1-40 of Rfa2 (S. cerevisiae) 
andRpa2 (H. sapiens). Serine (S) and threonine (T) residues are highlighted, and their 
locations are denoted above or below the amino acid sequence. 
	  
RPA phosphorylation regulates interaction with single-stranded DNA and proteins 
Rpa2 phosphorylation not only acts as a signal for DNA damage, but also can 
help initiate repair by changing interaction with DNA and proteins. The Rpa2 
phosphorylated protein binds pyrimidine rich long sequences with affinity similar to WT 
RRA, but it shows decreased affinity towards short purine rich sequences (PATRICK et al. 
2005). The N-terminus of Rpa1 and hyper-phosphorylation mimicking Rpa2 were shown 
to interact with each other showing a functional link between these domains (BINZ et al. 
2003a). This interaction is thought to modulate the interaction of the complex with 
single-stranded DNA (ssDNA) and other proteins. The interaction between human RPA 
and Rad9 increases, whereas RPA interaction with the MRN complex decreases when the 
Rpa2 N-terminus is hyper-phosphorylated (OAKLEY and PATRICK 2010). Homologous 
recombination is one of the pathways to fix the DNA double-strand breaks, and two of 
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the proteins necessary for HR are Rad51 and Rad52. Hyper-phosphorylated Rpa2 was 
shown to interact more efficiently with Rad51 and Rad52 in vitro (WU et al. 2005) and 
assist the transfer of ssDNA to Rad52 to facilitate recombination (DENG et al. 2009). 
RPA is modified in single-celled eukaryotes to regulate cellular function  
Rpa2 phosphoryaltion is not extensively studied in single-celled eukaryotes as 
compared to humans. However some studies indicate the role of Rpa2 phosphorylation in 
cell cycle regulation and repair. A recent study in C. albicans showed that the 
phosphorylation state of Rfa2 regulates the DNA damage response under genotoxic 
stress. Under stress, Mec1 and the Clb2-Cdc28 phosphorylate the Rfa2 N-terminus at 
T11, S18, S29 and S30, which leads to DNA repair. While the recovery of cells after 
repair is initiated by the dephosphorylation of Rfa2 by PPH3 and its counterparts (GAO et 
al. 2014). In Candida albicans Rfa2 is dephosphorylated by Pph3 phosphatase during G1 
phase and under replication stress. Phosphorylation sites under these two conditions were 
different in Rfa2, indicating specific form of phosphorylated Rfa2 was key in regulating 
these events (WANG et al. 2013). While deletion of Pph3 phosphatase or Psy2 (regulatory 
subunit of Pph3) results in increased sensitivity to MMS, indicating that de-
phosphorylation of Rfa2 may be important in some cases (HANWAY et al. 2002). 
The S. cerevisiae is a commonly used model organism in genetics. The Rfa2 
subunit in S. cerevisiae is also phosphorylated during S and G2 phase of cell cycle by 
Mec1 kinase (DIN et al. 1990; BRUSH et al. 1996).The phosphorylation of Rfa2 is thought 
to play role in recombination (BRUSH et al. 2001). However, the importance of Rfa2 
phosphorylation in S. cerevisiae is unclear. In S. cerevisiae Ime2 kinase specifically 
phosphorylates Rfa2 at S27 during meiosis (CLIFFORD et al. 2004). The Ime2 is required 
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for normal meiotic progression, and the Rfa2 phosphorylation is thought to be important 
for proper initiation of meiotic progression (CLIFFORD et al. 2005). 
Goal of this study 
Overall, studies in human cells indicate that Rpa2 phosphorylation acts as switch 
to regulate DNA repair. In S. cerevisiae, two damage-dependent target sites for 
phosphorylation have been identified (Rfa1-S178 and Rfa2-S122); however, the mutation 
of known Mec1 phosphorylation sites in Rfa1 (S178) and Rfa2 (S122) do not result in 
any cellular sensitivity to DNA damage (GHOSPURKAR et al. 2015). This indicated that 
although these sites are targeted by a damage-dependent checkpoint kinase, they do not 
have an important role in the DDR in yeast. Studies indicate that phosphorylation of the 
Rfa2 N-terminus can occur in a pathogenic yeast. In Figure 3.1, a sequence comparison 
between the budding yeast Rfa2 and human Rpa2 N-termini show very similar locations 
for potential phosphorylation sites, indicating a potential role of this domain in DDR. 
Unlike its human counterpart, the specific sites involved in Rfa2 phosphorylation in 
response to DNA damage are relatively unexplored. We hypothesized that the Rfa2 N-
terminus is phosphorylated and may regulate RPA function in budding yeast. The focus 
of this chapter is on the role of the budding yeast Rfa2 N-terminus, and this chapter 
describes the following avenues of research by:  
1. Examining the role of the Rfa2 N-terminus and its phospho-state in yeast cell 
survival. 
2. Examining the role of the Rfa2 N-terminus and its phospho-state in DNA damage 
repair and cell cycle regulation. 
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3. Identifying important region(s)/site(s) located in Rfa2-N-terminus and their role 
in cell survival and the DDR.  
4. Examining the role of Rfa2 N-terminus and its phosphorylation in suppression of 
an Rfa1 mutant phenotype. 
Materials and Methods 
Strains and plasmids 
RMY122-A, RMY122-A-mre11Δ (deletion of the MRE11 gene), EGY48, RM26-
26C (M163) and RM-K264-10D (M403) yeast strains (Appendix A) were used to test 
cell viability and DNA damage survival of Rfa2 extreme mutants. RM26-26C and RM-
K264-10D are commonly used for meiotic analyses; however, in these studies, they 
provided for analysis of Rfa2 extreme mutant phentoypes in independent strain 
backgrounds. The RMY122A cells have a chromosomal deletion of the RFA1 and the 
RFA2 genes, which are complemented with two plasmids: (1) pRS313-RFA1 (HIS3 
selectable marker) and pRS315-RFA2 (LEU2 selectable marker) (Appendix A). All 
plasmids containing rfa2 extreme N-terminal mutants are derivatives of pRS315-RFA2.  
Plasmid Shuffle Assay 
Cells were typically grown on non-selective rich media, YPD (2% dextrose, 1% 
yeast extract, and 2% peptone), unless requiring dropout media to retain a plasmid(s). For 
plasmid shuffle assays to test for cell viability, various synthetic complete dropout media 
were required. The plasmid pRS313-RFA1 and appropriate pRS315-RFA2 mutant was 
co-transformed with LiAc/PEG method into RMY122A cells (GIETZ and WOODS 2002). . 
Transformants were recovered on synthetic complete media (0.5% ammonium sulfate 
and 0.17% yeast nitrogen base without amino acids) containing 2% dextrose (SD) and 
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lacking the amino acids histidine, leucine, and uracil (-HLU). An overnight culture in 
SD-HLU was inoculated with a colony and grown at 30°C (220 RPM) in an incubator 
shaker. The next day the cultures were pulse sonicated five times at 20% power (0.5 sec 
on, 1 sec off) and were counted using a cellometer Nexcelom. The concentration was 
adjusted to 1(10)7 cells/mL followed by 1:10 serial dilutions. Five microliters (5 µL) of 
each of the dilutions were spotted in a row on YPD, YPG (2% glycerol, 1% yeast extract, 
and 2% peptone), SD-HLU, and (SD+)5-FOA (0.8 µg/mL) plates to test viability. YPG 
media is used to assess whether cells have functional mitochondria, SD-HLU selects for 
cells that have retained all plasmids and 5-FOA selects for cells that have lost the URA3-
containing plasmid pJM132 (which also contains wild-type copies of RFA1 and RFA2). If 
the cells can survive with mutated rfa1 and rfa2 genes, then the cells will lose pJM132 
and survive on 5-FOA plates. Simultaneously 50 µL of 1(10)6 cells/mL was plated onto 
5-FOA plates to recover colonies that have lost the pJM132 plasmid. In this assay we are 
examining the ability of cells to lose pJM132 and survive on 5-FOA, and in the process, 
we are also recovering mutant cells. 
DNA damage assays 
The colonies that have lost the pJM132 plasmids were used to inoculate an 
overnight YPD culture incubated at 30°C. The next day the cultures were pulse sonicated 
five times at 20% power (0.5 sec on, 1 sec off) and were counted using cellometer 
(Nexcelom). The concentration was adjusted to 1(10)7 cells/mL followed by 1:10 serial 
dilutions. Five microliters (5 µL) of each dilution were spotted in a row on different YPD 
plates containing various concentrations of DNA damaging agents (Table 2.2) to assay 
cell sensitivity to DNA damage. 
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In vitro site-directed mutagenesis to generate rfa2 N-terminus mutants 
The Rfa2 extreme mutant plasmids were generated by Dr. Andre Walther (Cedar 
Crest College, Allentown, PA) and described in GHOSPURKAR et al. (2015). In order to 
generate Rfa2 N-terminus single and multi-mutants, primers were designed to be 60 
nucleotides (nt) in length, contain the desired missense mutation (S/T to either D or A), 
and in most cases, contain a silent mutation that either generated or removed a diagnostic 
restriction site. Colony cracking (crude plasmid DNA isolation) followed by restriction 
digestion was used to identify correct clones. Each mutagenesis reaction utilized a single 
mutagenic primer as described in http://www.molecularstation.com/forum/protocols-
methods-forum/19707-site-directed-mutagensis.html. The components of the reaction 
were: (1) 50 ng template DNA (pRS315-RFA2), (2) 0.2 µM single mutagenic primer, (3) 
0.2 mM dNTP mix, (4) 1x Phusion DNA polymerase buffer, (5) 3 mM MgCl2 and high 
fidelity Phusion DNA polymerase (New England BioLabs). The mutagenic primers are 
listed in Appendix C. Following mutagenesis, the reaction was digested with DpnI 
digestion at 37°C for 2 hr. A half of a microliter (0.5 µL) of the reaction was then 
transformed into DH10B E. coli cells via electroporation, and cells were plated onto LB 
plates containing 100 µg/mL ampicillin (LB+Amp) to select for transformants. Correct 
mutagenic plasmids were verified by DNA sequencing (Eton Biosciences). 
In vitro site-directed mutagenesis to generate rfa1 aromatic mutants 
We used a unique strategy to generate the rfa1 aromatic mutants. There are two 
aromatic amino acids in DBD-A and two in DBD-B, which are important for interaction 
between Rfa1 and ssDNA. To mutagenize each of these sites required four individual 
mutagenic primers (Appendix C). However, to generate all possible mutant combinations 
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(Table 3.1), all four mutagenic primers were added to the same mutagenesis reaction 
using pRS313-RFA1 as the template. Again, this was followed by DpnI digestion at 37°C 
for 2 hr and transformation of the reaction into DH10B cells. Mutations were identified 
by restriction digestion using diagnostic enzymes BglII (rfa1-A1), BlpI (rfa1-A2), NaeI 
(rfa1-B1) and EcoRV (rfa1-B2) .All possible combinations of rfa1-aro mutants were 
recovered and verified by DNA sequencing (Eton Biosciences). 
Table 3.1: Potential combinations of rfa1 aromatic mutants arising from in vitro 
site-directed mutagenesis using all four mutagenic primers in one reaction 
 
Number of rfa1 mutations 
Potential mutant 
combinations 
0 (no mutation) WT 
1 (single mutation) A1, A2, B1, B2 
2 (double mutation) A12, A1B1, A1B2, A2B1, A2B2, 
B12 
3 (triple mutation) A12B1, A12B2, A1B12, A212 
4 (quadruple mutation) A12B12 
 
DBD-A and DBD-B are denoted as A and B, respectively. Superscripts indicate the 
location of the aromatic residue in DBD-A or DBD-B (A1 = F238A; A2 = F269A; B1 = 
W360A; B2 =F385A).  
 
Detection of correct clones by colony cracking 
One µL of muatagenesis reaction was transformed in to DH10B cells using 
electroporation. Cells were plated on LB+Ampicillin plates. Individual colonies were 
used to inoculate overnight LB+Ampicillin cultures. 1mL of this culture was pelleted and 
the pellet was dissolved in 50µL of 1X lysis buffer (2mg/ml lysozyme, 15% sucrose, 
0.2mg/ml RNase A, 10mM Tris Cl pH 8.0, 1mM EDTA pH 8.0, 0.1mg/mL BSA). This 
mixture was boiled at 100°C for 90sec, followed by centrifugation at 15,000 RPM for 10 
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min. The supernatant is used to set up a reaction using appropriate restriction enzyme. 
The pRS315-Rfa2 mutants were further confirmed by sequencing from Eton Biosciences. 
Protein extraction, SDS-PAGE and Western Blotting 
The rfa2 extreme mutants were grown overnight in YPD at 30°C. The next day 
cultures growing in logarithmic phase were divided into two cultures, and one set of each 
culture was treated with 0.03% MMS. The cultures were allowed to grow for an 
additional 3 hr. Following the 3 hr growth period, the concentration of cells was 
determined using a cellometer, and approximately 5-6(10)7cells were harvested. Protein 
was isolated using the method of Kushnirov (2000). The separation of protein was carried 
out using standard Laemlli SDS-PAGE at constant current (30 mAmp). For detection of 
Rad53, an 8% (37.5:1 acrylmono:bis) SDS-PAGE gel was used. Rfa2 was detected using 
a 12% (37.5:1 mono:bis) SDS-PAGE gel containing 0 µM, 25 µM, or 50 µM Phos-Tag 
(Wako Pure Chemical Industries). The proteins were transferred to 0.45 µm nitrocellulose 
membrane at constant current 40 mAmp for 13 hr at 4°C. 
Dr. Steve Brill provided the rabbit polyclonal Rfa2 antibody. The rabbit 
polyclonal Rad53 antibody was ordered from Abcam (ab104232). Blots were blocked 
using 10% non-fat dry milk in 1x TBS-T followed by primary antibody incubation with a 
1:20,000 dilution of anti-Rfa2 antibody in 10% milk in 1x TBS-T overnight.  After the 
primary antibody incubation, blots were washed 3 times with 1x TBS-T and incubated for 
1 hr with goat anti-rabbit IgG (1:40,000) by Abcam (ab6721). The blots were again 
washed 3 times using 1x TBS-T and developed using Pierce ECL kit. To detect Rad53, 
blots were incubated overnight with anti-Rad53 antibody diluted 1:6,000 in 10% milk in 
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1x TBS-T. The rest of the procedure was followed similar to Rfa2 blot development as 
described above. 
Results 
The rfa2 N-terminus extreme mutants are viable but the rfa2-Dx and rfa2-ΔNx are 
sensitive to DNA damage 
The rfa2 N-terminus extreme mutants (Figure 3.3) were co-transformed with WT 
Rfa1 and cells were recovered on SD-HLU. The plasmid shuffle assay was performed, 
and the loss of pJM132 (containing Rfa1 and Rfa2) was assessed by growing cells on 5-
FOA plates. If the mutant rfa2 can support cell growth as a sole copy of RFA2 in cells, 
then cells will lose pJM132 plasmid and survive on 5-FOA plates.  The shuffle out assay 
showed that all of the Rfa2 N-terminus extreme mutants are able to support cell growth in 
unstressed condition (Figure 3.2).  The rfa2-ΔNx mutant was shown to survive in a 
deletion mutation study carried by Philipova (1996). In this study, we observed the same 
phenotype by rfa2-ΔNx. The shuffle out frequency of the extreme mutants was very 
similar to WT cells, as shown in the Figure 3.2. 
 	  
Figure 3.2: Plasmid shuffle assay of Rfa2 extreme mutants. Growth on 0.8 µg/mL 5-
FOA indicated viability, and the rfa1-t11 mutant serves as a control in this assay. 
 	   79 
An interesting observation about the phenotype of the RMY122A cells with Rfa2 
N-terminus mutants is the difference in growth rates (Table 3.2). The growth rate here 
represents the ability of these cells to grow under unstressed condition and reflects ability 
of cells to replicate and divide. The WT cells were used as the positive control while 
rfa1-t11 cells were used as a negative control reference. As represented in the Table 3.2 
we can see that rfa2-Ax has a slightly better growth rate than WT cells, which further 
asserts that rfa2-Ax does not interfere with the cellular function (Figure 3.4). The rfa2-Dx 
and rfa2-ΔNx show similar growth rate. Although these mutants do not grow as slow as 
rfa1-t11, they grow slightly slower than WT. This indicates that rfa2-Dx and rfa2-ΔNx are 
growth deficient (or sick) and indicates that the presence of the Rfa2 N-terminus is 
essential for cell growth. It is noteworthy, that these two mutants represent completely 
different phospho-states, yet show a similar phenotype.	  	  
Table 3.2: Growth rates for rfa2 extreme mutants in the RMY122-A background 
 
rfa mutant 
Generation time 
(min) 
WT 105.6 ± 11.9 
rfa1-t11 161.9 ± 16.6 
rfa2-Dx 112.1 ± 6.0 
rfa2-Ax 102.4 ± 11.9 
rfa2-ΔNx 111.5 ± 6.0 
 
We also tested Rfa2 N-terminus extreme mutants in multiple strain backgrounds 
to measure damage sensitivity and to determine if phenotypes observed were generally 
due to the rfa2 mutation or are strain-specific. We also tested different types and 
concentrations of DNA damaging agents. This tests if the phosphorylation state of Rfa2 
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N-terminus affects the different types of DNA damage response and helps to elucidate 
subtle differences between the mutants. For example, the camptothecin inhibits 
Topoisomerase Type-I while Hydroxyurea stalls replication fork. Although these two 
agents cause double stranded breaks, the mechanism is different and possibly they might 
use different response mechanism.   
 
Figure 3.3: A diagrammatic representation of rfa2 N-terminus extreme mutants. 
The WT Rfa2 shows the different Ser and Thr sites. In the mutants all the sites are 
mutated at the same time to Asp (Dx), or to Ala (Ax). The mutant where aa 1-38 are 
deleted is known as rfa2-ΔNx and represents absence of domain.    	  
As shown in Figures 3.4-3.7, irrespective of the strain background or 
type/concentration of DNA damaging agent, the rfa2-Dx and rfa2-ΔNx are the most 
sensitive mutants to DNA damage. For example in Figure 3.4, in the presence of 0.06% 
MMS, the WT and rfa2-Ax cells continue to survive up to 4th dilution the rfa2-Dx and 
rfa2-ΔNx mutant show growth up to the 2nd dilution. This was somewhat surprising, as the 
rfa2-ΔNx mutation is more similar to rfa2-Ax with respect to phosphorylation potential 
(i.e., neither can be phosphorylated at S/T residues). However, rfa2-Ax showed a 
phenotype nearly indistinguishable to WT. The rfa2-Dx was predicted to be DNA-
damage resistant, as it is mimicks the phospho-state that occurs in response to DNA 
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damage; however, it is DNA-damage sensitive. We propose that this might be due to this 
mutant mimicking a constitutively phosphorylated state, and that the inability to be 
“dephosphorylated” might lead to this phenotype.  
 
 
 
 
Figure 3.4: DNA damage assay of rfa2 extreme mutants in RMY122A strain 
background. The various damaging agents are denoted at the bottom left of each row. 
The rfa1-t11 served as a negative control in these experiments. 
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Figure 3.5: A picture showing DNA damage assay of rfa2 N-terminus extreme 
mutants in a 403 strain background. The various damaging agents are denoted at the 
bottom left of each row. The rfa1-t11 served as a negative control in these experiments.In 
this strain the rfa2-Dx and rfa2-ΔNx are sensitive in stressed condition irrespective of the 
type and concentration of damaging agent. 
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Figure 3.6: A picture showing DNA damage assay of rfa2 N-terminus extreme 
mutants in an EGY48 strain background. The various damaging agents are denoted at 
the bottom left of each row. The rfa1-t11 served as a negative control in these 
experiments. As seen in the picture all the mutants are able to survive in unstressed 
condition (YPD) and the most sensitive mutants are rfa2-Dx and rfa2-ΔNx in both strains 
and all DNA damaging conditions. 
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Figure 3.7: A picture showing DNA damage assay of rfa2 N-terminus extreme 
mutants in 163 strain background. The various damaging agents are denoted at the 
bottom left of each row. The rfa1-t11 served as a negative control in these experiments.  	  
The Rfa2-N-terminus single mutants are viable but are not affected by DNA damage 
A study carried in our lab showed that the known Mec1 phosphorylation sites in 
Rfa1 and Rfa2 when mutated to Alanine, do not show damage sensitivity (GHOSPURKAR 
et al. 2015).  However, the rfa2 extreme mutants tested in this study show DNA damage 
sensitivity. This indicates that phosphorylation of Rfa2 might be involved in damage 
response like its human counterpart. In humans, it is known that the phosphorylation at 
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one site in N-terminus triggers phosphorylation of the other sites. For example, the 
phosphorylation of S33 by ATR in meiotic cells triggers phosphorylation at S23 and S29 
by CDK (ANANTHA et al. 2007). We hypothesized that like its human counterpart, the 
phosphorylation of Rfa2 in yeast is also sequential and is useful to amplify the DNA 
damage response signal. To test this hypothesis we developed Rfa2 single mutants, 
whereby we mutated one site at a time to either Asp (rfa2-Di) or Ala (rfa2-Ai). 
The first step was to test the ability of the single mutants to support the viability 
of cells in unstressed condition and lose the pJM132 plasmid. In the shuffle out assay we 
observed that all the rfa2-Di and rfa2-Ai mutants were able to support cell viability in 
unstressed condition (Figure3.8). Also the frequency of shuffle out was found to be 
similar to the WT cells. These cells were recovered on 5-FOA plates and were then 
subjected to DNA damage assay. In this assay we tested CPT, HU and MMS in the 
optimal concentrations. As seen in Figure 3.9 the rfa1-t11 rfa2-Dx double mutant shows 
“no growth” phenotype and serves as a negative control. This shows that these 
concentrations are enough to induce damage sensitivity.  We observed that the rfa2-Ai3 
mutant has a high sectored colony phenotype (red and white colonies); this is indication 
of high mutation rate, which can be effect of rfa2-Ai3 mutant. When tested further, it was 
found to be a defect in the particular patch and had no direct connection with the mutant 
(data not shown). However as shown in Figure 3.9 A and B, both the rfa2-Di and rfa2-Ai 
set of mutants do not show any sensitivity and have a phenotype closer to WT cells. This 
suggests that phosphorylation at individual sites may not be enough to trigger DNA 
damage sensitive phenotype in S. Cerevisiae.  
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Figure 3.8: The shuffle out assay of rfa2-Di and rfa2-Ai mutants. The Aspartic 
mutants are denoted by Di and Alanine mutants are denoted by Ai. The symbol ‘i’ stands 
for the amino acid site in Rfa2 NT. Both types of mutants support the cell viability. And 
the frequency of shuffle out is observed similar to the WT cells.  	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A. 
 
B. 
                           
 
Figure 3.9:  The DNA damage assay of rfa2 NT single mutants. A) The DNA damage 
assay of rfa2-Di mutants shows that all the individual mutants are resistant to DNA 
damage unlike the rfa1-t11+rfa2-Dx, which is sensitive. B) The DNA damage assay of 
rfa2-Ai mutants show that all the individual mutants are resistant to DNA damage. 
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The Rfa2-multi-mutants are viable and decipher the important regions responsible 
for DNA damage sensitivity 
The Rfa2 extreme mutants in this study show that the phosphorylation domain’s 
presence and its phosphorylation state affects the DDR pathway. However, we could not 
impart this sensitivity to any particular phosphorylation site in this domain. Therefore, we 
developed mutants by dividing them into three different groups. These groups consist of 
3-4 phosphorylation sites (Figure 3.10); and will be referred as multi-mutants (Dm, Am or 
Nm). The multi-mutants were tested for supporting cell viability in shuffle out assay. All 
the rfa2-Dm and rfa2-Am multi-mutants were found to shuffle out the pJM132 plasmid 
supporting the cell growth. The frequency was found to be similar to WT cells and better 
than the extreme mutants rfa2-Dx and rfa2-Ax Figure 3.11 A. The rfa2-Dm1 mutant was 
found to be lethal in this shuffle out assay but when more candidates were tested it was 
recovered (data not shown). 
	  	  
Figure 3.10: Diagrammatic representation of Rfa2 multi-mutants showing different 
clusters of phosphorylation site mutated together to form multimutants. S= Serine, 
T=Threonine, Dm = multiple sites mutated to Aspartic acid, Am = multiple sites mutated 
to Alanine and ΔN= a portion of amino acid region deleted.  
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A. 
 
 
B. 
 
 
Figure 3.11:  The cell viability and DNA damage assay of rfa2 NT multimutants. A) 
Shuffle out assay of Rfa2 multi-mutants showing successful shuffle out of all multi-
mutants in RMY122A cells. B) DNA damage assay of all Am multi-mutants shows that 
all the alanine multi-mutants are resistant to DNA damage.  
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C. 
 
 
Figure 3.11:  The cell viability and DNA damage assay of rfa2 NT multimutants 
(continued). C) DNA damage assay of all Dm multi-mutants showing that Dm1+3 is 
sensitive to DNA damage.  
 
 
 
Figure 3.12: The DNA damage assay of three independent candidates showing rfa2-
Dm1. The rfa2-Dm1 is resistant to DNA damage. The rfa2-Dm2+3 was used as control. The 
above DNA damage concentrations were picked so that they are not toxic but can show 
even subtle sensitivity differences.   
 
When the rfa2-Dm and rfa2-Am multi-mutants were subjected to DNA damage 
assay we found that all the Am multi-mutants were resistant to DNA damage Figure 3.11 
B. This was expected, as the rfa2-Ax mutant is resistant to DNA damage. When the rfa2-
Rfa2 multi-mutants were tested the rfa2-Dm1+3 mutant was found to be slightly sensitive. 
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The rfa2-Dm1 and rfa2-Dm3 mutant however was found to be resistant to DNA damage 
(Figure 3.12 and 3.11 respectively). It is noteworthy, that rfa2Dm1+3 sensitivity was 
similar to rfa2-Dx and rfa1-t11 rfa2-Dx double mutant is synthetically lethal. Hence, we 
can conclude that the region 1 and region 3 together contribute the damage sensitivity to 
the rfa2-Dx mutant.  
A) 
 
 
B) 
 
 
Figure 3.13:  The cell viability and DNA damage assay of rfa2-ΔNm multimutants. 
A) shuffle out assay of rfa2-Nm mutants in RMY122A background. All the multi-
mutants shuffle out similar to WT cells.B) DNA damage assay of rfa2-ΔNm mutants in 
RMY122A background. The rfa2-ΔNm3 mutant shows damage sensitivity similar to rfa2-
ΔNx. 
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The rfa2-ΔNm multi-mutants were all able to shuffle out with similar frequency to 
that of WT and rfa2-ΔNx cells. It is noteworthy that rfa1-t11 rfa2-Dx double mutant was 
found to be synthetically lethal 3.13 A. The cells were recovered and subjected to DNA 
damage assays. The rfa1-t11 served as a negative control in this assay. The rfa2-ΔN3 
mutant is showing a damage sensitive phenotype similar to rfa2-ΔNx mutant Figure 3.13 
B. Hence, we can conclude that the 3rd region of Rfa2- N-terminus that is S30, T32 and T34 
are important for DNA damage response. 
The phosphorylation state of Rfa2-N-terminus affects RFA-Mre11 inter-complex 
interaction 
In previous study, it is shown that the human Rpa1 N-terminus and Rpa2 
phosphorylation are key components that regulate RPA and MRN complex interactions 
(OAKLEY et al. 2009). Also the component of MRN complex; NBS1 is shown to trigger 
Rpa2 phosphorylation by ATR (MANTHEY et al. 2007). Hence we chose to study this 
interaction further. In this study, we found that in mre11Δ rfa2-Dx double mutant is not 
viable (3.14B). To locate the key site responsible for this phenotype and in extension 
responsible for regulating RFA-MRX complex interaction, we tested the rfa2-Di mutants 
in mre11Δ background.  
All the individual mutants were able to support cells as sole copy of Rfa2 that is 
viable on 5-FOA (data not shown). The mre11Δ cells by themselves are sensitive to DNA 
damage. Therefore as shown in Figure 3.14A, all the individual mutants are sensitive to 
DNA damage and we cannot attribute this phenotype to any particular site. We further 
tested the rfa2-Dm mutants and as shown in Figure 3.14B the rfa2-Dm2+3 and rfa2-Dm3 
mutants are sensitive in terms of cell viability on 5-FOA plates. However, they are not as 
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sensitive as rfa2-Dx. The rfa2-Dm1+3 mutant is as sensitive as rfa2-Dx, it is noteworthy 
that rfa2-Dm3 itself survives slightly better. Hence the combination of region 1 and 3 
leads to DNA damage sensitivity. This implies that phosphorylation of S3, S11, S12, S30, 
T32 and T34 interferes with cell cycle regulation in absence of functional Mre11 protein. 
We also tested all the rfa2-Am multi-mutants for viability on 5-FOA and all can survive as 
expected (data not shown).  However, DNA damage assay was not performed since 
mre11Δ itself leads to sensitivity to DNA damage. In this study we used rfa1-t11 as a 
control and we observed that in mre11Δ rfa1-t11 double mutant is lethal for cells. This 
data imitates the data found in human cells, whereby both Rpa1 and Rpa2 N-terminus 
regions were important for interaction with MRN complex (OAKLEY et al. 2009).  
The phosphorylation state of Rfa2 N-terminus affects intra-complex interactions in 
RFA complex  
The Rfa1 subunit of RFA is thought to be the majorly involved in DNA-binding 
activity, through DBD-A and DBD-B. The DBD-F of this subunit is thought to be 
responsible in protein-protein interaction. A well-studied mutation in this domain is rfa1-
t11 (K45E). Interestingly this mutant is; replication proficient but recombination deficient 
mutant (WANG and HABER 2004). It triggers checkpoint response after DNA damage, 
however it interferes in the homologous recombination repair (VANOLI et al. 2010). In 
our studies, we found that in cell viability assay rfa1-t11 rfa2-Dx double mutant is viable 
but rfa1-t11 rfa2-ΔNx mutant is lethal for cells. This was a very interesting observation 
for us since DBD-F and Rfa2 N-terminus asp peptide were shown to interact by NMR. 
We further wanted to locate the region responsible for this phenotype and therefore we 
co-transformed the rfa1-t11 mutant plasmid with rfa2-ΔNm multi-mutants. After that we 
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tested for their recovery on 5-FOA plates as described in methods. We found that the 
rfa1-t11 rfa2-ΔNm1 and rfa1-t11 rfa2-ΔNm3 were sensitive on 5-FOA (Figure 3.15). Hence 
we can conclude that region 1 (S3, S11and S12) and region 3 (S30, T32 and T34), 
contribute to the lethality of rfa1-t11 rfa2-ΔNx double mutant.  
A) 
 
 
Figure 3.14:  The DNA damage and cell viability assay of rfa2-Di and rfa2-Dm 
mutants in mre11Δ background. A) A DNA damage assay showing that the rfa2-Di 
mutants can survive in unstressed condition in mre11Δ background but are sensitive to 
DNA damage. 
 
 
 
 
 
 
 
 
 
 
 	   95 
B) 
 
 
Figure 3.14:  The DNA damage and cell viability assay of rfa2-Di and rfa2-Dm 
mutants in mre11Δ background (continued). B) A shuffle out assay of rfa2-Dm multi-
mutants showing mre11 Δ rfa2-Dx double mutant is lethal and that region 1 and 3 are 
responsible for this phenotype. 
 
 
 
Figure 3.15: The shuffle out assay showing viability of rfa1-t11 rfa2-ΔNm double 
mutants. The cell viability is determined on the basis of ability to grow on 5-FOA plates. 
The rfa1-t11 rfa2-ΔNx mutant is lethal while Nm1 and Nm3 region with rfa1-t11 are 
showing reduced growth on 5-FOA plates. 
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Deletion of Rfa2 N-terminus rescues the synthetic lethality caused by Rfa1 aromatic 
mutants 
RFA is a heterotrimeric complex with multiple roles in DNA metabolism. It is 
well known that, proteins forming a single complex affect each other’s function. The N-
terminus of Rfa1 and Rfa2 are hypothesized to affect the function of RFA complex by 
interacting with other subunits. In humans, an NMR study showed direct interaction 
between the N-terminus of Rpa1 and Rpa2 (BINZ et al. 2003b). This interaction is 
thought to play role in regulating protein-protein interactions. We have previously shown 
that the rfa2-ΔNx rfa1-t11 double mutant is not viable indicating that these mutants are 
not involved in the same pathway. In this study, we use mutagenesis to examine if the 
phosphorylation status of Rfa2 N-terminus affects function of Rfa1with the help of rfa1-
Aro mutants (Figure 3.16A). These aromatic residues are important for ssDNA-binding 
activity of Rfa1 and these residues are conserved in humans, mouse, drosophila and yeast 
(HASS et al. 2012).   
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
 	   97 
A)	  
	  	  	  
B)	   	  
	  	  
 
Figure 3.16: A diagram representing the rfa1-Aro mutants sites in Rfa1 and the 
shuffle out assay of rfa1-Aro single mutants. A) A diagrammatic representation of rfa1-
Aro mutants showing location of aromatic amino acids essential for ssDNA-binding in 
DBD-A and DBD-B.  These are renamed as A1, A2, B1 and B2 as shown here. B) All 
single rfa1-Aro single mutants expressed with WT copy of Rfa2 are shown n the left side 
while with rfa2-ΔNx mutant are shown on the right.  
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A) 
 
B) 
 
 
Figure 3.17: Shuffle out assay of rfa1-Aro double mutants. A) All the rfa1-Aro double 
mutant combinations located in different DBD are shown here, these are not viable in 
presence of WT Rfa2 but are rescued in presence of rfa2-Nx. B) All double mutants 
located in the same DBD are shown here this data indicates that aromatic a.a. in DBD-A 
are more important for cell survival as compared to DBD-B.  
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The rfa1-Aro mutant plasmids were co-transformed with WT Rfa2. All the triple 
and quadruple rfa1-Aro mutants were lethal and we did not recover any colonies on 5-
FOA. All single mutants were viable except the rfa1-AroA2 mutant; in all three 
independent experiments we did not recover any colonies on 5-FOA. This was 
contradictory to previous study carried out by Philipova et al, which showed that rfa1-
AroA1 (Phe 238) is lethal for cells (PHILIPOVA et al. 1996).  In humans, it was shown that 
the individual aromatic residue mutated to alanine reduces the affinity towards DNA only 
moderately (WALTHER et al. 1999). Hence the recovery of rfa1-A1, B1 and B2 is not 
surprising and shows that in yeast it follows a similar pattern Figure 3.16 B.   
It was previously shown that the ssDNA-binding activity of the RPA complex 
requires both DBD-A and DBD-B. In fact the A and B domains by themselves bind DNA 
weakly and stable ssDNA interactions is achieved only when both the domains are 
present (BRILL and BASTIN-SHANOWER 1998; ARUNKUMAR et al. 2003). When we 
studied combination double mutants whereby both domains have one mutation, we did 
not recover cells. This is because function of both the domains was hampered. It was 
shown that when we both the sites in the same domain are mutated it reduces the binding 
of that domain (BASTIN-SHANOWER and BRILL 2001). These double mutants were 
interesting to study, as we did not recover rfa1-AroA12 and rfa1-AroB12 was viable (Figure 
3.17B). This suggests that the DBD-B has a dispensable function in ssDNA-binding, 
which is also suggested by single mutant data where both DBD-B single mutants were 
viable. 
In order to study the effect of phosphorylation state of Rfa2 N-terminus on Rfa1 
function, we studied rfa1-Aro rfa2-ΔNx double mutants. As shown in Figure 3.16, Figure 
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3.17 and Table 3.4 surprisingly rfa2-ΔNx rescues the rfa1-Aro single and double mutants. 
The only mutant that remains unaffected is rfa1-AroA2. All the DBD-B single and double 
mutants were found viable in presence of WT Rfa2, and we recovered more colonies in 
presence of rfa2-ΔNx. This indicates that the absence of Rfa2 N-terminus enhances the 
growth. It is noteworthy that the rfa1-AroA2 mutant shows a dominant negative 
phenotype. All the triple and quadruple mutants are lethal for the cells and were not 
recovered by rfa2-ΔNx expression.  
The Rfa2 extreme mutants do not interfere with DNA damage response and induce 
phosphorylation of Rfa2 in a region other than N-terminus  
When subjected to DNA damage the cells undergo two processes, one is halt cell 
cycle progression and the second is to recognize and fix damage. The halting occurs via 
the DDR pathway, a complex signal transduction network, which regulates the response. 
The phosphorylation of checkpoint kinase Rad53 is considered as an ultimate mark of 
activation of the DDR pathway (MA et al. 2006) (JANKE et al. 2010). Another important 
feature of DDR pathway is the phosphorylation of Rfa2 in response to DNA damage by 
Mec1 (BRUSH et al. 1996) (JANKE et al. 2010). In this pathway the Rfa2 and Rad53 
phosphorylation events are important and we hypothesize that they affect each other. 
In this study we tested the phosphorylation of Rfa2 and Rad53 in cells, which 
contain the Rfa2 extreme mutants as the sole copy of Rfa2.  
As shown in Figure 3.18 (A) when induced with 0.03% MMS we can see 
increased expression of Rfa2 as compared to unstressed samples in blot without Phos-Tag 
(upper blot). This increased expression is not unusual, it was previously demonstrated 
that RFA expression increases in response to DNA damage (TKACH et al. 2012). When 
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we add 50µM Phos-Tag we can see a doublet all across (lower blot). Again, the Rfa2 is 
known to be phosphorylated during G1/S transition and M phase of cell cycle (DIN et al. 
1990) (FANG and NEWPORT 1993). However the distinct observation in this assay is that 
in rfa2-Dx sample the phosphorylated species is slightly higher in MMS induced sample 
as compared to WT and rfa1-t11 cells. Also the phosphorylated species in the MMS 
induced rfa2-ΔNx cells is higher and defined species. We lowered the concentration of 
Phos-Tag to 25 µM and we see doublet in MMS induced rfa2-Dx and rfa2-ΔNx samples 
only validating the results we saw with 50µM Phos-Tag. This indicates that although 
Rfa2 gets phosphorylated during cell cycle, the rfa2-ΔNx and rfa2-Dx mutants induce a 
different response (or condition), which triggers phosphorylation of Rfa2 at a site other 
than N-terminus.  
We further tested if the Rfa2 extreme mutants cause any defect in DDR pathway 
and hence trigger phosphorylation of Rfa2. The Rad53 phosphorylation event is 
considered a hallmark of functional DDR pathway. As shown in Figure 3.18 C that 
Rad53 phosphorylation remains unaffected by all the Rfa2 extreme mutants. This 
indicates that in this experiment the DNA damage was successfully induced by MMS 
treatment and that Rfa2 mutants do not affect the DDR pathway.  
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A)                                                                  B) 
         
	  
C)	  	  
	  	  	  	  	   	  
 
Figure 3.18: Western blots of rfa2 NT extreme mutants for detection of Rfa2 and 
Rad53 phoshprylation. A) The WB of Rfa2 extreme mutants unstressed (0) and MMS 
induced samples (+) with α-Rfa2 antibody. The upper blot is developed from 12% SDS-
PAGE without Phos-Tag while lower one contains 50µM Phos-Tag. B) The WB of rfa2 
extreme mutants unstressed (0) and MMS induced (+) samples. The upper blot is 
developed from 12% SDS-PAGE gel without Phos-Tag while lower one contains 25µM 
Phos Tag. C) WB of Rfa2 extreme mutants in unstressed (0) and MMS induced (+) 
samples developed with α Rad53 antibody showing Rad53 phosphorylation in all samples 
stressed with MMS.   
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Discussion 
The Rfa2 N-terminus is essential but its phosphorylation is dispensable in yeast 
It is well established in human cells, that the Rpa2 N-terminus is hyper-
phosphorylated in response to DNA damage. In this study we established that in S. 
Cereviciae, the Rfa2 N-terminus phosphorylation is dispensable. There are 11 potential 
Ser and Thr sites located in this region and are similar in sequence as compared to their 
human counterpart. The rfa2-Dx mimics hyper-phosphorylated for of Rfa2 and supports 
cell viability. This mutant leads to a sensitive phenotype in presence of DNA damage. 
However, rfa2-Ax; a mutant incapable of getting phosphorylated in the Rfa2 N-terminus 
survives like WT cells in presence of damage. In fact its growth rate is better than wild 
type cells. This implies that in yeast cells phosphorylation at Rfa2 N-terminus can be 
avoided in presence of DNA damage. Despite the data shown by rfa2-Ax mutant we still 
see rfa2-Dx cells being sensitive to DNA damage.  
This can be explained by considering three different points. Firstly, the rfa2-Dx 
represents continual phosphorylation that is an irreversible event, this indicates that de-
phosphorylation of this domain would be important. Secondly, the phosphorylation 
mimicking state might trigger a cell cycle checkpoint. And lastly, the mutation affects the 
stability of the domain. We addressed this in some other studies carried out in our lab, 
which are explained further (see section on adaptation Figure 3.21).  
Another important observation in this study shows that the rfa2-ΔNx is able to 
support cell viability. This mutant represents absence of the Rfa2 NT (amino acids 1-38). 
However, in presence of DNA damage this mutant also shows sensitive phenotype. The 
rfa2-Ax and rfa2-ΔNx both mutants are incapable of getting phosphorylated, the 
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difference is physical absence of the domain in the later. Hence, the cells require Rfa2 N-
terminus to recover from DNA damage in yeast irrespective of its phosphorylation state. 
This was also supported by the western blot data, when treated with MMS all the rfa2 
extreme mutants show phospho-species (Figure 3.18A).  
Region 1 and region 3 of Rfa2 NT are accountable for DNA damage sensitivity in 
yeast 
In humans, the phosphorylation of Rpa2 N-terminus occurs sequentially. This 
pattern is seen because different kinases (CDK or PIKK) have different sites as substrate. 
And phosphorylation at one site by a particular kinase known as priming, leads to 
phosphorylation at other sites (LIU et al. 2012). In order to decipher if similar priming 
reaction occurs in S. Cerevisiae we developed rfa2 single mutants. If this priming 
reaction occurred the rfa2-Ai mutants would block further phosphorylation of Rfa2. 
However all the rfa2-Ai and rfa2-Di mutants showed robust growth and were resistant to 
DNA damage.  
We further developed Rfa2 N-terminus multi-mutants to test if the priming 
requires more than one site and if any particular group was responsible for the DNA 
damage phenotypes shown by rfa2-Dx and rfa2-ΔNx. We divided Rfa2 N-terminus in to 
group1 (S3, S11, S12 and T14), group2 (S21, S23 and S27) and group3 (S30, T32 and 
T34) as shown in Figure 3.9. The rfa2-ΔNx mutant is sensitive to DNA damage and when 
we divided it to sub regions, rfa2-ΔNm1 and rfa2-ΔNm3 were found sensitive. Similarly, 
the rfa1-t11 rfa2-ΔNx  double mutant is lethal and this phenotype can also be attributed to 
region1 and 3. The rfa2-Dx mutant is sensitive to DNA damage and although rfa2-Dm1 is 
not sensitive as rfa2-Dm3 when combined as Rfa2-Dm1+3 these two regions show the most 
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sensitive phenotype. Hence overall a combination of these two regions was found most 
sensitive. We conclude that all phenotypes observed with rfa2-Dx and rfa2-ΔNx can be 
accounted to combination of region1 and region3. It is noteworthy that the similar region 
was found important in humans, to activate DNA damage response (LIU et al. 2012). 
The Rfa2 is phosphorylated to a site located in unknown region of Rfa2 in rfa2-Dx 
and rfa2-ΔNx mutants 
Since rfa2-Ax and rfa2-ΔNx cannot be phosphorylated at the N-terminus it is 
evident that phosphorylation is occurring at some other site on Rfa2. A well-known site is 
S122 a substrate for Mec1 and the only known site phosphorylated in response to DNA 
damage. Other sites include T38, S115, S116, Y120, S122 and S189, which were 
suggested by mass spec analysis of phospho-peptides, but the conditions were not stated 
(www.phosphogrid.org). The western blot analysis of Rfa2 extreme mutants showed a 
phospho species in response to MMS induced DNA damage. Since all the three rfa2 
extreme mutants were incapable of getting phosphorylated at N-terminus, this species is 
generated due to phosphorylation at an unknown site. However, it is noteworthy that 
these distinct phospho-species are generated only in rfa2-Dx and rfa2-ΔNx samples. It is 
possible that these mutants trigger Rfa2 phosphorylation for a cellular event apart from 
DDR. 
It is clear from the Rad53 blots that all rfa2 extreme mutants have a functional 
DDR pathway. And hence we can say that the N terminal phosphorylation does not affect 
DDR signaling pathway. In the future it will be interesting to study which sites are 
phosphorylated in the rfa2-Dx and rfa2-ΔNx mutants using mass spectrometry.  
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The genetic interaction studies reveal rfa2-Dx and rfa2-ΔNx show similar phenotype 
but have different mode of action 
In this study, we found that rfa2-Dx and rfa2-ΔNx are sensitive to DNA damage. 
The rfa2-Dx represents the hyper-phosphorylated state of the N-terminus or continual 
phosphorylation. While the rfa2-ΔNx cannot be phosphorylated and might cause loss of 
interaction with other repair proteins. We found that both these mutants have different 
mode of action, through genetic interaction studies. 
	  
 
Figure 3.19: A model explaining the differences in mode of action of rfa2-Dx and 
rfa2-Nx mutants with the help of genetic interaction studies with rfa1-t11. This study 
indicates that rfa1-t11 and rfa2-Dx have synergistic effect on cell survival. 
 
 The MRN complex has a role in DNA replication, DNA damage recognition, cell 
cycle regulation and repair (LAVIN 2007).  In humans, the N-terminus of Rpa1 interacts 
with Mre11. When phosphorylated, Rpa2 disrupts tis interaction by binding to the Rpa1 
N-terminus (OAKLEY et al. 2009). In yeast cells, we found that both rfa1-t11, rfa2-Dx and 
mre11Δ mutants are sensitive to DNA damage, but are viable in unstressed condition. 
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This indicates that individually they affect the DNA repair process. However, the rfa2-Dx 
mre11Δ double mutant is not viable in unstressed cells, showing additive effect of these 
mutants.  We saw a similar phenotype with rfa1-t11 mre11Δ double mutant. This implies 
that rfa2-Dx affects cellular processes that are independent of Mre11. 
	  	  
Figure 3.20: A model explaining the synergistic effect of rfa1-t11 and rfa2-Dx 
mutants utilizing genetic interaction studies with Mre11. Both rfa1-t11 and rfa2-Dx 
show non-viability in presence of mre11Δ. 	  
As described previously, the proteins involved in the same complex regulate each 
other’s function. We chose to study the rfa1-t11 mutant because it lies in the same 
complex but different protein and it is a recombination deficient mutant. The rfa1-t11 
mutant itself in unstressed cells is slightly sensitive while rfa2-ΔNx  is not. When 
combined together, the rfa1-t11 rfa2-ΔNx double mutant is lethal for cells in unstressed 
condition. Again, this indicates additive effect of the two mutants. It is noteworthy that 
the rfa1-t11 rfa2-Dx mutant is sensitive but not lethal for cells. Overall this indicates that 
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rfa2-Dx and rfa2-ΔNx have different effects on cellular growth and DNA damage (Figure 
3.19). Also, the rfa1-t11 and rfa2-Dx have synergistic effect (Figure 3.20).  
Rfa2 N-terminus has a unique role in yeast cells and supports the data in this study 
The role of Rfa2 N-terminus phosphorylation is dispensable in response to DNA 
damage, but it has a unique role in checkpoint adaptation. Data produced by my 
colleague Mr. Timothy Wilson shows that rfa2 extreme mutants have differences in 
checkpoint adaptation and can possibly explain the differences in phenotypes of these 
mutants. Checkpoint adaptation is the ability of cells to override the G2/M checkpoint 
even in presence of DNA damage. The adaptation phenotype is assessed with the help of 
Rad53 phosphorylation. As the cells adapt in presence of broken DNA, the rad53 is 
dephosphorylated with time. While in adaptation deficient cells, the Rad53 is continually 
phosphorylated (PELLICIOLI et al. 2001). It was shown that the rfa1-t11 mutation induces 
adaptation in ku70Δ cells and tid1Δ cells, which are otherwise adaptation deficient (LEE 
et al. 1998) (LEE et al. 2001). Similarly, in our studies we were able to show that rfa2-Dx 
induces adaptation in ku70Δ cells (GHOSPURKAR et al. 2015) see Figure 3.21. Again, this 
data shows that rfa1-t11 and rfa2-Dx have a synergistic effect. This also explains the 
DNA damage sensitive phenotype of rfa2-Dx. On plates, the cells are undergoing 
continuous DNA damage (for around 48-50 hrs). The adaptation proficient cells have 
more genomic instability and hence show sensitivity. In all the assays the rfa2-Ax mutant 
phenotype found similar to WT cells. In this assay as well we found that the rfa2-Ax 
ku70Δ double mutant was adaptation deficient like the WT cells. We hypothesize that the 
rfa2-ΔNx will be adaptation deficient since it has been showing a phenotype different 
from rfa2-Dx.  
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Figure 3.21: Western blot assay to detect Rad53 phosphorylation over the course of 
time depicting adaptation. This experiment analyses rad53 phosphorylation in response 
to DNA damage induced by HO endonuclease. The yku70Δ cells are adaptation deficient, 
and they can adapt only in presence of rfa1-t11 and rfa2-Dx.   
 
Rfa2 N-terminus deletion rescues the effect of Rfa1 aromatic mutants  
Some of the rfa1-Aro single and double mutants display a ‘no growth’ phenotype 
in unstressed condition. However all of them except rfa1-AroA2 recover when rfa2-ΔNx is 
present in cells Figure 3.22. The no growth phenotype can mean two things one, the cells 
are dead or two the cells are arrested i.e. the growth is temporarily inhibited. The ability 
to overcome the ‘no growth’ phenotype in presence of rfa2-ΔNx indicates that the rfa1-
Aro single or double mutants are inducing cell cycle arrest. And the presence of Rfa2 N-
terminus is important for the inducing this checkpoint.  In human cells, the rpa1-AroA12 
and rpa1-AroB12 mutants caused cells to accumulate in G2/M phase of cell cycle and they 
do not localize to sites of DNA repair (HARING et al. 2008). 
This data shows that the DBD-A aromatic residues are more important than the 
DBD-B residues. Because all the rfa1-AroB single mutants and rfa1-AroB12 mutant 
survive in unstressed condition. However, they show better recovery in presence of rfa2-
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ΔNx indicating that they also contribute probable DNA lesions but not to the point of 
inducing checkpoint.  
The triple and quadruple mutant phenotypes are expected since 75% to 100% of 
the sites are mutated the RPA cannot bind ssDNA at all and therefore cells die. This was 
also shown with the help of in vitro data, whereby rfa1-AroA12B12 mutant did not bing 
ssDNA at all (BASTIN-SHANOWER and BRILL 2001). If we consider that, like humans, 
rfa1-Aro single and double mutants are inducing G2/M checkpoint it indicates that 
irrespective of their ability to bind ssDNA the cells are able to go through replication. 
This can be explained using a model developed from previous work (BASTIN-SHANOWER 
and BRILL 2001) (BOCHKAREVA et al. 2001).  
The model here explains that the ssDNA-binding is initiated by DBD-A followed 
by binding of DBD-B. These two domains are essential in 8-10 nucleotide ssDNA-
binding. As the length of ssDNA increases, the other DBDs of Rfa1 and Rfa2 are 
involved. Now, the longer ssDNA molecules are generated mostly during replication. 
Hence, this explains why the rfa1-Aro mutants are able to replicate but not able to repair. 
The odd one out of these mutants is rfa1-AroA2 which despite being a single mutant does 
not recover in presence of rfa2-ΔNx. This indicates that even this single mutation does not 
allow RFA binding to DNA and cells die.  
One interesting observation is that in humans, these cells are shown to accumulate 
in G2/M, which is rescued by rfa2-ΔNx. However, the rfa2-ΔNx does not help cells 
override the G2/M checkpoint induced by DSB (see section on adaptation). This indicates 
that the rfa1-Aro mutants induce checkpoint using a pathway dissimilar to that used in 
DSB induced repair. 
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Figure 3.22: A model summarizing the results of rfa1-Aro mutants phenotype and 
their rescue in presence of rfa2-ΔNx. 	  
The potential molecular mechanism of Rfa2 NT in checkpoint activation 
The genetic interaction data and the adaptation data indicated that the rfa2-Dx and 
rfa2-ΔNx mutants have different molecular mechanism. As shown in Figure 3.23 we 
propose a model explaining the molecular mechanism through which these mutants may 
differ in their function. DBD-F of Rpa1 and the hyper-phosphomimetic Rfa2 NT peptides 
were shown to interact with each other in solution with NMR. The negatively charged 
Rpa2 NT peptide was proposed to act like a DNA molecule, which now can interact with 
the DBD-F, which has ssDNA-binding properties (OB fold). DBD-F of Rfa1 is also 
known to interact with a number of proteins. Thus we propose that the rfa2-Dx mutant is 
a phosphomimetic mutant and can interact with DBD-F (because of negative charges of 
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Aspartic acid). This then sequesters DBD-F from interacting with its potential protein 
partner (represented in model by ‘X’): an interaction that activates checkpoint arrest. 
Therefore the rfa2-Dx causes loss of DBD-F interactions leading to checkpoint 
adaptation. The rfa2-ΔNx mutant on the other hand does not have N- terminus thus it 
cannot sequester DBD-F from interacting with other proteins. Therefore the proper 
checkpoint arrest is activated.  
                
Figure 3.23: A molecular mechanism of Rfa2 N terminus extreme mutants. In the 
wild type cells DBD-F of Rfa1 has potential to interact with both Rfa2 NT and other 
protein partners. In rfa2-Dx cells the DBD-F is sequestered away from potential protein 
partners. This may play a role in overcoming checkpoint arrest. 	  
Future directions 
1. It will be interesting to locate the sites of Rfa2 phosphorylation in rfa2-Dx 
and rfa2-ΔNx mutants by mass spectrometry. Also, if those are sites known to be 
phosphorylated by a kinase or not. 
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2. The rfa1-Aro mutants arrested in G2/M checkpoint in humans, and we 
hypothesized that the in yeast similar checkpoint is induced. To prove this 
hypothesis we have developed degron system. Unfortunately at this point the 
degron fails to induce degradation at 37°C and needs to be retested. 
3. We also want to utilize flow-cytometry to check if the rfa1-Aro mutants 
accumulate in G2/M like their human counterpart. 
4. We have already tested that during adaptation the Rfa2 N-terminus gets 
phosphorylated (data not shown), in an experiment carried by my colleague Mr. 
Timothy Wilson. It would be interesting to see if region 1 and region 3 are 
phosphorylated in this assay. Also with the help of rfa2-Ai mutants we will be 
able to locate important residues and priming if at all it occurs.  
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CHAPTER 4. THE MCM COMPLEX INTERACTS WITH RFA1 THROUGH 
MCM5, A NOVEL INTERACTION DISCOVERED THROUGH THE YEAST 
TWO-HYBRID SYSTEM 
Introduction  
Proper genome duplication and maintenance are essential for cell survival. 
Replication, repair, and cell cycle regulation are interdependent processes that are 
coordinated to maintain genome stability. An error in any one of these processes can 
influence or affect the other process and have potentially negative consequences for the 
cell. The coordination of these processes is occurs through a complex network of proteins 
and protein modifications. In short, the protein-protein interactions serve to transduce 
“signals” that can regulate functions of a cell. Therefore, studying protein-protein 
interaction is an important aspect of understanding these processes.  
A common intermediate to all DNA metabolic processes is ssDNA. Replication 
Protein A is ssDNA-binding protein and thus acts as a “sensor” of the intermediate to 
coordinate factors important in all of these processes. When ssDNA is generated, it is 
almost immediately bound by RPA. Thus whether the ssDNA needs to be processed by 
replication machinery or repair machinery is somewhat dependent on RPA. It is 
presumed that different ssDNA structures and how RPA interacts with these structures 
may be important for proper recruitment of downstream processing factors; however, it is 
currently unclear how RPA directs the cell to perform a particular process? 
We and others have hypothesized that RPA regulates the fate of ssDNA generated 
through coordination of protein interactions, and that some of these protein interactions 
may be regulated by the post-translational modification of RPA. In this chapter, we 
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employ yeast two-hybrid assay to discover novel protein interactions of RPA. These 
assays were aimed to study two specific aspects of RPA: (1) whether differences in 
protein interactions between Rpa2 and Rpa4 might influence their differing functions, 
and (2) whether hyper-phosphorylation of the of Rfa2 NT affects the protein-protein 
interactions of the RFA complex. 
Exploring protein-protein interactions through the yeast two-hybrid assay 
Proteins are essential for carrying out the many cellular processes necessary for 
living cells. One can gain a lot of information about protein function by exploring protein 
sequence and structure, cellular localization, post-translational modifications, and 
protein-protein interactions These properties define the function of a particular protein(s) 
in the cell. Furthermore, protein-protein interactions are important because they are 
useful for characterization of function and identification of the molecular mechanism(s) 
by which a protein functions in the context of other proteins. 
There are number of biochemical and biophysical methods available for studying 
protein interactions (Table 4.1). Most of the biophysical (e.g. spectrophotometric) assays 
require the proteins to be isolated from cells with their substrate or as a crystal. These 
assays are very informative and look closely into enzyme active site, mechanism of 
binding, and can lead to the identification of the essential binding regions on the basis of 
structure. One potential drawback of using these techniques is that the proteins are not in 
their native/natural biological state (i.e., they are not in the context of other cellular 
proteins).  
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Table 4.1: List of methods used to study protein-protein interactions 
 
Type of method Method 
Biophysical/ Spectroscopic Mass Spectrometry, X-ray Diffraction, 
Surface Plasma Resonance, Fluorescence 
resonance energy transfer (FRET), and 
NMR.   
Biochemical Affinity Chromatography, 
Coimmunoprecipitation 
Bioinformatics Sequence based predictions 
Molecular Biology/ Genetics Yeast two-hybrid Assay, Mutagenesis 
 
Although performed in vitro, the biochemical assays provide insight into these 
interactions. Mostly these are performed in an environment that mimics cellular 
conditions. These are generally performed with cell extracts or purified proteins. The 
success of detection of protein interaction in these assays depends on the (a) abundance/ 
amount of protein (PHIZICKY and FIELDS 1995), (b) whether the interaction is strong and 
direct, and (c) availability of antibody without cross reactivity. The challenges in this 
assay are purification of protein and stability of tag. Affinity purification followed by 
mass spectrometry detection is a very widely used technique. Potential obstacles to this 
type of assay include cost and accessibility to equipment.  
One way to look at protein interactions in the cell is through the use of the yeast 
two-hybrid assay. When considering this methodology, one must keep in mind the 
advantages and disadvantages of this system. Some disadvantages include: (1) false-
positives (VAN CRIEKINGE and BEYAERT 1999), (2) the fact that the assay uses S. 
cerevisiae as the host organism (lack of organism’s other protein or improper protein 
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expression/folding/modification) (OSBORNE et al. 1995), (3) the potential toxicity of 
proteins, and (4) artifact/biologically irrelevant interactions (due to protein fragments 
and/or mislocalization. However, this system also has many advantageous features, 
including: (1) it is in vivo assay, (2) does not require purification or high quantity of 
protein (generally reduces cost, time, and effort), (3) can detect a wide range of strengths 
of interactions, (4) can provide relative quantitation of interaction, (5) can be used to 
screen a library of potential interactors, (6) since done in yeast, often provides for 
extrapolation to higher organisms, and (7) provides a simple system to detect interactions 
and map interacting regions. 
 Our aim was to screen through a library of proteins to find novel interactions with 
RPA subunits. We chose the yeast two-hybrid assay because it would allow us to screen 
through numerous potential interactors, allow for recovery of the clone expressing the 
interacting region, and allow for relatively straightforward mapping of the interacting 
region. The MCF7 cDNA library was screened with human Rpa1 and human Rpa4 as 
bait. The success of this screening was limited (as discussed in this chapter); however, 
my colleague, Mr. Gunjan Piya, used this same system to successfully screen a yeast 
genomic library with Rfa1-FLAB as a bait (PIYA et al. 2015). Also described in this 
chapter is work examining a novel interaction found in this screen between Mcm5 and 
Rfa1. 
Why the Mcm5-Rfa1 interaction is of interest 
Minichromosome Maintenance Complex (MCM complex) is a hetero-hexameric 
complex (i.e. it is made up of six closely-related proteins). These are named as Mcm2-7, 
and Mcm5 is a part of this complex. The MCM complex is a helicase important in 
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initiation and elongation of DNA replication (HESKETH et al. 2015). Two MCM 
hexamers are loaded on the dsDNA by the Origin Recognition Complex (ORC) along 
with Cdc6 and Cdt1 (SAMEL et al. 2014a). The six proteins form a closed ring structure 
around dsDNA, which passes through a gap between Mcm2 and Mcm5 (SAMEL et al. 
2014b). In fact, this coordination between Mcm2 and Mcm5 is important in helicase 
loading and serves as the DNA entry gate (SAMEL et al. 2014a; BRUCK and KAPLAN 
2015). The two hexamers then move in opposite directions to unwind dsDNA.  
It is evident that Mcm5 and Rfa1 work in same pathway (i.e. replication). The 
RPA and MCM interaction has been suggested in literature a few times (OAKLEY and 
PATRICK 2010; LEVIDOU et al. 2012a). This is because the product of helicase activity of 
MCM complex (i.e. ssDNA) is a substrate for RPA. In fact, when human RPA was 
expressed as a complex in insect cell line it interacted with Mcm3-7 (NAKAYA et al. 
2010). In mouse, Rpa1 and Rpa2 were reported to interact with Mcm2 and Mcm4 while 
Mcm6 interacted with Rpa1 only (KNEISSL et al. 2003). These studies have not 
investigated these interactions any further, and the identification of an interaction 
between Rfa1 and a fragment of Mcm5 provided for an opportunity to map this 
interaction further. Interestingly, in the previous studies, Mcm5 was not identified as in 
interactor. 
Mcm5 overexpression is correlated with certain cancers (KELLY et al. 2012; DAS 
et al. 2013; YU et al. 2014). Also, interrelation of Rpa2 and Mcm5 expression was 
considered as prognostic significance in ovarian cancer (LEVIDOU et al. 2012b). A study 
carried out in our lab showed that in S. cerevisiae Mcm5 interacts with Rfa1, and that this 
interaction is slightly affected by the phospho-state of the Rfa2 N-terminus. These data 
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indicate the importance of Rfa1-Mcm5 interaction and in this study we aimed to further 
characterize this interaction.    
Methods 
Strains and plasmids 
The yeast two-hybrid kit was ordered from Origene (DKT100). In this kit, four 
different yeast strains (Appendix A) were provided with reporter genes developed to 
detect different sensitivity levels of interaction. These four strains were EGY48, 
EGY194, EGY188, and EGY40, which contain a LEU2 reporter gene regulated by 
decreasing numbers of lexA operator (OlexA) sequences. EGY48 cells contain 6xOlexA, 
providing for the most sensitivity for potentially weak interactions, while EGY40 cells 
containing no lexA operator sequences can serve as a negative control. All the tests were 
carried out in EGY48 cells, unless otherwise noted. 
All plasmids used are described in Appendix B. The bait plasmid used in this 
study was pEG202 (HIS3, 2µ, ampr) which contains the constitutive PADH1 promoter to 
drive gene expression of the lexA DNA-binding domain (BD)-fused bait protein (i.e., 
RpaX, where X could be any of the subunits). pSH18-34 served as an additional reporter 
plasmid (URA3, 2µ, ampr, 8x OlexA-lacZ). Prey plasmids were constructed in the vector 
pJG4-5 (TRP1, 2µ, ampr), which contains an inducible PGAL1 promoter driving expression 
of the B42 transcription activation domain (AD)-fused prey protein. For the yeast two-
hybrid screening we ordered MCF7 cDNA library from Origene (DLH117). All bait 
plasmids containing rfa1 gene fragments that encode for the individual domains of Rfa1 
(Figure X) are derivatives of pGAL-lexA and were kindly provided by Dr. Susan Gasser 
(Friedrich Miescher Institute for Biomedical Research, Switzerland). 
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The various bait and prey vectors were generated using an in vivo homologous 
recombination cloning method. First, an RPA/RFA subunit was amplified by PCR using 
the appropriate pEGFP-RPA plasmid as a template and primers 260-269 (Appendix C). 
The primers used had homologous ends to pEG202 (bait). My colleague Mrs. Erica 
Mueller generated the prey RPA/RFA vectors.For generating the MCM prey vectors, 
genomic DNA isolated from RMY122-A cells was used as template. The various MCM 
subunits were amplified using primers 596-605. The genomic DNA from RMY122A 
cells was used as a template to amplify the 3 subregions of the MCM5 gene. The primer 
sets (520-533) used to amplify these sub-regions are listed in appendix C. The pJG4-5-
Mcm5108-359 isolated from the yeast two-hybrid screen was used as template to generate 
the 50aa deletion plasmids. The 50 amino acid regions were deleted using mutagenic 
primers 509-513. The pEG202 vector was linearized utilizing the NcoI site, while pJG4-5 
was linearized by a XhoI-EcoRI double digest. The linearized plasmid and PCR were co-
transformed into EGY48 cells. Plasmid DNA were recovered from these cells and further 
confirmed by both diagnostic restriction digestion and DNA sequencing (Eton 
Biosciences). All generated plasmid constructs are listed in Appendix B. 
Media used for two-hybrid assays 
The viability of cells was tested on YPD plates (2% dextrose, 1% yeast extract 
and 2% peptone), and to detect any defects in mitochondria that might affect cell growth, 
cells were grown on YPG plates. The YPG media was similar to YPD except the carbon 
source was 3% glycerol. SD-HTU plates were used to recover cells with bait, prey, and 
reporter vectors in each cell. The effect of galactose induction on cells was tested on SG-
HTU plates. Auto-activation was examined using SD-HLTU plates, and potential protein-
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protein interactions were detected on SG-HLTU plates. The synthetic complete media 
was made with 2% dextrose (or 2% galactose), 0.5% ammonium sulfate, and 0.17% yeast 
nitrogen base without amino acid, and an appropriate amount of amino acid dropout 
mixture was added to this media. For the detection of expression of the lacZ reporter gene 
(encoding for β-galactosidase), 40 µg/mL of 5-bromo-4-chloro-3-indolyl-b-D-
galactopyranoside (X-gal) was added to SG-HTU media. 
Yeast two-hybrid screen 
Once the bait constructs were tested for auto-activation, the plasmid pPLG? (BD-
Rpa1) was co-transformed with pSH18-34 (8xOlexA-lacZ reporter) into EGY48 cells, and 
transformants were selected for by plating onto SD-HU (lacking histidine and uracil) 
media. One colony was used to make competent cells, the transformation efficiency of 
the cells was measured, and the MCF7 cDNA library was transformed into these cells 
and plated onto SD-HTU (lacking histidine, tryptophan, and uracil) media (40 
independent transformation reactions). The resulting 1.68x106 independent transformants 
were collected, titered, and 1.68x107 cells (10-fold excess of original number of 
transformants) were plated onto diagnostic SG-HLTU (containing 2% galactose and 
lacking histidine, leucine, tryptophan, and uracil) media. Plates were incubated at 30°C, 
and starting on day four post-transformation, larger colonies were patched onto SD-HTU 
plates through day fifteen for Rpa4 and day ten for Rpa1. These initial patch master 
plates were then replica plated onto both SD-HLTU (negative growth control) and SG-
HLTU; retest) and grown at 30°C for 3-4 days. Patches that only grew on the SG-HLTU 
plates were re-picked onto SD-HTU plates as secondary master plates and maintained for 
further characterization. 
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Isolation and analysis of prey plasmids (TRP1 plasmids) 
In our assay with BD-Rpa4 as bait, we had a system whereby all the three 
plasmids (bait, prey and reporter) contained an ampicillin-resistance (ampr) marker. First, 
the plasmids were isolated as a part of genomic DNA prep from each individual colony. 
These plasmids were transformed into DH10B bacterial cells through electroporation. 
Then individual bacterial colonies recovered on the LB+Amp plates were then tested with 
colony cracking followed by restriction enzyme digestion. This was to locate the 
individual bacterial colony with prey plasmid from a particular yeast candidate recovered 
in yeast two-hybrid. This process was performed until we found the prey plasmid for that 
particular candidate.  
To overcome this tedious process for the BD-Rpa1 screen, we switched the ampr 
marker on bait (pEG202) and reporter (pSH18-34) plasmids to kanamycin-resistance 
(kanr). This allowed us to directly recover prey plasmid on LB+Kan plates after 
electroporation. These isolated candidates were tested by restriction enzyme digest to 
avoid any empty prey vectors.  
After the prey plasmids were isolated they were sent for DNA sequencing (Eton 
Biosciences). The resulting sequences were then subjected to Nucleotide BLAST analysis 
to find the corresponding gene in the database. 
Replica plating assays 
About 200 ng of bait, prey, and reporter plasmid were co-transformed into 
EGY48 cells and isolated on SD-HTU plates. Individual colonies were picked as patches 
on SD-HTU media. These plates were then replica plated on YPD, YPG, SD-HTU, SG-
HTU, SD-HLTU, SG-HLTU and SG-HTU+X-gal plates. The protein interaction was 
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determined by growth on SG-HLTU plates after replica plating. The development of blue 
color on SG-HTU+X-gal was considered as indicator of strong growth.   
Results 
Testing auto-activation for RPA subunit candidates 
The canonical and alternative RPA complexes function differently with respect to 
DNA replication; the canonical RPA supports DNA replication while the alternative RPA 
does not (HARING et al. 2010). We hypothesize that Rpa2 and Rpa4 interact with 
different proteins, potentially leading to differences in function. To test this hypothesis 
we developed baits of all the four subunits. Before proceeding to the yeast two-hybrid 
assay, it was important to test auto-activation. If a bait protein can activate the expression 
of the reporter gene in the absence of an interacting prey partner, this is termed as auto-
activation and indicates a false-positive interaction. In this case, the ability of cells to 
grow on SD-HLU plates indicates auto-activation. The lack of His and Ura in the media 
ensures that the cells retain bait and reporter plasmid respectively. The lack of leucine in 
the media tests the expression of reporter. To test auto-activation we transformed the 
various bait (pEG-202-Rpa1 through Rpa4) constructs with the reporter plasmid (pSH-
18-34) and recovered them on SD-HU plates. The colonies were picked on a fresh plates 
as patches and grown at 30°C for 2 days. These were then replica plated to YPD, YPG, 
SD-HLU and SD-HU plates. We found that both yeast and human Rpa2 auto-activate 
(Figure 4.1). The auto-activation of human BD-Rpa2 was reported in a previous study 
(KESHAV et al. 1995). A slight auto-activation was observed for BD-Rpa4 for 4 
independent isolates. 
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Figure 4.1: Testing auto-activation of RPA and RFA subunits. A schematic 
representation of RPA and RFA subunits shows both human and yeast Rpa2 auto-
activates. The Rpa4-bait shows slight auto-activation.   
 
Since the initial aim of the study was to compare the protein interactions between 
Rpa2 and Rpa4, the observation of auto-activation, especially for BD-Rpa2, made this a 
difficult task. Since BD-Rpa2 showed auto-activation we attempted to overcome this by 
lowering the sensitivity of detection of interaction by using a strain with a reduced 
number of lexA operators (Figure 4.2A). This would lead to detection of only strong bait-
prey interaction and may reduce/eliminate the auto-activation observed. Unfortunately, a 
reduction in lexA operators did not reduce the observed auto-activation. 
Because auto-activation was still observed for BD-Rpa2, we attempted to map the 
region causing transcriptional activation by using Rpa2-Rpa4 hybrid protein expressing 
constructs. Since the Rpa2 homolog Rpa4 displayed only a slight auto-activation, Rpa2-
Rpa4 hybrid constructs (Figure 4.2B and C) were generated similar to Haring et al. The 
aim here was to replace the Rpa2 region responsible for auto-activation with the 
equivalent region of Rpa4; however, all of the hybrid proteins displayed auto-activation. 
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We would later determine that a full-length BD-Rpa4 also displays transcription 
activation activity. 
A) 
 
 
B) 
 
 
C) 
 
 
Figure 4.2: Overcoming LexA-Rpa2 auto-activation. A) Strains with different number 
of LexA operators do not reduce LexA-Rpa2 auto-activation. LexA-Rpa1 served as a 
positive control.  B) A schematic diagram of Rpa2-Rpa4 hybrid constructs. The Blue 
color regions represent Rpa2 regions while the orange color regions represent Rpa4 
regions. C) Eight different candidates were tested for each Rpa2/4 hybrid constructs on 
SD-HLU plates. Except Rpa422 we saw auto-activation for all constructs. However this 
construct was not chosen as slight auto-activation was observed.    
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Table 4.2: List of selected candidates discovered in yeast two-hybrid assay with 
Rpa4 as bait 
 
Candidate (Gene 
Symbol) 
Number of 
Hits Description 
Rpa2 2 Homologue of Rpa4 
YY1 1 Transcription factor/ transcription 
repressor 
INO80 1 Chromatin remodeling complex 
RuvB like 2 1 Helicase 
E4F1 2 Transcription factor, ubiquitin ligase, 
cellular signaling 
MAPKKK14 4 Cellular Signaling, involved in CFC 
syndrome 
HAX1 5 Promotes cell survival 
RNA pol II (RBP II 
a) 
1 RNA synthesis 
 
Yeast two-hybrid assay with BD-Rpa4 
BD-Rpa4 was chosen as the ‘bait’ vector to screen for novel protein interactions 
of alternative RPA complex, as it showed little auto-activation. The MCF7 cDNA library 
was chosen as the prey library. Colonies started appearing on SG-HLTU plates after 5 
days and were picked over the next 10 days (15 day period post-transformation). About 
150 candidates were picked, and replica plated on various diagnostic media plates as 
described in the methods. About 100 strong interactions were chosen on the basis of 
growth on SG-HLTU and development of blue color on SG-HTU+X-gal. The prey 
plasmids were first diagnosed using a colony cracking method, and then isolated by 
plasmid miniprep kit (Omega E.Z.N.A. Plasmid mini kit D6942-02). Isolated plasmids 
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were sent for sequencing to Eton Biosciences. The selected candidates are listed in Table 
4.2. The INO80, YY1, and RuvB-like 2 form a complex, which functions in the same 
pathway (i.e., homologous recombination repair) (WU et al. 2007). It is known that Rpa4 
supports homologous recombination and hence isolating these proteins in the screen was 
supportive of possible novel interaction discovery (KEMP et al. 2010). However, we 
identified that the pEG202-Rpa4 had a truncation (stop codon) after 34 amino acids, thus 
the assay was not performed with full-length protein. Therefore, the interactions 
recovered in this assay were not pursued further. 
Testing auto-activation of full-length Rpa1 as bait  
    
 
Figure 4.3: Preliminary data for yeast two-hybrid assays. Left panel Auto-activation 
of full-length BD-Rpa1 and BD-Rpa4 shows that the BD-Rpa1 does not activate and was 
used further for two-hybrid screen. Right panel In a screen performed by Mr. Gunjan 
Piya a novel interaction between Mcm5-Rfa1 was discovered this interaction is altered by 
rfa2-Dx. 
 
 The previous constructs were made with Taq DNA polymerase, which had 
introduced undesired mutations. We developed new constructs using Phusion DNA 
polymerase (New England BioLabs); these constructs were sequenced and carefully 
analyzed for mutations before use. Next, the constructs were tested for auto-activation. 
We found that like its homolog Rpa2, full-length Rpa4 displays auto-activation (Figure 
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4.3A). The BD-Rpa1 construct does not auto-activate, and a two-hybrid assay was 
performed using BD-Rpa1 as bait. 
Yeast two-hybrid assay with Rpa1 
Table 4.3: A list of candidates discovered during yeast two-hybrid assay with Rpa1 
as bait. 
 
Candidate 
(Gene Symbol) 
Number of 
Hits 
Fusion 
Junction 
 (Base 
number) Description 
Rpa2 100+ Not 
calculated 
Replication protein A subunit 
(Known Rpa1 interaction) 
HAX1 2 Not found Promotes cell survival 
E4F1 5 27 Transcription factor 
HCFC1 (Host 
cell factor C1) 
3 -70 Cell cycle and transcriptional 
regulation during herpes simplex 
virus infection. 
HSPA8 3 542 Heat shock protein 8 
DEAF1 1 27 Transcription factor 
ZMYND19 9 -70 Binds to the C terminus of 
melanin-concentrating hormone 
receptor-1 
TCEB2 16 -15 Transcription elongation 
DNAJB6 2 90 DNAJ (Hsp40) homologue 
DNAJA2 2 183 DNAJ (Hsp40) homologue 	  
We recovered around 300 candidates in the yeast two-hybrid assay with Rpa1 as 
bait. Candidates chosen were also selected on the basis of blue color developed on SG-
HTU+Xgal in addition to growth on SG-HLTU. Prey plasmid DNA were isolated from 
100 candidates and sent for sequencing. The sequences were analyzed with BLAST tool 
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to identify the gene and the protein it encodes. Many of these candidates were Rpa2, 
which is a known interaction of Rpa1. This confirmed the authenticity of assay; however, 
it was also an unfortunate drawback for this assay. The Rpa1-Rpa2 interaction dominated 
the screen; and we could not recover many other novel candidates unless we screened 
through 1000’s of additional candidates. Some of the interactions recovered in this assay 
(besides Rpa2) are listed in Table 4.3.	  
Rfa1 interacts with Mcm5 in the 108-359 amino acid region 
In a yeast two-hybrid assay with Rfa1-FLAB (lacking DBD-C) as bait, a novel 
interaction with Mcm5 was discovered (PIYA et al. 2015). This interaction appears to be 
negatively affected by the state of the Rfa2 N-terminus (GP, unpublished data; Figure 4.3 
B). The prey plasmid was identified to encode an Mcm5 fragment containing amino acids 
108-359. We further characterized this interaction using different regions of the MCM5 
gene encoding for different regions of Mcm5 as prey and full-length Rfa1 as bait. Mcm5 
was divided into three regions: 1-107 (Mcm51-107), 108-359 (Mcm5108-359) , and 360-end 
(Mcm5360-775). We observed that Mcm5108-359 shows strongest interaction with Rfa1 
(Figure 4.4). We also tested full length Mcm5 as prey; however, detectable interaction 
with Rfa1 was not observed (data not shown; see discussion). The interaction observed 
with all three Mcm5 fragments indicates that the Rfa1-Mcm5 protein may not be limited 
to the Mcm5108-359 region. 
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Figure 4.4: Replica plating assay-testing interaction of Mcm5 fragments with BD-
Rfa1. In the BD-Rfa1-FLAB yeast two-hybrid screen we isolated the middle region of 
Mcm5 (108-359 aa). To analyze further points of interaction the other two regions 1-108 
aa and 359-775 aa were cloned in pJG4-5 plasmid. Here we observe maximum growth 
with Mcm5108-359. Growth Scale: 0 < - < + < ++  	  
A 50 amino acid subregion in Mcm5 appears important for interaction with Rfa1 
To characterize the Mcm5108-359 interaction with Rfa1, we generated 50 amino 
acid deletion mutants of the Mcm5108-359 region. Five different deletion mutants were 
created as shown in Figure 4.5A. We tested interaction of these deletion mutants with 
Rfa1. If a region is important for interaction with Rfa1, its deletion will lead to 
reduced/lack of growth on SD-HLTU plates. We found that the 208-257 amino acid 
fragment of Mcm5 leads to reduced growth (Figure 4.5B).  
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A) 
 
B) 
 
 
Figure 4.5: A 50 amino acid region is important for Mcm5-Rfa1 interaction. A) The 
cartoon representation of 50 amino acid deletion mutants created to locate important 
region in the Mcm5108-359 fragment. B) A deletion of amino acids 208-257 in Mcm5108-359 
fragment lead to disruption of interaction with BD-Rfa1 indicating that this region is 
important for the Rfa1-Mcm5 interaction.  
 
Rfa1 DBD-B is important for interaction with Mcm5 
To further characterize the Rfa1-Mcm5 interaction, we tested different regions of 
Rfa1. The Rfa1 bait vectors, which encode for various regions of Rfa1, were kindly 
provided by Dr. Susan Gasser (Figure 4.6). The full length Rfa1 and Rfa2 served as a 
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control in these reactions while the vector 965 was empty backbone of bait vectors. In 
this study, we found that the DBD-B is important for interaction with Mcm5 (Figure 
4.7A), as this combination provided for growth on SG-HLTU. All the controls show no 
growth with empty bait vector pGAL-lexA (965) or with prey vector pJG4-5 (see Figure 
4.7C). We did not see development of blue color on SG-HTU+Xgal plates in this assay 
(data not shown). This lack of blue indicates that the Mcm5-Rfa1 interaction is a weak or 
transient interaction. 
 
 
Figure 4.6: A diagrammatic representation of various BD-Rfa1 constructs provided 
by Dr. Susan Gasser. The Rfa1 protein is divided on the basis of its DNA-binding 
domains. 
 
Rfa1 DBD-B is important for interaction with MCM complex 
Although we located the 50 amino acid region in Mcm5 important for interaction 
with Rfa1, we cannot overlook that Rfa1 also interacted with Mcm51-108 and Mcm5360-775 
fragments. This indicated that other regions of Mcm5 could contribute to the interaction 
with Rfa1. The MCM complex proteins Mcm2-7 are all a closely related group of 
proteins and share sequence and structure similarities (FORSBURG 2004). 
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A) 
 
 
B) 
 
C) 
 
Figure 4.7: Replica plating assay to determine important region of interaction in 
Rfa1: A) Only DBD-B of Rfa1 interacts with Mcm5108-359. B) Replica plating assay 
indicates Mcm5108-359 does not show interaction with full length Rfa1 and Rfa2. C) 
Controls for replica plating assay of Mcm5108-359 with Rfa1 constructs provided by Dr. 
Susan Gasser.   
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Hence, it is possible that Rfa1 interacts with multiple subunits of MCM complex 
and indirectly with these other Mcm5 fragments. To test this possibility we developed 
prey vectors with different MCM subunits. These constructs were tested with Rfa1 bait 
vectors provided by Dr. Susan Gasser. We found in this assay that all the MCM subunits 
were able to interact with Rfa1 DBD-B (Figure 4.8) to various extents, although 
interaction with Mcm4 and Mcm5 appeared to be the strongest as indicated by growth on 
SG-HLTU. 
 
 
Figure 4.8: Replica plating assay to determine if Rfa1 interacts with other MCM 
subunits. The picture here indicates that all MCM subunits interact with Rfa1 through 
DBD-B (growth on SG-HLTU plates). 	  
A model based on Sulfolobus solfataricus hints at function of Rfa1-Mcm5 interaction 
	  The known full crystal structure of MCM complex is based on the MCM 
complexes from Sulfolobus solfataricus, Methanothermobacter thermautotrophicus, and 
Pyrococcus furiosus. We compared the 50 amino acid sequence of Mcm5 important for 
Rfa1 interaction with the MCM sequence of S. solfataricus. We found that this region is 
similar, and have some conserved residues (Figure 4.9).  
 	   139 
 
 
Figure 4.9: Sequence alignment of Saccharomyces cerevisiae Mcm5208-257 and 
Sulfolobus solfataricus Mcm. The 50 amino acid region important for interaction 
between Rfa1 and Mcm5 is found to have similar sequence in Sulfolobus solfataricus 
Mcm. We utilized the crystal structure of Mcm from S. solfactaricus to gain insight on 
importance of this region in Rfa1-Mcm5 interaction.  	  
The C terminus MCM structure of S. solfataricus was aligned with the near full 
length MCM structure from S. solfataricus and created a full MCM hexameric complex 
mimicking S. cerevisiae MCM with the help of PyMOL (The model was made by Ms. 
Jaime Jensen courtesy Colbert Lab). This was developed using the crystal structures 
available PDB ID 2VL6 (Sso N-terminal domain) and 3F9V (near full length crystal 
structure of S. solfataricus MCM). The 50 amino acid region similar in both species is 
highlighted in cyan blue (Figure 4.10 and 4.11). The model here illustrates the potential 
orientation of both the complexes on DNA. Based on this model the ssDNA generated 
due to helicase activity of archaeal MCM complex emerges from the N-terminus end. 
The Mcm5208-257 region important for Mcm5-Rfa1 interaction is predicted to be located 
exposed and available for interaction on the N-terminal side. Thus supporting the 
hypothesis that after helicase activity of the MCM complex, the RFA complex would be 
in a position to readily bind ssDNA.  
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Figure 4.10: A ribbon structure of side view of MCM complex from S. solfactaricus 
The C terminal region of the complex binds the dsDNA, the middle region is responsible 
for the helicase activity and N terminus is where ssDNA binds. The region similar to S. 
cerevisiae Mcm5208-257 is indicated in cyan (developed using PyMol).   
   
 
Figure 4.11: A ribbon structure of top view of S. solfactaricus MCM complex from 
N terminal side. An accompanying cartoon shows the arrangement of MCM subunits 
forming MCM complex in S. cerevisiae.  
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Discussion 
The Rpa1 construct should be modified for successful yeast two-hybrid assay 
In our yeast two-hybrid assay we found that the full-length Rpa1 does not auto-
activate. Therefore, we performed our screen utilizing the BD-Rpa1 construct. However, 
since this construct had the ability to form functional RPA complex and the affinity 
amongst the subunits is very high (WOLD 1997), all the strong interactions recovered 
were Rpa2. Thus having full-length Rpa1 containing DBD-C (the region necessary to 
interact with other RPA subunits) while screening limited our ability to “fish-out” other 
potential protein candidates. Hence, for a successful screen we need to develop Rpa1-
FLAB construct to limit its interaction with Rpa2. The downside of doing this would be 
an Rpa1 not present in the context of a full RPA complex, and this might influence which 
proteins are recovered.    
The Mcm5208-257 region appears important for Mcm5-Rfa1 interaction 
In the screen performed with BD-Rfa1-FLAB as the bait, Mcm5108-359 fragment 
was identified. This interaction was of interest, because it appeared to be affected by the 
phospho-mimetic state of yeast Rfa2 and these two protein complexes are involved in 
DNA replication (PIYA et al. 2015). Further mapping revealed that this interaction 
probably involves a 50 amino acid subregion in Mcm5 (i.e. Mcm5208-257). However, this 
interaction was not tested with the deletion of 208-257 amino acid region in full length 
Mcm5. In fact, we did not see interaction of Rfa1 with full-length Mcm5. Sometimes 
over-expression or epitope-tagged versions of certain protein can be toxic to yeast cells. 
Alternatively, it is possible that full-length Mcm5 and full-length Rfa1 do not show 
interaction due to steric hindrance (full MCM and RPA complex) and/or that full-length 
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Mcm5 is recruited away from the two-hybrid reporter by its normal function in the cell. 
The lack of interaction between Rfa1 and Mcm5 might be attributed to one or more of 
these phenomenons, and this was not determined. The Mcm5108-359 does not show this 
effect due to lack of functional full-length protein.  
The potential importance of a putative interaction with this region of Mcm5 is 
indicated by a model developed on the basis of S. solfataricus MCM crystal structure 
(Figure 4.8). The positioning of this region is on the ssDNA exit side of the complex. 
Also, this region is not important for the Sso MCM complex formation. A P62L mutation 
in Mcm5, also known as the mcm5-bob1 mutation, bypasses a kinase required for 
replication initiation and affects helicase activity of the complex (FLETCHER and CHEN 
2006). This mutation is in the N-terminus of Mcm5 and indicates a regulatory role of N 
terminus via protein binding. This region of Mcm5 might facilitate interaction with 
downstream factors in replication, such as RFA. 
Rfa1 DBD-B is important for interaction with MCM complex 
The N-terminal domain (i.e., DBD-F) is thought to mediate many of the Rfa1 
protein-protein interactions. Our lab has demonstrated that DBD-F facilitates interactions 
with DDR proteins, and these interactions appear to be the strongest. On the other hand, 
the major contribution to RPA function of DBD-A and DBD-B is through ssDNA-
binding activity. In our assay, DBD-B shows interaction with MCM subunits, which is 
somewhat novel. Also in our lab, many of the interactions we identified to occur with 
domains other than DBD-F are with proteins not specific to the DDR, and these 
interactions are typically weaker. The DBD-B binding to the Mcm5 in this case, seems 
more conveniently explained in the model diagrammed in Figure 4.12.  
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Figure 4.12: A model demonstrating the possible orientation of MCM and RFA 
complex (only Rfa1-FLAB) to DNA. The dsDNA enters the C-terminus side of the 
MCM complex, unwinds due to helicase activity located in the middle region and exits 
the complex from N-terminal side. At the N-terminal end the ssDNA is exposed to Rfa1, 
which can facilitate loading onto one of the ssDNA strands in the proper orientation.  	  
The activity of the MCM complex is distributed in three regions; the C-terminus 
(aa 600-700) binds dsDNA and is important for heterohexameric formation. The central 
region (approximately aa 340-575) has the helicase activity and the N-terminus (aa 1-
320) is where the ssDNA exits. The binding of Mcm5 to DBD-B might enhance two 
things: (1) positioning DBD-A and DBD-B closer and in proper orientation with one 
strand of the ssDNA, since RPA binds ssDNA with polarity, and (2) may assist in MCM 
movement by acting as a recipient for the newly unwound DNA. MCM helicase activity 
occurs in vitro; however, it has not been measured whether or not RPA enhances this 
helicase activity. It might not be surprising if it did, since RPA is known to interact with 
other helicases. 
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Future Directions 
In most of our replica plating assays with various Mcm5 and Rfa1 mutants we did 
not find any substantial β-galactosidase activity (development of blue color on SG-
HTU+Xgal plate). This was an indication of a transient or weak interaction between Rfa1 
and Mcm5. We also, utilized liquid β-galactosidase assays and spot dilution assays (data 
not shown), which failed to show any reliable differences in interaction strength or allow 
for the observations of subtle differences in growth. The assays also showed a lack of 
consistency in results. To study the relevance of this particular interaction, it will be 
important to utilize or develop new methods. Some future directions to further improve or 
retest the assays discussed in this chapter are outlined below: 
1. To test the novel interaction of human RPA subunits we should generate a BD-
Rpa1-FLAB construct to limit the interaction with Rpa2. 
2. The INO80/YY1/RuvB-like2 proteins act in the same pathway. In an experiment 
we found that all these proteins were able to interact with Rpa1. We further found 
that exogenous expression of Rpa4 interferes with this interaction and the Rpa1 
DBD-B is important for this interaction (data not shown). However, since use of 
Taq DNA polymerase introduced random mutations in these constructs the data is 
not reliable. However, it will still be interesting to retest these interactions with a 
full-length non-mutated BD-Rpa1. 
3.  The Rfa1-Mcm5 interactions appear to be weak. Biochemical techniques like co-
immunoprecipitation or testing in vitro interaction of purified RPA and MCM5 
complex would be informative about the biological relevance of this interaction. 
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4. To determine the importance of the Mcm5 aa 208-257 region, a mutant of Mcm5 
with the deletion of this mutant should be generated. Further, it should be tested if 
this mutant can support cellular replication (i.e., test physiological relevance). 
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CHAPTER 5.  FINAL REMARKS AND FUTURE DIRECTION 
Introduction 
DNA damage poses a daunting challenge to the cell. The cell must recognize and 
fix DNA damage in order to maintain the integrity of the genome and ensure proper cell 
function. Two things occur in response to DNA damage; along with DNA repair, the cells 
arrest the progression of cell cycle. RPA is a key player in replication, repair, and cell 
cycle regulation (FANNING et al. 2006). The primary biochemical function of RPA is to 
bind and protect ssDNA from nucleases and prevent secondary structure formation. 
Proteins necessary to process this ssDNA intermediate into dsDNA are presumably 
coordinated and loaded on to ssDNA through RPA. Subsequent displacement of RPA 
would then be required to completing the DNA processing. Therefore, the distinction as 
to which proteins will process the ssDNA is likely made through interaction with RPA. 
Coordination of RPA function is likely regulated by two factors: (1) differences in 
protein interactions at different stages of cell cycle, and (2) post-translational 
modifications of RPA and/or interacting proteins.  
An extensively studied post-translational modification that RPA complex 
undergoes is phosphorylation. Of particular interest is the phosphorylation of Rpa2 N-
terminus. The RPA complex is phosphorylated in a cell cycle dependent manner by 
cyclin-dependent kinases (CDK) (DIN et al. 1990; FANG and NEWPORT 1993), although 
the importance of this post-translational modification remains unclear. However, in 
human cells, the Rpa2 N-terminus is hyper-phosphorylated in response to DNA damage 
(LIU and WEAVER 1993; CARTY et al. 1994a). The Rpa2 hyper-phosphorylation has been 
studied predominantly in human cells, and only peripherally or recently in other 
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organisms such as D. melanogaster, X. laevis, and C. albicans (FANG and NEWPORT 
1993; MITSIS 1995; WANG et al. 2013; GAO et al. 2014). The work presented in this 
thesis aims to elucidate the role of the Rpa2 N-terminus in response to DNA damage 
utilizing S. cerevisiae as a model organism. In order to understand the role of the Rpa2 N-
terminus, we focused on answering the following specific questions: (1) Is the Rfa2 N-
terminus hyper-phosphorylated in response to DNA damage? (2) What regions or amino 
acids of Rfa2 N-terminus are important for the DNA damage response, (3) Does Rfa2 
hyper-phosphorylation affect protein interaction pattern of RFA complex? and (4) Can S. 
cerevisiae serve as a model to study other eukaryotic Rpa2 hyper-phosphorylation? The 
overarching goal of all of these studies was to use a simple organism with unique tools to 
study the importance of the Rpa2 N-terminus and gain insight into its function. 
Discussion and future directions 
Rpa2 NT phosphorylation has different implication in H. sapiens and S. cerevisiae 
Rpa2 NT is phosphorylated in cell cycle dependent manner and in response to 
DNA damage in humans. The Rpa2 NT phosphorylation has important role in DNA 
repair while the role of Rfa2 NT phosphorylation remains elusive; based on following 
data discussed. 
The human Rpa2 NT has 9 different S/T phosphorylation sites in the unstructured 
Rpa2 N terminus. These sites are phosphorylated by PI3 family of kinases ATM, ATR 
and DNA-PK in response to DNA damage. The cellular extracts from adozelesin treated 
293 and HeLa cells were unable to support SV40 DNA replication in vitro, the 
replication resumed when purified non-phosphorylated RPA was added (CARTY et al. 
1994b; LIU et al. 2000). The adozelsin (a drug used to teat cancer alkylates DNA) 
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treatment causes hyper-phosphorylation of the Rpa2 NT and thus indicates that the hyper-
phosphorylated Rpa2 does not support replication. In human cells the Rpa2D mutant (8 
sites mutated to D except S4) did not localize to the replication centers in vivo instead 
showed competent binding to DNA damage foci (VASSIN et al. 2004a). Rad51 failed to 
localize to HR induced damaged sites when Rpa2A mutant (7 sites mutated) is expressed 
exogenously, indicating that the Rpa2 phosphorylation is important for Rad51 
recruitment (SHI et al. 2010). Rad51 is essential in homologous recombination repair. 
Rpa2A mutant (S26, S31 and T35) in Xenopus laevis stimulated S phase dependent 
checkpoint signaling, while the Rpa2D could not. This data indicated that the Rpa2 
phosphorylation is not involved in checkpoint activation but maybe involved in repair or 
restart arrested fork. In fact, phosphorylated Rpa2 recruits PALB2 at stalled replication 
forks to maintain its integrity during replication stress (MURPHY et al. 2014).  
The budding yeast Rpa2 NT has 11 different S/T potential phosphorylation sites. 
However the only known phosphorylation in this region occurs at S27 by Ime2 kinase, 
and this event is important in initiation of meiosis. Apart from this the Mec1 kinase 
phosphorylate both Rfa1 (at 178) and Rfa2 (at 122) subunits of the RFA complex; and 
the Rfa2 site lies outside of Rfa2 NT. However, when these sites were mutated to ALA 
they did not show any DNA damage sensitivity (GHOSPURKAR et al. 2015a). Therefore, 
we tested the rfa2 NT extreme mutants and found that all these mutants are viable in 
unstressed condition (5-FOA). Although it is not a direct measurement of replication 
activity, the ability of these mutants as a sole Rfa2 copy to grow in unstressed condition 
indicates that these mutants can support DNA replication. This indicates that rfa2-Dx 
unlike its human counterpart can support DNA replication.  
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The rfa2-Dx and rfa2-ΔNx mutants are sensitive to DNA damage irrespective of 
the type of DNA damaging agent and strain. The Rad53 phosphorylation data indicated 
that none of the rfa2 extreme mutants cause defect in inducing DDR in presence of 
MMS. The ability of rfa2-Ax to act like WT Rfa2 indicates that for proper cellular 
replication and repair a ‘normal’ Rfa2 NT is required. The ‘normal’ here indicates that 
the Rfa2 NT must be present and should be devoid of any additional negative charges. 
Collectively, this data indicated that the Rfa2 NT is required for DDR but its 
phosphorylation is dispensable in yeast.   
The rfa2-ΔNx mutant was known to be viable as demonstrated in previous study 
(PHILIPOVA et al. 1996). However, we are the first group to show its DNA damage 
sensitivity in S. cerevisiae.  
The human and yeast Rpa2 mechanisms differ in other two ways (1) The Rfa2 
was shown to be phosphorylated even after deletion of 1-40 aa, this required a fully 
functional Mec1 kinase (SCHRAMKE et al. 2001). On contrary the deletion of N terminal 
33 amino acids of Rfa2 eliminated Rpa2 phosphorylation in humans (HENRICKSEN et al. 
1996). (2) The human Rpa2 NT phosphorylation is further intricately regulated by several 
kinases using single site priming mechanism discussed below. 
The human Rpa2 NT is phosphorylated by several kinases and their target sites 
are somewhat overlapping, suggesting interplay of DDR regulation through Rpa2 NT 
phosphorylation. When RPA2 S33 was mutated to alanine, this mutation suppressed the 
phosphorylation at the S29 and S4/8 sites of human Rpa2 NT (ANANTHA et al. 2007). 
Similarly, RPA2 T21 and S33 when mutated to ALA showed an S phase checkpoint after 
UV induced damage, indicating that T21 is also important in establishing the primary 
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response in DNA damage (OLSON et al. 2006; ANANTHA et al. 2007).  The RPA2 S4/ S8 
when mutated to ALA showed to block phosphorylation of S23 and S12 (LIU et al. 
2012). All these data indicate that the phosphorylation at one site can regulate the 
phosphorylation of other, known as priming. The data is summarized in Figure 1.3. 
All our rfa2 extreme mutants showed phosphorylation of Rfa2 in response to 
DNA damage, supporting the 40 amino acid deletion data and this phosphorylation was 
thought to occur at the Mec1 site. Interestingly, both our damage sensitive mutants rfa2-
Dx and rfa2-ΔNx showed a slower migrating Rfa2 species compared to WT and rfa2-Ax. 
This implies that there is a different phosphorylation site(s) in these mutants apart from 
the known Mec1 site. Now, as both these mutants are damage sensitive it is possible that 
this phosphorylation is required for a process that is not addressed in this thesis (see 
section on adaptation below).  
Since the WT Rfa2 phosphorylation is not detectable without PhosTag, and is 
thought to be subtle the detection of any priming reaction was impossible to detect. But 
the rfa2-Dx and rfa2-ΔNx show DNA damage sensitivity so we tested if this phenotype 
can be attributed to a single phosphorylation site. We developed rfa2 NT single mutants 
rfa2-Ai and rfa2-Di and none of these mutants show any DNA damage sensitivity. 
Therefore we mutated multiple sites at a geographically convenient region and tested 
DNA damage sensitivity. The DNA damage phenotype can be attributed to the rfa2 
region 1 and region 3, i.e., Serine residues at position 3,11,12 and 30 and Threonine 
residues at 14, 32 and 34. Although, region 1 and region 2 of Rfa2 NT are shown to 
contribute to damage sensitivity, the fact that the extreme mutants show Rfa2 
phosphorylation supports that, the phosphorylation of Rfa2 NT does not influence the 
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overall Rfa2 phosphorylation in yeast cells. Interestingly these regions coordinate that 
target regions of ATM and ATR in humans. The homologues of these kinases are present 
in yeast (Tel1 and Mec1). It is possible that these may be the potential kinases that 
phosphorylate this region under suitable conditions. However, the data in this thesis is 
just suggestive and there is no strong evidence (Figure 5.1).  A) 
 
 
B) 
 
 
Figure 5.1: The phosphorylation pattern of Rpa2 NT in H. sapiens and S. cerevisiae 
A) Phosphorylation of different Rpa2 NT sites by various kinases in H. sapiens (courtesy: 
Liu et al 2012) B) A phosphorylation pattern predicted on the basis of Liu et al in S. 
cerevisiae. The DNA-PK is questionable as there is no known homolog in yeast. 
 
In future to further identify the sites of phosphorylation (observed in rfa2-Dx and 
rfa2-ΔNx) and importance of their function, I suggest that the following experiments can 
be conducted (1) To locate the site the protein should be purified and sent for mass 
spectrometry analysis. (2) To test whether the Mec1 phosphorylation site is involved, we 
can combine the rfa2-Dx mutation with rfa2-122A should be combined and tested for 
Rad53 and Rfa2 phosphorylation. (3) To locate the kinase responsible for the 
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phosphorylation of rfa2-Dx and rfa2-ΔNx we can combine these mutants with kinase 
deletion strains and test effect on Rfa2 phosphorylation. 
Phosphorylation state of Rfa2 NT affects protein-protein interactions 
The post-translational modifications of proteins can result in changes in their 
structure and function. The protein-protein interactions are often affected/regulated by 
post-translational modification. Since, human Rpa2 NT phosphorylation occurs in 
response to DNA damage, it is proposed to alter the interaction of RPA with DNA and 
the replication/repair proteins (GEORGAKI and HÜBSCHER 1993; OAKLEY and PATRICK 
2010). An Rpa2 NT mimicking peptide was shown to interact with DBD-F of Rfa1 (BINZ 
et al. 2003). The Rpa2 phosphorylation is also known to affect the interaction of RPA 
with Mre11, Nbs1, Rad51, and Rad52 (JACKSON et al. 2002; OAKLEY et al. 2009). All 
these proteins have repair specific function. The hyper-phosphorylated RPA is recruited 
away from the replication centers to the repair foci (VASSIN et al. 2004b). This can be 
implying towards changes in RPA-DNA as well as the protein interactions. 
The projects discussed in this thesis had utilized two molecular biology methods 
to study protein-protein interaction: (1) through genetic interactions (i.e. double-mutant 
analysis) and (2) through yeast two-hybrid. The known Rpa2 NT interactions with Mre11 
and Rpa1 were utilized in the genetic interaction analysis. 
The genetic interaction data demonstrated that the rfa2-ΔNx when combined with 
rfa1-t11 is lethal, and when combined with mre11Δ survives. On the contrary the rfa2-Dx 
survives when combined with the rfa1-t11 and both rfa1-t11 mre11Δ and rfa2-Dx mre11Δ 
double mutants are lethal. This data indicated that the rfa2-Dx and rfa1-t11 are involved 
in same pathway and rfa2-ΔNx and mre11Δ are involved in same pathway (Figure 5.2).  
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The model is based on the type of damage and the response it generates. During 
replication stress the RPA is already present at the replication site and does not follow 
Mre11 activity while the general two stranded breaks (caused by agents like MMS and 
UV) first require recognition of break followed by Mre11 activity. The resected DNA is 
then bound by RPA.  
 
 
Figure 5.2: A model depicting the role of Rfa2 NT in DDR and checkpoint 
adaptation. A model based on the genetic interaction data between Rfa1, Rfa2 NT and 
Mre11. The model shows the placement of Rfa2 NT mutants according to agreement with 
genetic interactions. The model also suggests role of Rfa2 NT phosphorylation in Mec1/ 
Tel1 interplay.   
  
We also utilized the rfa1-aro mutants to study the effect of Rfa2 phosphorylation 
on complex interaction and DNA-binding. In humans, the rfa1-aro mutations lead to 
accumulation of cells in G2/M phase (HARING et al. 2008; HASS et al. 2012).  In our 
study, we developed single through quadruple rfa1-aro mutants. We also combined the 
rfa2-ΔNx with rfa1-aro mutants. The rfa2-ΔNx is found to rescue the absence or reduced 
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growth induced by rfa1-aro single and double mutants. This was another interesting 
observation. The ability of cells to be rescued by rfa2-ΔNx indicates that the cells can go 
through replication. Whether this replication is defective or leads to any replication stress 
is unknown at this point. However, since the cells survive in presence of rfa2-ΔNx it 
indicates the rfa1-aro mutants activated checkpoint (this hypothesis is discussed in the 
last section).  
We utilized yeast two-hybrid assay as a direct approach to detect protein-protein 
interaction. The yeast two-hybrid screen with Rpa1 and Rpa4 were not successful. The 
screen conducted by my colleague Mr. Gunjan Piya clearly found new interactions of 
Rfa1. The work further elucidated that some of the Rfa1 protein interactions are 
influenced by Rfa2 NT phosphorylation state (PIYA et al. 2015). One such interaction 
between Rfa1 and Mcm5 is investigated in detail in this thesis.  
The Mcm5 interaction with Rfa1 is novel, as it is not observed in human or 
mouse. A 50 amino acid region in Mcm5, 208-257 was found important for this 
interaction. However, our data indicates that this is a transient or weak interaction and 
needs to be investigated using other biochemical assays.  
The S. cerevisiae can serve as a model system to study Rfa2 NT function 
The Rpa2 NT phosphorylation is extensively studied in humans. However, there 
is still lack of clear understanding when it comes to function of this event. This is because 
the Rpa2 NT phosphorylation affects more than one aspect of DDR. The human cell line 
system although ideal, is not always convenient to handle and manipulate. Furthermore, 
experiments affecting essential genes often can only be tracked for 1-2 generations. 
While providing a snapshot into what is affected, it does not provide for determination of 
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whether effects have physiological consequences. Therefore, a simplistic model is would 
be greatly beneficial to study the function of Rpa2 NT phosphorylation. 
S. cerevisiae is a single celled eukaryote, which executes all DNA metabolic 
processes similar to humans. These are easy to handle and more importantly are easy to 
manipulate genetically, which gives them great advantage over human cell lines. 
Therefore we first attempted to develop a ‘humanized yeast’ system to study RPA. In 
that, we aimed to develop yeast cells with human RPA as a sole copy of RPA.  
It was important to understand the complex formation between in inter-species 
and intra-species subunits of RPA from human and budding yeast. To understand this we 
utilized yeast-two hybrid assay. This assay demonstrated that the Rpa1 /Rpa3 interaction 
is mediated by Rpa2 or Rpa4. Previous data have shown that the human RPA can form a 
stable complex with all three genes or a sub-complex of Rpa2-Rpa3 (HENRICKSEN et al. 
1994). A direct interaction between Rpa1 and Rpa3 is not known. In our study, we found 
that the RFA1 does not interact with the RPA subunits and vice a versa. This can explain 
why previous attempts to replace Rfa1 with Rpa1 and Rfa2 with Rpa2 have failed. 
Therefore in this study we attempted to replace the full RFA complex with the RPA 
complex. However this attempt was not successful, as we did not achieve required level 
of RPA subunits expression. 
Meanwhile, a study carried out by my colleague Mr. Timothy Wilson showed 
that, a hybrid protein whereby Rpa2 NT replaces the Rfa2 NT could survive in the yeast 
cells (GHOSPURKAR et al. 2015b). Now, since our data showed that the Rfa2 NT 
phosphorylation was dispensable in yeast, we further investigated if yeast cells have 
capability to phosphorylate the Rpa2 NT. We did observe hyper-phosphorylation of Rpa2 
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NT in response to DNA damage in yeast cells. This data indicated that the yeast cells 
conserve the capability of Rpa2 NT hyper-phosphorylation, even if the event itself did 
not appear necessary for DDR in yeast (Table5.1). Surprisingly, the phosphorylation of 
the human Rpa2 NT occurred very similarly to that observed in human cells. 
Table 5.1: A summary of Rpa2 NT phosphorylation observed in various hybrid 
proteins 
Species Phosphoryl
ation 
Species Phosphoryl
ation 
S. cerevisiae 0 O. sativa (1) + 
S. pombe + O. sativa (2) 0 
C. albicans + X. laevis + 
A. thaliana (A) + M. musculus + 
A. thaliana (B) + H. sapiens + 
 
Scale: 0 = no phosphorylation and + = phosphorylation 
 
This data indicate that the role of Rpa2 NT phosphorylation as a regulatory 
mechanism may have arisen during evolution. Further, the capability of yeast cells to 
phosphorylate Rpa2 NT made them ideal to study human Rpa2 NT. In this study we 
further investigated the evolutionary aspect of Rpa2 phosphorylation.  
We developed mutants that encode the hybrid 2NT proteins from around six 
different species apart from humans. The various species are listed in the Table 5.1. The 
phylogenetic tree developed utilizing the Rpa2 NT sequences from all these organisms is 
shown in Figure 5.3. 
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Figure 5.3: A phylogenetic tree developed from Rpa2 NT sequences from organisms 
in this study. Plant species, fungi and animal species studied in this dissertation club 
together. The S. pombe is closer to humans (1 branch) as compared to S. cerevisiae. The 
O. sativa homolog 2 is not phosphorylated although is closer to A. thaliana species which 
both get phosphorylated (1 branch).   	  
The plants, animals and fungi are at the end of the phylogenetic tree. The fungi 
are closer to animals than plants. In this study we have selected organisms from each 
branch to understand the evolution of Rpa2 NT.  First, the Rpa2 NT is an unstructured 
domain, as in the tree these sequences club the plant, fungi and animal species together 
indicated that the sequence is conserved. This is surprising because generally 
unstructured domain show less sequence conservation. Secondly the S. pombe is closer to 
humans as compared to any other fungi studied. A definite statement about how the 
evolution of this domain may have occurred is difficult to state with just eight different 
samples.  
However, a phosphorylation pattern emerges when we take a closer look at the 
Rpa2 NT sequences from these species (Figure 5.4).  The kinases recognize the SQ/TQ 
motif in the Rpa2 NT. The S. cerevisiae is the only species in this study, which lacks the 
SQ/TQ motif in the sequence. And this is the only species, which does not show any 
detectable phosphorylation in the Rpa2 NT. The Os2NT-2 sample did not show 
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phosphorylation even though SQ/TQ motif is present, this can be attributed to differences 
in functional compartmentalization of these proteins in plants. 
 
Figure 5.4: A sequence alignment of Rpa2 NT from different species. The S. 
cerevisiae Rpa2 NT lacks the SQ/ TQ motif in its Rpa2 N terminus. The other species 
studied in this dissertation show the SQ/TQ motif conserved (denoted in Red). 
 
So the convergent evolution (?) of the Rpa2 NT can be explained as follows the 
plant species have both SQ/TQ in the Rpa2 NT sequence and the kinases with ability to 
recognize them. The S. cerevisiae have lost the SQ/ TQ motif while diverging from the 
other fungi but retained the SQ/TQ motif recognizing kinases. The S. pombe have 
evolved differently from other fungi it retains both the parameters. The human cells not 
only retain both parameters but also have more intricate regulation of the Rpa2 
phosphorylation event.   
The Rfa2 NT phosphorylation has a unique role in S. cerevisiae 
The data presented in this thesis demonstrates that the Rfa2 NT phosphorylation 
does not have a significant role in DNA damage response in S. cerevisiae. However, the 
rfa2-Dx and rfa2-ΔNx are sensitive to DNA damage. A study by our group shows that the 
Rpa2 NT phosphorylation has a role in checkpoint adaptation. The experiments 
performed by my advisor Dr. Stuart Haring and Colleague Mr. Timothy Wilson indicated 
that the rfa2-Dx mutant is adaptation proficient while the rfa2-Ax is adaptation deficient 
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(GHOSPURKAR et al. 2015b). The rfa2-ΔNx also shows adaptation deficient phenotype 
(unpublished SJH). Now the question is why these mutants with antagonistic function 
show similar phenotype. 
In response to DNA damage the cells can lead to three distinct pathways. Firstly, 
they can successfully fix the damage and continue to progress through cell division. 
Secondly, the cells will not be able to fix damage and die i.e. apoptosis. Thirdly, the cells 
can cease the progression through cell cycle until they fix the damage. Curiously, the 
phenotypes of the (a) cells arrested in cell cycle and (b) cells that die are very similar, i.e. 
there is no substantial colony growth seen on the plates. We think, that the rfa2-Dx and 
rfa2-ΔNx are similar in phenotype but different in mechanism as discussed above Figure 
5.5.  
Also, the rfa2-ΔNx adaptation poses a question about the hypothesis we made in 
section on rfa1-Aro mutants. The hypothesis was, the rfa1-Aro mutants trigger a 
checkpoint leading to arrest of cells and expression of rfa2-ΔNx leads to adaptation 
caused due to these mutations. In human cells, the rpa1-Aro mutants are shown to trigger 
a G2/M checkpoint arrest (HARING et al. 2008). Now the phosphorylated N terminus is 
proposed to bind the DBD-F of Rpa1 (BINZ et al. 2003). However, in study carried by 
our group have shown that the phosphorylated Rpa2 N terminus also interferes with 
DBD-B (Mueller and Haring unpublished). In this thesis, we have seen that the Rfa1-
Mcm5 interaction is affected by Rfa2 phosphorylation and all the interactions are located 
in DBD-B of the Rfa2.  
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It is possible that the Rfa2 N terminus interaction (or phosphorylated N termius) 
is important to activate and establish checkpoint caused by rfa1-Aro mutants and since 
rfa2-ΔNx lacks the ability to interact with DBD-B the checkpoint is override in these 
conditions.  
 
 
Figure 5.5: A model depicting various pathways that cells can undergo after 
damage. After exposed to DNA damage the cells can have different fate depending upon 
the type of DNA damage, whether it is fixed or whether the cells have suitable 
environment to survive. The model here represents the fate of cells depending upon the 
Rfa2 NT mutants present in the cells.    
 
Summary 
Overall, this study contributed four major things to previously unknown details 
about Rpa2 NT phosphorylation and are listed below 
I. The Rfa2 NT is required for DDR in S. cerevisiae but its phosphorylation 
is dispensable. However Rfa2 NT phosphorylation plays a role in 
checkpoint adaptation.   
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II. The rfa2-ΔNx and rfa2-Dx have similar observed damage sensitivity but 
have different modes of action. Their action might lie in the ability of 
cells to release from a checkpoint properly. The genetic interaction study 
indicated that the phosphorylation state of Rfa2 NT directs the protein 
interaction pathway.  
III. The phosphorylation of Rfa2 NT influences the protein binding activity of 
RFA complex (Mcm5 interaction). 
IV. The S. cerevisiae do not require phosphorylation of Rfa2 NT in DDR, 
however the machinery for phosphorylation is conserved.  This provided 
evidence for the potential of S. cerevisiae to be used as a model system to 
study eukaryotic Rpa2 NT phosphorylation. 
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APPENDIX A. STRAINS 
STRAIN GENOTYPE 
RMY122A MATα leu2-3,112 trp1-1 can1-100 ura3-1 his3-11,15 rad5-535 
rfa1Δ::TRP1 rfa2Δ::TRP1; this strain contains pJM132 
RMY122A-mre11Δ mre11Δ::kanMX derivative of RMY122 
403 (K264-10D) MATa, lys2-2, tyr1-2, his7-1,ura3-1, met13-c, cyhr, trp5-c, 
leu1-c, ade2-1 
163 (RM26-26C) MATα, lys2-1, canr, ura3-1, his1, ade5, CYHs, trp5-2, leu1-12, 
ade2-1 
EGY48 MATα trp1 his3 ura3 leu2::6 LexAop-Leu2 
EGY194 MATa trp1 his3 ura3 leu2::4 LexAop-Leu2 
EGY188 MATa trp1 his3 ura3 leu2::2 LexAop-Leu2 
EGY40 MATα trp1 his3 ura3 leu2::0 LexAop-Leu2 
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APPENDIX B. PRIMERS 
 
Primer 
Number 
Primer 
Name Sequence 
Function Chapter 
5 Rpa1intoRfa
1up 
ATTACGGTAAAGGCGAAAC
CAGCAAGAAGACCAGATTA
TACTTACAAGAGATGGTCGG
CCAACTGAGCGAGGGGG 
Cloning 2 
6 Rpa1intoRfa
1down 
ACATTTCTCATATGTTACAT
AGATTAAATAGTACTTGATT
ATTTGATACATCACATCAAT
GCACTTCTCCTGATG 
Cloning 2 
7 Rpa2intoRfa
2up 
GCAAAATCGATAGCGACTA
TCTAGAACAGGCTAGTTTAA
GCATATACATAATGTGGAAC
AGTGGATTCGAAAGCT 
Cloning 2 
8 Rpa2intoRfa
2down 
AAATACACAAACGAATACT
AAGAAATGCTAAAAAAATA
ATCTATATATTTTTATTCTGC
ATCTGTGGATTTAAAA 
Cloning 2 
9 Rpa3intoRfa
3up 
CACCCTTCACCATTCTTGTA
GAACATCGTCTACCAGTAAC
ACAAGTAAAAATGGTGGAC
ATGATGGACTTGCCCA 
 
Cloning 2 
10 Rpa3intoRfa
3down 
AGACATATAGAGGCAACAG
TACATAAAGGTAAGAATAA
AAGCGATTTTAGTCAATCAT
GTTGCACAATCCCTAAA 
 
Cloning 2 
11 Rpa4intoRfa
2up 
 
GCAAAATCGATAGCGACTA
TCTAGAACAGGCTAGTTTAA
GCATATACATAATGAGTAA
GAGTGGGTTTGGGAGCT 
Cloning 2 
12 Rpa4intoRfa
2down 
AAATACACAAACGAATACT
AAGAAATGCTAAAAAAATA
ATCTATATATTTTCAATCAG
CAGACTTAAAATGCTCC 
 
Cloning 2 
81 ura3-G418 
newFOR 
TGCCCAGTATTCTTAACCCA
ACTGCACAGAACAAAAACC
TCGTACGCTGCAGGTCGACG
G 
 
Cloning 2 
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Primer 
Number 
Primer 
Name Sequence Function Chapter 
82 ura3-G418 
newREV 
TAATAACTGATATAATTAAA
TTGAAGCTCTAATTTGTGAG
ATCGATGAATTCGAGCTCGT 
Cloning 2 
101 shRPA1F GATCCGGAATTATGTCGTAA
GTCATTCAAGAGATGACTTA
CGACATAATTCCTTTTTTAC
GCGTG 
 Gene 
Silencing 
 
2 
102 shRPA1R AATTCACGCGTAAAAAAGG
AATTATGTCGTAAGTCATCT
CTTGAATGACTTACGACATA
ATTC 
Gene 
Silencing 
 
2 
103 shRPA2F GATCCGCCTAGTTTCACAAT
CTGTTTTCAAGAGAAACAGA
TTGTGAAACTAGGTTTTTTA
CGCGTG 
Gene 
Silencing 
 
2 
    104 shRPA2R AATTCACGCGTAAAAAACCT
AGTTTCACAATCTGTTTCTC
TTGAAAACAGATTGTGAAA
CTAGGCG 
Gene 
Silencing 
 
2 
105 shRPA3F GATCCGATTGTAAATGAGCT
ATATTTCAAGAGAATATAGC
TCATTTACAATCTTTTTTACG
CGTG 
Gene 
Silencing 
 
2 
106 shRPA3R AATTCACGCGTAAAAAAGA
TTGTAAATGAGCTATATTCT
CTTGAAATATAGCTCATTTA
CAATCG 
Gene 
Silencing 
 
2 
107 shRPA4F-1 GATCCGCACACATGATGCTG
GATAATTCAAGAGATTATCC
AGCATCATGTGTGTTTTTTA
CGCGTG 
Gene 
Silencing 
 
2 
108 shRPA4R-1 AATTCACGCGTAAAAAACA
CACATGATGCTGGATAATCT
CTTGAATTATCCAGCATCAT
GTGTGCG 
Gene 
Silencing 
 
2 
109 shRPA4F-2 GATCCGAGAGAAAGTCAAG
CAGGTTTCAAGAGAACCTGC
TTGACTTTCTCTCTTTTTTAC
GAGTG 
Gene 
Silencing 
 
2 
110 shRPA4R-2 AATTCACGCGTAAAAAAGA
GAGAAAGTCAAGCAGGTTC
TCTTGAAACCTGCTTGACTT
TCTCTCG 
Gene 
Silencing 
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Primer 
Number 
Primer 
Name Sequence Function Chapter 
111 shRPA4F-3 GATCCGCCGACAGTGGTTTG
GTAGATTCAAGAGATCTACC
AAACCACTGTAGGTTTTTTA
CGCGTG 
Gene 
Silencing 
 
2 
112 shRPA4R-3 AATTCACGCGTAAAAAACC
GACAGTGGTTTGGTAGATCT
CTTGAATCTACCAAACCACT
GTCGGCG 
Gene 
Silencing 
 
2 
113 shRPA4F-5 GATCCGCATCCAGCTGTGAG
TAATTTTCAAGAGAAATTAC
TCACAGCTGGATGTTTTTTA
CGCGTG 
Gene 
Silencing 
 
2 
114 shRPA4R-5 AATTCACGCGTAAAAAACA
TCCAGCTGTGAGTAATTTCT
CTTGAAAATTACTCACAGCT
GGATGCG 
Gene 
Silencing 
 
2 
260 pEG202-
Rpa1-FOR 
TATTCGCAACGGCGACTGGC
TGGAATTCCCGGGGATCCTT
ATGGTCGGCCAGCTGAGCG
A 
Cloning 2/4 
261 pEG202-
Rpa1-REV 
AAATTCGCCCGGAATTAGCT
TGGCTGCAGGTCGACTCGAG
TCACATCAATGCACTTCTCC 
Cloning 2/4 
262 pEG202-
Rpa2-FOR 
TATTCGCAACGGCGACTGGC
TGGAATTCCCGGGGATCCTT
ATGTGGAACAGTGGATTCA 
Cloning 2/4 
263 pEG202-
Rpa2-REV 
AAATTCGCCCGGAATTAGCT
TGGCTGCAGGTCGACTCGAG
TTATTCTGCATCTGTGGATT 
Cloning 2/4 
264 pEG202-
Rpa3-FOR 
TATTCGCAACGGCGACTGGC
TGGAATTCCCGGGGATCCTT
ATGGTGGACATGATGGACTT 
Cloning 2 
265 pEG202-
Rpa3-REV 
AAATTCGCCCGGAATTAGCT
TGGCTGCAGGTCGACTCGAG
TCAATCATGTTGCACAATCC 
Cloning 2 
266 pEG202-
Rpa4-FOR 
TATTCGCAACGGCGACTGGC
TGGAATTCCCGGGGATCCTT
ATGAGTAAGAGTGGGTTTG
G 
Cloning 2/4 
267 pEG202-
Rpa4-REV 
AAATTCGCCCGGAATTAGCT
TGGCTGCAGGTCGACTCGAG
TCAATCAGCAGACTTAAAAT 
Cloning 2/4 
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Primer 
Number 
Primer 
Name Sequence Function Chapter 
268 pEG202-
RFA1-FOR 
TATTCGCAACGGCGACTGGC
TGGAATTCCCGGGGATCCTT
ATGAGCAGTGTTCAACTTT 
Cloning 2/4 
269 pEG202-
RFA1-REV 
AAATTCGCCCGGAATTAGCT
TGGCTGCAGGTCGACTCGAG
TTAAGCTAACAAAGCCTTGG 
Cloning 2/4 
369 RPA1mRNA
FOR-RT 
CTAAGGCTTATGGTGCTTCA
AAGAC 
q-PCR 2 
370 RPA1mRNA
FOR-RT 
CTAAGGCTTATGGTGCTTCA
AAGAC 
q-PCR 2 
371 RPA2mRNA
FOR-RT 
GCACCTTCTCAAGCCGAAAA q-PCR 2 
372 RPA2mRNA
REV-RT 
CAGCTGAGATATAGTACAG
GGCACAA 
q-PCR 2 
373 RPA3mRNA
FOR-RT 
GGAACCCCTTGATGAAGAA
ATCT 
q-PCR 2 
374 RPA3mRNA
REV-RT 
TGGCCTTGGCGGTTACTC q-PCR 2 
375 RPA4mRNA
FOR-RT 
GCAGAGAAGGCTTCAAATC
ACA 
q-PCR 2 
376 RPA4mRNA
REV-RT 
CGGGCCTCGATTGGTTT q-PCR 2 
658 Rfa1-cDNA 
FWD Set1 
CTTCAAGGGCTGGGAAGAA
A 
q-PCR 2 
659 Rfa1-cDNA 
REV Set1 
TCCATAGGCCAACAGAGAT
AG 
q-PCR 2 
660 Rfa2-
cDNA FWD 
Set1 
GTGAGGGCAAAGACGCTAA
T 
q-PCR 2 
661 Rfa2-
cDNA REV 
Set1 
GTCAAGGTCGTACAGCAGTT
T 
q-PCR 2 
662 Rfa3-
cDNA FWD 
Set2 
CGACTCGTGGTATGAGTTTG
T 
q-PCR 2 
663 Rfa3-
cDNA REV 
Set2 
AAAGCAACCACACCGTTTA
AG 
q-PCR 2 
256 rfa2-S3D-
remake 
TTAAGCATATACAAAATGGC
AGATTATCAACCATATAAC 
Mutagenesis 3 
152 rfa2-S11D 
FOR 
CATATAACGAATATGATTCA 
GTAACGGGCG 
 
Mutagenesis 3 
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Primer 
Number 
Primer 
Name Sequence Function Chapter 
154 rfa2-S12D-
FOR 
CCATATAACGAATATAGTGA
TGTAACGGGCGGTG 
Mutagenesis 3 
156 rfa2-T14D-
FOR 
GAATATTCATCAGTAGATGG
CGGTGGCTTTGAG 
Mutagenesis 3 
158 rfa2-S21D-
FOR 
GGCTTTGAGAACGACGAGA
GTCGCCCAGGTAGTG 
Mutagenesis 3 
257 rfa2-S23D-
remake 
GTGGCTTTGAGAACTCAGAG
GATCGCCCAGGTAGTG 
Mutagenesis 3 
162 rfa2-S27D-
FOR 
GTCCCGCCCAGGTCGTGGGG
AGTCGGAAAC 
 
Mutagenesis 3 
164 rfa2-S30D-
FOR 
GTCCCCGCCCAGGATCCGGG
GAGGATGAAACTAACACTA
G 
Mutagenesis 3 
258 rfa2-T32D-
remake 
GGGGAGTCGGAAGATAACA
CTCGAGTTAACACCTTG 
Mutagenesis 3 
168 rfa2-T34D-
FOR 
GTCGGAAACTAACGATAGA
GTAAACACCTTGACAC 
Mutagenesis 3 
170 rfa2-T38D-
FOR 
GAAACTAACACTAGAGTCG
ACACCTTGACACCTGTG 
Mutagenesis 3 
245 rfa2-S3A TTAAGCATATACAAAATGGC
AGCTTATCAACCATATAAC 
Mutagenesis 3 
246 rfa2-S11A CATATAACGAATATGCTTCA
GTAACGGGCG 
Mutagenesis 3 
247 rfa2-S12A CCATATAACGAATATTCAGC
TGTAACGGGCGGTG 
Mutagenesis 3 
248 rfa2-T14A GAATATTCATCAGTAGCCGG
CGGTGGCTTTGAG 
Mutagenesis 3 
249 rfa2-S21A GGCTTTGAGAACGCTGAGA
GTCGACCAGGTAGTGGGGA
G 
Mutagenesis 3 
250 rfa2-S23A GTGGCTTTCAGAACTCAGAG
GCCCGCCCAGGTAGTG 
Mutagenesis 3 
251 rfa2-S27A GTCCCGCCCAGGTGCCGGCG
AGTCGGAAACTAAC 
Mutagenesis 3 
472 rfa2-S30A GTCCCGCCCAGGATCCGGG
GAGGCTGAAACTAACACTA
G 
Mutagenesis 3 
253 rfa2-T32A GGGGAGTCGGAAGCTAACA
CTCGAGTTAACACCTTG 
Mutagenesis 3 
254 rfa2-T34A GTCGGAAACTAACGCTAGA
GTAAACACCTTGACAC 
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Primer 
Number 
Primer 
Name Sequence Function Chapter 
255 rfa2-T38A GAAACTAACACTCGAGTTA
ACGCGTTGACACCTGTGACG 
Mutagenesis 3 
180 rfa1-F238A-
BglII-FOR 
CCGAGCCACGGCGGCTAAT
GATTTTGCTAC 
Mutagenesis 3 
182 rfa1-F269A-
BlpI-FOR 
CTCCAACCAGCTAAACCCCA
AGCTACTAATCTAACAC 
Mutagenesis 3 
184 rfa1-W360A-
EcoRV-FOR 
CTCTGGGTTTTCGATATCTG
TTGGCCTAGCGAATCAGCAA
GCC 
Mutagenesis 3 
186 rfa1-F385A-
NaeI-FOR 
GTTCGTGTGACGGATGCCGG
CGGCAAATCTTTGTC 
Mutagenesis 3 
327 rfa2-
Asp(3,11,12,
14)   
or rfa2-Dm1 
ATATACACCATGGCAGATTA
TCAACCATATAACGAATATG
ATGATGTAGATGGCGGTGG
C 
Mutagenesis 3 
328 rfa2-
Asp(21,23,27
,30,32,34) 
or rfa2-
Dm2+3 
TTTGAGAACGACGAGGATC
GCCCAGGTGATGGGGAGGA
TGAAGATAACGATAGAGTT
AAC 
Mutagenesis 3 
329 rfa2-
Asp(21,23,27
) or rfa2-
Dm2 
TTTGAGAACGACGAGGATC
GCCCAGGTGATGGGGAGTC
GGAAACTAAC 
Mutagenesis 3 
330 rfa2-
Asp(30,32,34
) or rfa2-
Dm3 
CGCCCAGGTAGTGGGGAGG
ATGAAGATAACGATAGAGT
TAACACCTTGACA 
Mutagenesis 3 
331 rfa2-
Ala(3,11,12,
14) or rfa2-
Am1 
ATATACACCATGGCAGCTTA
TCAACCATATAACGAATATG
CTGCTGTAGCCGGCGGTGGC 
Mutagenesis 3 
332 rfa2-
Ala(21,23,27
,30,32,34) or 
rfa2-Am2+3 
TTTGAGAACGCTGAGGCCCG
CCCAGGTGCCGGGGAGGCT
GAAGCTAACGCTAGAGTTA
AC 
Mutagenesis 3 
333 rfa2-
Ala(21,23,27
) or rfa2-
Am2 
TTTGAGAACGCTGAGGCCCG
CCCAGGTGCCGGGGAGTCG
GAAACTAAC 
Mutagenesis 3 
334 rfa2-
Ala(30,32,34
) or rfa2Am3 
CGCCCAGGTAGTGGGGAGG
CTGAAGCTAACGCTAGAGTT
AACACCTTGACA 
Mutagenesis 3 
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Primer 
Number 
Primer 
Name 
Sequence Function Chapter 
338 RFA2-UP-
NEW 
TAGCAATTCCTTTGGCCTCG
ATGAGCTTCC 
Sequencing 3 
339 RFA2-
DOWN-
NEW 
GATAAAACCCTGGTCAGTCA
AGGTCGTAC 
Sequencing 3 
340 pJG4-5-UP-
Sequence 
GATCCAGCCTGACTGGCTGA
AATCGAATGG 
 
Sequencing 4 
341 pJG4-5-UP-
Recover 
TGGCGGATCAGGCGATTAA
CGTGGTGCCGG 
 
Sequencing 4 
420 pEG202-
LexA-SEQ-
FOR 
GGGCAATAAAGTCGAACTG
TTGCCAG 
Sequencing 4 
 
421 pEG202-
LexA-SEQ-
REV 
CCTGACCTACAGGAAAGAG
TTACTCAAGAACAAGAATTT
TCG 
Sequencing 4 
425 Rpa1-MID-
FOR-SEQ 
CAGCCTGTCACACACTTCTG
GGGG 
Sequencing 4 
509 pJG4-5-
mcm5-
Delta308-
359 
TATTCCATCTATAATTCTAA
AAATGGTGCCCGGAATTCG
GCCGACTCGAGAAGCTTTGG
A 
Mutagenic-
deletion 
4 
510 mcm5-
Delta258-
307 
TCAAAGTTTATTGATCAACA
GTTTTTAAAAGGATCCGGAA
GGAGCGGGGGTGGAAAT 
Mutagenic-
deletion 
4 
511 mcm5-
Delta208-
257 
AATTCTATCACAGGCAATAC
CGTCAGTTTATTACAGGAAA
TCCCAGAACTGGTTCCAGTA 
Mutagenic-
deletion 
4 
512 mcm5-
Delta158-
207 
TTGAGAGATTTGGATTCTGA
ACACGTCTCCCCACGTTCTT
GCTTATCTACGATTGAGAGT 
Mutagenic-
deletion 
4 
513 pJG4-
5mcm5-
Delta108-
157 
GTGCCAGATTATGCCTCTCC
CGAATTCCCTAAGATTGTCC
GTTTATCAGGTATTATAATA 
Mutagenic-
deletion 
4 
520 NEW-pJG4-
5-MCM5-
FOR 
CTACCTTATGATGTGCCAGA
TTATGCCTCTCCCGAATTCA
TGTCATTTGATAGACCGGA 
Cloning 4 
521 pJG4-5-
mcm5(1-
107)-REV 
TTGACCAAACCTCTGGCGAA
GAAGTCCAAAGCTTCTGCAG
TCAAGCTCTGCTTAGAATAC 
 
Cloning 4 
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Primer 
Number 
Primer 
Name Sequence Function Chapter 
522 pJG4-5-
mcm5(360-
775)-FOR 
CTACCCTTATGATGTGCCAG
ATTATGCCTCTCCCGAATTC
CTAAGTAGAAACCCGAAGC
T 
Cloning 4 
523 NEW-pJG4-
5-MCM5-
REV 
TTGACCAAACCTCTGGCGAA
GAAGTCCAAAGCTTCTCGAG
TCATACACCACTTCTGTAAA 
Cloning 4 
532 pJG4-5-
MCM5-FOR 
(108-359) 
GCAACGGCGACTGGCTGGA
ATTCCCGGGGATCCGTCGAC
ATGTCATTTGATAGACCGGA
A 
Cloning 4 
533 pJG4-5-
MCM5-REV 
(108-359) 
AATTAGCTTGGCTGCAGGTC
GACTCGAGCGGCCGCCATGT
CATACACCACTTCTGTAAAT 
 
Cloning 4 
596 MCM2FL-
pJG4-5-FOR 
TCACCTTATGATGTGCCAGA
TTATGCCTCTCCCGAATTCA
TGTCTGATAATAGAAGACGT 
Cloning 4 
597 MCM2FL-
pJG4-5-REV 
TTGACCAAACCTCTGGCGAA
GAAGTCCAAAGCTTCTCGAG
TTAGTGACCCAAGGTATAAA 
Cloning 4 
598 MCM3FL-
pJG4-5-FOR 
TCACCTTATGATGTGCCAGA
TTATGCCTCTCCCGAATTCA
TGGAAGGCTCAACGGGATTT 
Cloning 4 
599 MCM3FL-
pJG4-5-REV 
TTGACCAAACCTCTGGCGAA
GAAGTCCAAAGCTTCTCGAG
TCAGACTCTCCAAACTTTAT 
Cloning 4 
600 MCM4-
pJG4-5-FOR 
TCACCTTATGATGTGCCAGA
TTATGCCTCTCCCGAATTCA
TGTCTCAACAGTCTAGCTCT 
Cloning 4 
601 MCM4-
pJG4-5-REV 
TTGACCAAACCTCTGGCGAG
AAGTCCAAAGCTTCTCGAGT
CAGACACGGTTATTCAGGC 
Cloning 4 
602 MCM6-
pJG4-5-FOR 
TCACCTTATGATGTGCCAGA
TTATGCCTCTCCCGAATTCA
TGTCATCCCCTTTTCCAGCT 
Cloning 4 
603 MCM6-
pJG4-5-REV 
TTGACCAAACCTCTGGCGAA
GAAGTCCAAAGCTTCTCGAG
TTAGCTGGAATCCTGTGGTT 
Cloning 4 
604 MCM7-
pJG4-5-FOR 
TCACCTTATGATGTGCCAGA
TTATGCCTCTCCCGAATTCA
TGAGTGCGGCACTTCCATCA 
 
Cloning 4 
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Number 
Primer 
Name Sequence 
Function Chapter 
605 MCM7-
pJG4-5-REV 
TTGACCAAACCTCTGGCGAA
GAAGTCCAAAGCTTCTCGAG
TCAAGCGTCTTGTAGATCGA 
Cloning 4 
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APPENDIX C. PLASMIDS3 
Plasmid 
Name 
Mutation Backbone Perm 
Number 
pPLG1 pRS315-rfa2-S3D pRS315-Rfa2 B-696 
pPLG2 pRS315-rfa2-S11D pRS315-Rfa2 B-697 
pPLG3 pRS315-rfa2-S12D pRS315-Rfa2 B-698 
pPLG4 pRS315-rfa2-T14D pRS315-Rfa2 B-699 
pPLG5 pRS315-rfa2-S21D pRS315-Rfa2 B-700 
pPLG6 pRS315-rfa2-S23D pRS315-Rfa2 B-701 
pPLG7 pRS315-rfa2-S27D pRS315-Rfa2 B-702 
pPLG8 pRS315-rfa2-S30D pRS315-Rfa2 B-703 
pPLG9 pRS315-rfa2-T32D pRS315-Rfa2 B-704 
pPLG10 pRS315-rfa2-T34D pRS315-Rfa2 B-705 
pPLG11 pRS315-rfa2-T38D pRS315-Rfa2 B-706 
pPLG12 pRS315-rfa2-S3A pRS315-Rfa2 B-707 
pPLG13 pRS315-rfa2-S11A pRS315-Rfa2 B-708 
pPLG14 pRS315-rfa2-S12A pRS315-Rfa2 B-709 
pPLG15 pRS315-rfa2-T14A pRS315-Rfa2 B-710 
pPLG16 pRS315-rfa2-S21A pRS315-Rfa2 B-711 
pPLG17 pRS315-rfa2-S23A pRS315-Rfa2 B-712 
pPLG18 pRS315-rfa2-S27A pRS315-Rfa2 B-713 
pPLG19 pRS315-rfa2-S30A pRS315-Rfa2 B-714 
pPLG20 pRS315-rfa2-T32A pRS315-Rfa2 B-715 
pPLG21 pRS315-rfa2-T34A pRS315-Rfa2 B-716 
pPLG22 pRS315-rfa2-T38A pRS315-Rfa2 B-717 
pPLG23 pRS315-rfa2-Am1 pRS315-Rfa2 B-718 
pPLG24 pRS315-rfa2-Am2 pRS315-Rfa2 B-719 
pPLG25 pRS315-rfa2-Am3 pRS315-Rfa2 B-720 
pPLG26 pRS315-rfa2-Am4 pRS315-Rfa2 B-721 
pPLG27 pRS315-rfa2-Am1+3 pRS315-Rfa2 B-722 
pPLG28 pRS315-rfa2-Am1+4 pRS315-Rfa2 B-723 
pPLG29 pRS315-rfa2-Dm1 pRS315-Rfa2 B-724 
pPLG30 pRS315-rfa2-Dm2 pRS315-Rfa2 B-725 
pPLG31 pRS315-rfa2-Dm3 pRS315-Rfa2 B-726 
pPLG32 pRS315-rfa2-Dm4 pRS315-Rfa2 B-727 
pPLG33 pRS315-rfa2-Dm1+3 pRS315-Rfa2 B-728 
pPLG34 pRS315-rfa2-Dm1+4 pRS315-Rfa2 B-729 
pALS8 pRS315-rfa2-DeltaN1 pRS315-Rfa2 B-730 
pALS9 pRS315-rfa2-DeltaN2 pRS315-Rfa2 B-731 
pALS10 pRS315-rfa2-DeltaN3 pRS315-Rfa2 B-732 
pENM10 pJG4-5-B42-HA-RFA1 pJG4-5 B-848 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  3	  Note: NA in perm number column indicates the plasmids not stored in perms.	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Plasmid 
Name 
Mutation Backbone Perm 
Number 
pENM11 pJG4-5-B42-HA-RFA2 pJG4-5 B-849 
pENM12 pJG4-5-B42-HA-RFA3 pJG4-5 B-850 
pENM13 pJG4-5-B42-HA-Rpa1 pJG4-5 B-851 
pENM14 pJG4-5-B42-HA-Rpa2 pJG4-5 B-852 
pENM15 pJG4-5-B42-HA-Rpa3 pJG4-5 B-853 
pENM16 pJG4-5-B42-HA-Rpa4 pJG4-5 B-854 
pGP1 pEG202-lexA-rfa1-FLAB pEG202 B-856 
pSJH101 pEG202K-lexA-RFA1 pEG202 B-863 
pPLG63 pJM132-Rpa2-Rpa3-
Rpa1-kanMX (22G2) 
pJM132 B-894 
pPLG64 pJM132-Rpa4-Rpa3-
Rpa1-kanMX-1 (3G1) 
pJM132 B-895 
pPLG65 pJM132-Rpa4-Rpa3-
Rpa1-kanMX-2 (3G2) 
pJM132 B-896 
pPLG35 pRS313-Rfa1-A1 pRS313 B-912 
pPLG36 pRS313-Rfa1-A2 pRS313 B-913 
pPLG37 pRS313-Rfa1-B1 pRS313 B-914 
pPLG38 pRS313-Rfa1-B2 pRS313 B-915 
pPLG39 pRS313-Rfa1-A12 pRS313 B-916 
pPLG40 pRS313-Rfa1-B12 pRS313 B-917 
pPLG41 pRS313-Rfa1-A1B1 pRS313 B-918 
pPLG42 pRS313-Rfa1-A1B2 pRS313 B-919 
pPLG43 pRS313-Rfa1-A2B1 pRS313 B-920 
pPLG44 pRS313-Rfa1-A2B2 pRS313 B-921 
pPLG45 pRS313-Rfa1-A12B1 pRS313 B-922 
pPLG46 pRS313-Rfa1-A12B2 pRS313 B-923 
pPLG47 pRS313-Rfa1-A1B12 pRS313 B-924 
pPLG48 pRS313-Rfa1-A2B12 pRS313 B-925 
pPLG49 pRS313-Rfa1-A12B12 pRS313 B-926 
pPLG52 pJG4-5-MCM5 FL pJG4-5 B-929 
pPLG53 pJG4-5-MCM5 1-108 pJG4-5 B-930 
pPLG54 pJG4-5-MCM5 108-359 pJG4-5 B-931 
pPLG55 pJG4-5-MCM5 359-775 pJG4-5 B-932 
pPLG56 pJM132-Rpa4 pJM132 B-933 
pPLG57 pJM132-Rpa2 pJM132 B-934 
pPLG58 pJM132-Rpa4+3 pJM132 B-935 
pPLG59 pJM132-Rpa2+3 pJM132 B-936 
pPLG60 pEG202K-Rpa1-2 pEG202 B-937 
pPLG61 pEG202K pEG202 B-938 
pPLG62 pSH18-34K pSH18-34 B-939 
pPLG63 pJG4-5-MCM2 FL pJG4-5 NA 
pPLG64 pJG4-5-MCM3 FL pJG4-5 NA 
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Plasmid 
Name 
Mutation Backbone Perm 
Number 
pPLG65 pJG4-5-MCM4 FL pJG4-5 NA 
pPLG66 pJG4-5-MCM6 FL pJG4-5 NA 
pPLG67 pJG4-5-MCM7 FL pJG4-5 NA 
pPLG68 pJG4-5-MCM5 Δ108-157 pJG4-5 NA 
pPLG69 pJG4-5-MCM5 Δ158-207 pJG4-5 NA 
pPLG70 pJG4-5-MCM5 Δ208-257 pJG4-5 NA 
pPLG71 pJG4-5-MCM5 Δ258-307 pJG4-5 NA 
pPLG72 pJG4-5-MCM5 Δ308-359 pJG4-5 NA 
pPLG73 pLVX-shRNA2-shRPA1 pLVX-shRNA2 (ZsGreen) NA 
pPLG74 pLVX-shRNA2-shRPA2 pLVX-shRNA2 (ZsGreen) NA 
pPLG75 pLVX-shRNA2-shRPA3 pLVX-shRNA2 (ZsGreen) NA 
pPLG76 pLVX-shRNA2-shRPA4-
1 
pLVX-shRNA2 (ZsGreen) NA 
pPLG77 pLVX-shRNA2-shRPA4-
2 
pLVX-shRNA2 (ZsGreen) NA 
pPLG78 pLVX-shRNA2-shRPA4-
3 
pLVX-shRNA2 (ZsGreen) NA 
pPLG79 pLVX-shRNA2-shRPA4-
5 
pLVX-shRNA2 (ZsGreen) NA 
 
 
 
 
 
 
 
 
 
 
